Back to Browse Journals » Neuropsychiatric Disease and Treatment

Neuropsychiatric Disease and Treatment


Journal Articles:

- 2,109 records -

Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study

Savitz AJ, Xu H, Gopal S, Nuamah I, Ravenstijn P, Hough D, Mathews M, Feng Y, Yu L, Takahashi M, Liu D, Wang G, Yoon J, Chen JJ

Neuropsychiatric Disease and Treatment 2017, 13:2193-2207

Published Date: 17 August 2017

Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study

Okuda T, Asano K, Numata N, Hirano Y, Yamamoto T, Tanaka M, Matsuzawa D, Shimizu E, Iyo M, Nakazato M

Neuropsychiatric Disease and Treatment 2017, 13:2185-2191

Published Date: 16 August 2017

Bipolar II disorder as the initial presentation of CADASIL: an underdiagnosed manifestation

Wang J, Li J, Kong F, Lv H, Guo Z

Neuropsychiatric Disease and Treatment 2017, 13:2175-2179

Published Date: 14 August 2017

Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?

Porfirio MC, Gomes de Almeida JP, Stornelli M, Giovinazzo S, Purper-Ouakil D, Masi G

Neuropsychiatric Disease and Treatment 2017, 13:2167-2174

Published Date: 10 August 2017

Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study

Saragoussi D, Touya M, Haro JM, Jönsson B, Knapp M, Botrel B, Florea I, Loft H, Rive B

Neuropsychiatric Disease and Treatment 2017, 13:2151-2165

Published Date: 9 August 2017

Early predictors of brain damage in full-term newborns with hypoxic ischemic encephalopathy

Alkholy UM, Abdalmonem N, Zaki A, Ali YF, Mohamed SA, Abdelsalam NI, Abu Hashim MI, Abou Sekkien M, Elsherbiny YM

Neuropsychiatric Disease and Treatment 2017, 13:2133-2139

Published Date: 8 August 2017

An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis

Kuga A, Tsuji T, Hayashi S, Matsubara M, Fujikoshi S, Tokuoka H, Yoshikawa A, Escobar R, Tanaka K, Azekawa T

Neuropsychiatric Disease and Treatment 2017, 13:2105-2114

Published Date: 4 August 2017

Which psychological, psychophysiological, and anthropometric factors are connected with life events, depression, and quality of life in patients with cardiovascular disease

Slepecky M, Kotianova A, Prasko J, Majercak I, Gyorgyova E, Kotian M, Zatkova M, Popelkova M, Ociskova M, Tonhajzerova I

Neuropsychiatric Disease and Treatment 2017, 13:2093-2104

Published Date: 4 August 2017

Encephalitis with reversible splenial and deep cerebral white matter lesions associated with Epstein–Barr virus infection in adults

Guo YJ, Wang SH, Jiang B, Li JL, Liu L, Wang J, Zhao WQ, Jia J

Neuropsychiatric Disease and Treatment 2017, 13:2085-2092

Published Date: 3 August 2017

Suicidal and homicidal tendencies after Lyme disease: an ignored problem

Munir A, Aadil M, Rehan Khan A

Neuropsychiatric Disease and Treatment 2017, 13:2069-2071

Published Date: 2 August 2017

La belle indifférence revisited: a case report on progressive supranuclear palsy misdiagnosed as conversion disorder

van Meerkerk-Aanen PJ, de Vroege L, Khasho D, Foruz A, van Asseldonk JT, van der Feltz-Cornelis CM

Neuropsychiatric Disease and Treatment 2017, 13:2057-2067

Published Date: 2 August 2017

Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study

Zhao JP, Li LH, Shi JG, Li Y, Xu XF, Li KQ, Zhang LL, Cai SL, Feng Y, Zhuo JM, Liu WH, Lu HF

Neuropsychiatric Disease and Treatment 2017, 13:2045-2056

Published Date: 2 August 2017

MicroRNA expression profiles in chronic epilepsy rats and neuroprotection from seizures by targeting miR-344a

Liu XX, Liao YH, Wang XX, Zou DH, Luo C, Jian CD, Wu Y

Neuropsychiatric Disease and Treatment 2017, 13:2037-2044

Published Date: 31 July 2017

Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study

Durgam S, Landbloom RP, Mackle M, Wu X, Mathews M, Nasrallah HA

Neuropsychiatric Disease and Treatment 2017, 13:2021-2035

Published Date: 31 July 2017

Abnormal intrinsic functional hubs in alcohol dependence: evidence from a voxelwise degree centrality analysis

Luo X, Guo LH, Dai XJ, Wang Q, Zhu W, Miao X, Gong H

Neuropsychiatric Disease and Treatment 2017, 13:2011-2020

Published Date: 28 July 2017

Electrophysiological findings of Turkish patients with restless legs syndrome

Özsimsek A, Koyuncuoglu HR

Neuropsychiatric Disease and Treatment 2017, 13:2005-2010

Published Date: 27 July 2017

Involvement of up-regulation of miR-210 in a rat epilepsy model [Corrigendum]

Chen L, Zheng H, Zhang S

Neuropsychiatric Disease and Treatment 2017, 13:2003-2004

Published Date: 26 July 2017

Sleep problems in university students – an intervention

Schlarb AA, Friedrich A, Claßen M

Neuropsychiatric Disease and Treatment 2017, 13:1989-2001

Published Date: 26 July 2017

The economic burden of schizophrenia in Malaysia

Teoh SL, Chong HY, Abdul Aziz S, Chemi N, Othman AR, Md Zaki N, Vanichkulpitak P, Chaiyakunapruk N

Neuropsychiatric Disease and Treatment 2017, 13:1979-1987

Published Date: 28 July 2017

Risperidone-induced reversible neutropenia

Kattalai Kailasam V, Chima V, Nnamdi U, Sharma K, Shah K

Neuropsychiatric Disease and Treatment 2017, 13:1975-1977

Published Date: 25 July 2017

Spontaneous alterations of regional brain activity in patients with adult generalized anxiety disorder

Xia L, Li S, Wang T, Guo Y, Meng L, Feng Y, Cui Y, Wang F, Ma J, Jiang G

Neuropsychiatric Disease and Treatment 2017, 13:1957-1965

Published Date: 20 July 2017

SoCIAL – training cognition in schizophrenia: a pilot study

Palumbo D, Mucci A, Piegari G, D'Alise V, Mazza A, Galderisi S

Neuropsychiatric Disease and Treatment 2017, 13:1947-1956

Published Date: 20 July 2017

The regional neuronal activity in left posterior middle temporal gyrus is correlated with the severity of chronic aphasia

Li J, Du D, Gao W, Sun X, Xie H, Zhang G, Li J, Li H, Li K

Neuropsychiatric Disease and Treatment 2017, 13:1937-1945

Published Date: 20 July 2017

Impact of help-seeking behavior and partner support on postpartum depression among Saudi women

Almutairi AF, Salam M, Alanazi S, Alweldawi M, Alsomali N, Alotaibi N

Neuropsychiatric Disease and Treatment 2017, 13:1929-1936

Published Date: 20 July 2017

Convulsive syncope related to a small dose of quetiapine in an adolescent with bipolar disorder

Lai J, Lu Q, Huang T, Hu S, Xu Y

Neuropsychiatric Disease and Treatment 2017, 13:1905-1908

Published Date: 19 July 2017

Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study

Hamdy SM, Abdel-Naseer M, Shalaby NM, Elmazny AN, Nemr AA, Hassan A, Hegazy MI, Mourad HS, Kishk NA, Nada MA, Abdelalim A, Fouad AM, Shehata HS

Neuropsychiatric Disease and Treatment 2017, 13:1895-1903

Published Date: 18 July 2017

Cost-utility of collaborative care for the treatment of comorbid major depressive disorder in outpatients with chronic physical conditions. A randomized controlled trial in the general hospital setting (CC-DIM)

Goorden M, van der Feltz-Cornelis CM, van Steenbergen-Weijenburg KM, Horn EK, Beekman ATF, Hakkaart-van Roijen L

Neuropsychiatric Disease and Treatment 2017, 13:1881-1893

Published Date: 18 July 2017

Prevalence, symptomatic features, and factors associated with sleep disturbance/insomnia in Japanese patients with type-2 diabetes

Narisawa H, Komada Y, Miwa T, Shikuma J, Sakurai M, Odawara M, Inoue Y

Neuropsychiatric Disease and Treatment 2017, 13:1873-1880

Published Date: 18 July 2017

Excoriation (skin-picking) disorder: a systematic review of treatment options

Lochner C, Roos A, Stein DJ

Neuropsychiatric Disease and Treatment 2017, 13:1867-1872

Published Date: 14 July 2017

Depression in blepharospasm: a question of facial feedback?

Bedarf JR, Kebir S, Michelis JP, Wabbels B, Paus S

Neuropsychiatric Disease and Treatment 2017, 13:1861-1865

Published Date: 14 July 2017

Genetic and epigenetic mechanisms of epilepsy: a review

Chen T, Giri M, Xia ZY, Subedi YN, Li Y

Neuropsychiatric Disease and Treatment 2017, 13:1841-1859

Published Date: 13 July 2017

Anxiety sensitivity as a predictor of broad dimensions of psychopathology after cognitive behavioral therapy for panic disorder

Ino K, Ogawa S, Kondo M, Imai R, Ii T, Furukawa TA, Akechi T

Neuropsychiatric Disease and Treatment 2017, 13:1835-1840

Published Date: 13 July 2017

Real-time functional magnetic resonance imaging in obsessive-compulsive disorder

Gonçalves ÓF, Batistuzzo MC, Sato JR

Neuropsychiatric Disease and Treatment 2017, 13:1825-1834

Published Date: 12 July 2017

The most important psychological and psychosocial needs of Polish multiple sclerosis patients and their significant others

Potemkowski A, Brola W, Ratajczak A, Ratajczak M, Kowalewski M, Lewita M, Kapica-Topczewska K, Tarasiuk J, Stępień A, Gocyla-Dudar K, Zaborski J, Bartosik-Psujek H

Neuropsychiatric Disease and Treatment 2017, 13:1817-1824

Published Date: 12 July 2017

Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics

McConnell SA, Desai DN, Faldu SP, Hard ML, Wehr AY, Weiden PJ, von Moltke L

Neuropsychiatric Disease and Treatment 2017, 13:1815-1816

Published Date: 12 July 2017

Sleep disturbances among patients with epilepsy

Staniszewska A, Mąka A, Religioni U, Olejniczak D

Neuropsychiatric Disease and Treatment 2017, 13:1797-1803

Published Date: 10 July 2017

Necrostatin-1 attenuates early brain injury after subarachnoid hemorrhage in rats by inhibiting necroptosis

Chen F, Su X, Lin Z, Lin Y, Yu L, Cai J, Kang D, Hu L

Neuropsychiatric Disease and Treatment 2017, 13:1771-1782

Published Date: 7 July 2017

Attention–memory training yields behavioral and academic improvements in children diagnosed with attention-deficit hyperactivity disorder comorbid with a learning disorder

Farias AC, Cordeiro ML, Felden EPG, Bara TS, Benko CR, Coutinho D, Martins LF, Ferreira RTC, McCracken JT

Neuropsychiatric Disease and Treatment 2017, 13:1761-1769

Published Date: 6 July 2017

Brain regions associated with anosognosia for memory disturbance in Alzheimer’s disease: a magnetic resonance imaging study

Fujimoto H, Matsuoka T, Kato Y, Shibata K, Nakamura K, Yamada K, Narumoto J

Neuropsychiatric Disease and Treatment 2017, 13:1753-1759

Published Date: 5 July 2017

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity

Huss M, Duhan P, Gandhi P, Chen CW, Spannhuth CW, Kumar V

Neuropsychiatric Disease and Treatment 2017, 13:1741-1751

Published Date: 4 July 2017

Neuroprotective effects of curdione against focal cerebral ischemia reperfusion injury in rats

Li XJ, Liang L, Shi HX, Sun XP, Wang J, Zhang LS

Neuropsychiatric Disease and Treatment 2017, 13:1733-1740

Published Date: 30 June 2017

Reduced prefrontal activation during verbal fluency task in chronic insomnia disorder: a multichannel near-infrared spectroscopy study

Sun JJ, Liu XM, Shen CY, Zhang XQ, Sun GX, Feng K, Xu B, Ren XJ, Ma XY, Liu PZ

Neuropsychiatric Disease and Treatment 2017, 13:1723-1731

Published Date: 30 June 2017

The use of natalizumab for multiple sclerosis

Brandstadter R, Katz Sand I

Neuropsychiatric Disease and Treatment 2017, 13:1691-1702

Published Date: 28 June 2017

Adapting the short form of the Coping Inventory for Stressful Situations into Chinese

Li C, Liu Q, Hu T, Jin X

Neuropsychiatric Disease and Treatment 2017, 13:1669-1675

Published Date: 27 June 2017

The role of microglia in multiple sclerosis

Luo C, Jian C, Liao Y, Huang Q, Wu Y, Liu X, Zou D, Wu Y

Neuropsychiatric Disease and Treatment 2017, 13:1661-1667

Published Date: 26 June 2017

Brain metabolite values in children with breath-holding spells

Calik M, Sen Dokumaci D, Sarikaya S, Demir M, Isik I, Kazanasmaz H, Kaya C, Kandemir H

Neuropsychiatric Disease and Treatment 2017, 13:1655-1660

Published Date: 26 June 2017

Role of SIRT1/PGC-1α in mitochondrial oxidative stress in autistic spectrum disorder

Bu XS, Wu D, Lu XM, Yang L, Xu XY, Wang J, Tang JL

Neuropsychiatric Disease and Treatment 2017, 13:1633-1645

Published Date: 23 June 2017

Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review

Correia-Melo FS, Argolo FC, Araújo-de-Freitas L, Leal GC, Kapczinski F, Lacerda AL, Quarantini LC

Neuropsychiatric Disease and Treatment 2017, 13:1627-1632

Published Date: 21 June 2017

Effects of subthalamic nucleus deep brain stimulation on emotional working memory capacity and mood in patients with Parkinson's disease

Merkl A, Röck E, Schmitz-Hübsch T, Schneider G, Kühn AA

Neuropsychiatric Disease and Treatment 2017, 13:1603-1611

Published Date: 19 June 2017

Stress reactivity and emotion in premenstrual syndrome

Liu Q, Wang Y, van Heck CH, Qiao W

Neuropsychiatric Disease and Treatment 2017, 13:1597-1602

Published Date: 16 June 2017

Clinical features of limbic encephalitis with LGI1 antibody

Wang ML, Cao XY, Liu QX, Ma W, Guo XQ, Liu XW

Neuropsychiatric Disease and Treatment 2017, 13:1589-1596

Published Date: 16 June 2017

Suicide and Lyme and associated diseases

Bransfield RC

Neuropsychiatric Disease and Treatment 2017, 13:1575-1587

Published Date: 16 June 2017

Risk factors for the existence of attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders

Lamanna AL, Craig F, Matera E, Simone M, Buttiglione M, Margari L

Neuropsychiatric Disease and Treatment 2017, 13:1559-1567

Published Date: 15 June 2017

De Ritis ratio (AST/ALT) as an independent predictor of poor outcome in patients with acute ischemic stroke

Gao F, Chen C, Lu J, Zheng J, Ma XC, Yuan XY, Huo K, Han JF

Neuropsychiatric Disease and Treatment 2017, 13:1551-1557

Published Date: 15 June 2017

Intelligence profiles of Chinese school-aged boys with high-functioning ASD and ADHD

Li G, Jiang W, Du Y, Rossbach K

Neuropsychiatric Disease and Treatment 2017, 13:1541-1549

Published Date: 15 June 2017

Burnout and compassion fatigue: prevalence and associations among Israeli burn clinicians

Haik J, Brown S, Liran A, Visentin D, Sokolov A, Zilinsky I, Kornhaber R

Neuropsychiatric Disease and Treatment 2017, 13:1533-1540

Published Date: 15 June 2017

Pituitary abscess: report of two cases and review of the literature

Liu Y, Liu F, Liang Q, Li Y, Wang ZF

Neuropsychiatric Disease and Treatment 2017, 13:1521-1526

Published Date: 13 June 2017

Effects of Canon chord progression on brain activity and motivation are dependent on subjective feelings, not the chord progression per se

Kayashima Y, Yamamuro K, Makinodan M, Nakanishi Y, Wanaka A, Kishimoto T

Neuropsychiatric Disease and Treatment 2017, 13:1499-1508

Published Date: 12 June 2017

Sleep apnea leading to Parkinson’s disease – an important association

Shafqat MN, Aadil M, Shoaib M

Neuropsychiatric Disease and Treatment 2017, 13:1491-1492

Published Date: 9 June 2017

PAC1 receptor (ADCYAP1R1) genotype and problematic alcohol use in a sample of young women

Dragan WŁ, Czerski PM, Dragan M

Neuropsychiatric Disease and Treatment 2017, 13:1483-1489

Published Date: 8 June 2017

Disrupted small-world brain functional network topology in male patients with severe obstructive sleep apnea revealed by resting-state fMRI

Chen L, Fan X, Li H, Nie S, Gong H, Zhang W, Zeng X, Long P, Peng D

Neuropsychiatric Disease and Treatment 2017, 13:1471-1482

Published Date: 8 June 2017

Regional impairment of intrinsic functional connectivity strength in patients with chronic primary insomnia

Huang S, Zhou F, Jiang J, Huang M, Zeng X, Ding S, Gong H

Neuropsychiatric Disease and Treatment 2017, 13:1449-1462

Published Date: 6 June 2017

Ictal blinking, an under-recognized phenomenon: our experience and literature review

Saporito MAN, Vitaliti G, Pavone P, Di Stefano G, Striano P, Caraballo RH, Falsaperla R

Neuropsychiatric Disease and Treatment 2017, 13:1435-1439

Published Date: 31 May 2017

Effects of stimulus parameters on motor seizure duration in electroconvulsive therapy

Joo SW, Joo YH, Kim CY, Lee JS

Neuropsychiatric Disease and Treatment 2017, 13:1427-1434

Published Date: 29 May 2017

The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study

Rosic T, Naji L, Bawor M, Dennis BB, Plater C, Marsh DC, Thabane L, Samaan Z

Neuropsychiatric Disease and Treatment 2017, 13:1399-1408

Published Date: 24 May 2017

Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia

Aksay SS, Bumb JM, Remennik D, Thiel M, Kranaster L, Sartorius A, Janke C

Neuropsychiatric Disease and Treatment 2017, 13:1389-1394

Published Date: 23 May 2017

Developmental and behavioral outcomes of uncomplicated monochorionic diamniotic twins born in the third trimester

Sierakowski A, Eapen V, Črnčec R, Smoleniec J

Neuropsychiatric Disease and Treatment 2017, 13:1373-1384

Published Date: 19 May 2017

Effect of aripiprazole on non-24-hour sleep–wake rhythm disorder comorbid with major depressive disorder: a case report

Matsui K, Takaesu Y, Inoue T, Inada K, Nishimura K

Neuropsychiatric Disease and Treatment 2017, 13:1367-1371

Published Date: 19 May 2017

Productivity and deadweight losses due to relapses of schizophrenia in Japan

Nakamura Y, Mahlich J

Neuropsychiatric Disease and Treatment 2017, 13:1341-1348

Published Date: 17 May 2017

Potential role of pre- and postnatal testosterone levels in attention-deficit/hyperactivity disorder: is there a sex difference?

Wang LJ, Chou MC, Chou WJ, Lee MJ, Lee SY, Lin PY, Lee YH, Yang YH, Yen CF

Neuropsychiatric Disease and Treatment 2017, 13:1331-1339

Published Date: 16 May 2017

Psychosis in parkinsonism: an unorthodox approach

Onofrj M, Carrozzino D, D'Amico A, Di Giacomo R, Delli Pizzi S, Thomas A, Onofrj V, Taylor JP, Bonanni L

Neuropsychiatric Disease and Treatment 2017, 13:1313-1330

Published Date: 16 May 2017

Robot-assisted gait training for stroke patients: current state of the art and perspectives of robotics

Morone G, Paolucci S, Cherubini A, De Angelis D, Venturiero V, Coiro P, Iosa M

Neuropsychiatric Disease and Treatment 2017, 13:1303-1311

Published Date: 15 May 2017

Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population

Kishi T, Ikuta T, Matsunaga S, Matsuda Y, Oya K, Iwata N

Neuropsychiatric Disease and Treatment 2017, 13:1281-1302

Published Date: 11 May 2017

ESSENCE-Q – used as a screening tool for neurodevelopmental problems in public health checkups for young children in south Japan

Hatakenaka Y, Ninomiya H, Billstedt E, Fernell E, Gillberg C

Neuropsychiatric Disease and Treatment 2017, 13:1271-1280

Published Date: 10 May 2017

Novel urinary metabolite signature for diagnosing postpartum depression

Lin L, Chen X, Liu R

Neuropsychiatric Disease and Treatment 2017, 13:1263-1270

Published Date: 10 May 2017

Biomarkers for depression: recent insights, current challenges and future prospects

Strawbridge R, Young AH, Cleare AJ

Neuropsychiatric Disease and Treatment 2017, 13:1245-1262

Published Date: 10 May 2017

Factor structure, reliability, and validity of the Japanese version of the Hoarding Rating Scale-Self-Report (HRS-SR-J)

Tsuchiyagaito A, Horiuchi S, Igarashi T, Kawanori Y, Hirano Y, Yabe H, Nakagawa A

Neuropsychiatric Disease and Treatment 2017, 13:1235-1243

Published Date: 9 May 2017

Stigma associated with mental illness: perspectives of university students in Qatar

Zolezzi M, Bensmail N, Zahrah F, Khaled SM, El-Gaili T

Neuropsychiatric Disease and Treatment 2017, 13:1221-1233

Published Date: 9 May 2017

New standardized nursing cooperation workflow to reduce stroke thrombolysis delays in patients with acute ischemic stroke

Zhou Y, Xu Z, Liao J, Feng F, Men L, Xu L, He Y, Li G

Neuropsychiatric Disease and Treatment 2017, 13:1215-1220

Published Date: 9 May 2017

Anorexia nervosa of the restrictive type and celiac disease in adolescence

Nacinovich R, Tremolizzo L, Corbetta F, Conti E, Neri F, Bomba M

Neuropsychiatric Disease and Treatment 2017, 13:1211-1214

Published Date: 4 May 2017

Connectivity to computers and the Internet among patients with schizophrenia spectrum disorders: a cross-sectional study

Välimäki M, Kuosmanen L, Hätönen H, Koivunen M, Pitkänen A, Athanasopoulou C, Anttila M

Neuropsychiatric Disease and Treatment 2017, 13:1201-1209

Published Date: 27 April 2017

Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients

Talih FR, Ajaltouni JJ, Tamim HM, Kobeissy FH

Neuropsychiatric Disease and Treatment 2017, 13:1193-1200

Published Date: 26 April 2017

Protective efficacy of a single salvianolic acid A treatment on photothrombosis-induced sustained spatial memory impairments

Jiao CX, Zhou H, Yang CX, Ma C, Yang YX, Mao RR, Xu L, Zhou QX

Neuropsychiatric Disease and Treatment 2017, 13:1181-1192

Published Date: 26 April 2017

The genetic relationship between epilepsy and hemiplegic migraine

Huang Y, Xiao H, Qin X, Nong Y, Zou D, Wu Y

Neuropsychiatric Disease and Treatment 2017, 13:1175-1179

Published Date: 24 April 2017

Trichotillomania: the impact of treatment history on the outcome of an Internet-based intervention

Weidt S, Bruhl AB, Delsignore A, Zai G, Kuenburg A, Klaghofer R, Rufer M

Neuropsychiatric Disease and Treatment 2017, 13:1153-1162

Published Date: 21 April 2017

Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole

Salzman PM, Raoufinia A, Legacy S, Such P, Eramo A

Neuropsychiatric Disease and Treatment 2017, 13:1125-1129

Published Date: 20 April 2017

Long-term effect of galantamine on cognitive function in patients with Alzheimer’s disease versus a simulated disease trajectory: an observational study in the clinical setting

Nakagawa R, Ohnishi T, Kobayashi H, Yamaoka T, Yajima T, Tanimura A, Kato T, Yoshizawa K

Neuropsychiatric Disease and Treatment 2017, 13:1115-1124

Published Date: 19 April 2017

Perceived parental affectionless control is associated with high neuroticism

Takahashi N, Suzuki A, Matsumoto Y, Shirata T, Otani K

Neuropsychiatric Disease and Treatment 2017, 13:1111-1114

Published Date: 18 April 2017

Levodopa-responsive depression associated with corticobasal degeneration: a case report

Tarakita N, Nishijima H, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2017, 13:1107-1110

Published Date: 18 April 2017

Psychosis in behavioral variant frontotemporal dementia

Gossink FT, Vijverberg EGB, Krudop W, Scheltens P, Stek ML, Pijnenburg YAL, Dols A

Neuropsychiatric Disease and Treatment 2017, 13:1099-1106

Published Date: 13 April 2017

Treatment satisfaction with paliperidone extended-release tablets: open-label study in schizophrenia patients dissatisfied with previous antipsychotic medication

Yang FD, Li J, Tan YL, Liang WY, Zhang R, Wang N, Feng W, Cai S, Zhuo JM, Zhang LL

Neuropsychiatric Disease and Treatment 2017, 13:1089-1097

Published Date: 13 April 2017

Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with schizophrenia

Kadasah S, Arfin M, Rizvi S, Al-Asmari M, Al-Asmari A

Neuropsychiatric Disease and Treatment 2017, 13:1081-1088

Published Date: 12 April 2017

Are psychiatric comorbidities and associated cognitive functions related to treatment response to methylphenidate in boys with attention-deficit/hyperactivity disorder?

Chan MH, Leung PW, Ho TP, Hung SF, Lee CC, Tang CP, Cheung KC, Ching FY, Chan FH, Chen LH, Garcia-Barcelo M, Sham PC

Neuropsychiatric Disease and Treatment 2017, 13:1071-1080

Published Date: 11 April 2017

Metabolic screening and its impact in children with non-syndromic intellectual disability

Ali YF, EL-Morshedy S, Elsayed RM, EL-sherbini AM, El-Sayed SAM, Abdrahman NIA, Imam AA

Neuropsychiatric Disease and Treatment 2017, 13:1065-1070

Published Date: 19 April 2017

Clinical and biochemical study of D-serine metabolism among schizophrenia patients

El-Tallawy HN, Saleem TH, El-Ebidi AMA, Hassan MH, Gabra RH, Farghaly WMA, Abo El-Maali N, Sherkawy HS

Neuropsychiatric Disease and Treatment 2017, 13:1057-1063

Published Date: 10 April 2017

Pathogenic beliefs among patients with depressive disorders

Neelapaijit A, Wongpakaran T, Wongpakaran N, Thongpibul K

Neuropsychiatric Disease and Treatment 2017, 13:1047-1055

Published Date: 10 April 2017

Hashimoto encephalopathy with high plasma monoamine metabolite levels: a case report

Horikoshi S, Miura I, Kunii Y, Asano S, Kanno-Nozaki K, Mashiko H, Yabe H

Neuropsychiatric Disease and Treatment 2017, 13:1043-1045

Published Date: 7 April 2017

Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis

Maneeton B, Putthisri S, Maneeton N, Woottiluk P, Suttajit S, Charnsil C, Srisurapanont M

Neuropsychiatric Disease and Treatment 2017, 13:1023-1032

Published Date: 4 April 2017

Relationship between hypnosis and personality trait in participants with high or low hypnotic susceptibility

Zhang Y, Wang Y, Shen C, Ye Y, Shen S, Zhang B, Wang J, Chen W, Wang W

Neuropsychiatric Disease and Treatment 2017, 13:1007-1012

Published Date: 3 April 2017

An Internet-based program for depressive symptoms using human and automated support: a randomized controlled trial

Mira A, Bretón-López J, García-Palacios A, Quero S, Baños RM, Botella C

Neuropsychiatric Disease and Treatment 2017, 13:987-1006

Published Date: 31 March 2017

Punding following posterior cerebral artery infarction: a case report and review of literature

Lin CI, Lin YC, Lien WC, Hsieh PC, Lin SH, Kuan TS

Neuropsychiatric Disease and Treatment 2017, 13:981-985

Published Date: 31 March 2017

Twelve-week physical exercise does not have a long-lasting effect on kynurenines in plasma of depressed patients

Millischer V, Erhardt S, Ekblom Ö, Forsell Y, Lavebratt C

Neuropsychiatric Disease and Treatment 2017, 13:967-972

Published Date: 31 March 2017

Sleep apnea and the subsequent risk of Parkinson’s disease: a 3-year nationwide population-based study

Chou PS, Lai CL, Chou YH, Chang WP

Neuropsychiatric Disease and Treatment 2017, 13:959-965

Published Date: 30 March 2017

Comparing the ability of cognitive and affective Theory of Mind in adolescent onset schizophrenia

Li D, Li X, Yu F, Chen X, Zhang L, Li D, Wei Q, Zhang Q, Zhu C, Wang K

Neuropsychiatric Disease and Treatment 2017, 13:937-945

Published Date: 27 March 2017

Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia–reperfusion injury in rats by targeting multiple cellular processes

Wang M, Zhang Y, Feng L, Zheng J, Fan S, Liu J, Yang N, Liu Y, Zuo P

Neuropsychiatric Disease and Treatment 2017, 13:927-935

Published Date: 27 March 2017

The Maugeri Stress Index – reduced form: a questionnaire for job stress assessment

Massidda D, Giorgi I, Vidotto G, Tringali S, Imbriani M, Baiardi P, Bertolotti G

Neuropsychiatric Disease and Treatment 2017, 13:917-926

Published Date: 24 March 2017

Illness denial questionnaire for patients and caregivers

Rossi Ferrario S, Giorgi I, Baiardi P, Giuntoli L, Balestroni G, Cerutti P, Manera M, Gabanelli P, Solara V, Fornara R, Luisetti M, Omarini P, Omarini G, Vidotto G

Neuropsychiatric Disease and Treatment 2017, 13:909-916

Published Date: 23 March 2017

Association study of MIF promoter polymorphisms with suicide completers in the Japanese population

Shimmyo N, Hishimoto A, Otsuka I, Okazaki S, Boku S, Mouri K, Horai T, Takahashi M, Ueno Y, Shirakawa O, Sora I

Neuropsychiatric Disease and Treatment 2017, 13:899-908

Published Date: 22 March 2017

Dynamic balance in children with attention-deficit hyperactivity disorder and its relationship with cognitive functions and cerebellum

Goetz M, Schwabova JP, Hlavka Z, Ptacek R, Surman CBH

Neuropsychiatric Disease and Treatment 2017, 13:873-880

Published Date: 21 March 2017

Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion

Katahira H, Sunagawa M, Watanabe D, Kanada Y, Katayama A, Yamauchi R, Takashima M, Ishikawa S, Hisamitsu T

Neuropsychiatric Disease and Treatment 2017, 13:863-872

Published Date: 20 March 2017

Long-term efficacy and safety of lamotrigine for all types of bipolar disorder

Watanabe Y, Hongo S

Neuropsychiatric Disease and Treatment 2017, 13:843-854

Published Date: 20 March 2017

Some children with autism have latent social skills that can be tested

Hrdlicka M, Urbanek T, Vacova M, Beranova S, Dudova I

Neuropsychiatric Disease and Treatment 2017, 13:827-833

Published Date: 16 March 2017

Neuropsychiatric symptoms in untreated Parkinson’s disease

Szatmari S, Illigens BM, Siepmann T, Pinter A, Takats A, Bereczki D

Neuropsychiatric Disease and Treatment 2017, 13:815-826

Published Date: 16 March 2017

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder

Jha MK, Teer RB, Minhajuddin A, Greer TL, Rush AJ, Trivedi MH

Neuropsychiatric Disease and Treatment 2017, 13:803-813

Published Date: 15 March 2017

Validation and cultural adaptation of the Arabic versions of the Mini–Mental Status Examination – 2 and Mini-Cog test

Albanna M, Yehya A, Khairi A, Dafeeah E, Elhadi A, Rezgui L, Al Kahlout S, Yousif A, Uthman B, Al-Amin H

Neuropsychiatric Disease and Treatment 2017, 13:793-801

Published Date: 14 March 2017

Attention-deficit hyperactivity disorder in elementary school students in Shantou, China: prevalence, subtypes, and influencing factors

Huang Y, Zheng S, Xu C, Lin K, Wu K, Zheng M, Zhang J, Xu H

Neuropsychiatric Disease and Treatment 2017, 13:785-792

Published Date: 14 March 2017

Work–family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan

Sugawara N, Danjo K, Furukori H, Sato Y, Tomita T, Fujii A, Nakagami T, Kitaoka K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2017, 13:779-784

Published Date: 13 March 2017

Preliminary evaluation of a “formulation-driven cognitive behavioral guided self-help (fCBT-GSH)” for crisis and transitional case management clients

Naeem F, Johal RK, Mckenna C, Calancie O, Munshi T, Hassan T, Nasar A, Ayub M

Neuropsychiatric Disease and Treatment 2017, 13:769-774

Published Date: 10 March 2017

Confirmation of the factorial structure of the Japanese short version of the TEMPS-A in psychiatric patients and general adults [Corrigendum]

Nakato Y, Inoue T, Nakagawa S, Kitaichi Y, Kameyama R, Wakatsuki Y, Kitagawa K, Omiya Y, Kusumi I

Neuropsychiatric Disease and Treatment 2017, 13:767-768

Published Date: 9 March 2017

Lithium in late-life mania: a systematic review

De Fazio P, Gaetano R, Caroleo M, Pavia M, De Sarro G, Fagiolini A, Segura-Garcia C

Neuropsychiatric Disease and Treatment 2017, 13:755-766

Published Date: 9 March 2017

Monitoring brain multiparameters and hypothermia in severe traumatic brain injury

Vasconcelos FR, Andrade AF, Teixeira MJ, Paiva WS

Neuropsychiatric Disease and Treatment 2017, 13:721-722

Published Date: 8 March 2017

Prevalence of dementia in Egypt: a systematic review

Elshahidi MH, Elhadidi MA, Sharaqi AA, Mostafa A, Elzhery MA

Neuropsychiatric Disease and Treatment 2017, 13:715-720

Published Date: 6 March 2017

New opinion on the subtypes of poststroke depression in Chinese stroke survivors

Yue Y, Liu R, Cao Y, Wu Y, Zhang S, Li H, Zhu J, Jiang W, Wu A, Yuan Y

Neuropsychiatric Disease and Treatment 2017, 13:707-713

Published Date: 6 March 2017

Influence of CFH gene on symptom severity of schizophrenia

Zhang C, Lv QY, Fan WX, Tang W, Yi ZH

Neuropsychiatric Disease and Treatment 2017, 13:697-706

Published Date: 2 March 2017

Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan

Cheng YS, Shyu YC, Lee SY, Yuan SS, Yang CJ, Yang KC, Lee TL, Wang LJ

Neuropsychiatric Disease and Treatment 2017, 13:643-651

Published Date: 1 March 2017

Screening for bipolar disorder among migraineurs: the impact of migraine–bipolar disorder comorbidity on disease characteristics

Kivilcim Y, Altintas M, Domac FM, Erzincan E, Gülec H

Neuropsychiatric Disease and Treatment 2017, 13:631-641

Published Date: 1 March 2017

Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study

Horsdal HT, Benros ME, Köhler-Forsberg O, Krogh J, Gasse C

Neuropsychiatric Disease and Treatment 2017, 13:621-630

Published Date: 28 February 2017

Quality of life in children and adolescents with obsessive–compulsive disorder: a systematic review and meta-analysis

Coluccia A, Ferretti F, Fagiolini A, Pozza A

Neuropsychiatric Disease and Treatment 2017, 13:597-608

Published Date: 24 February 2017

Contemplating stem cell therapy for epilepsy-induced neuropsychiatric symptoms

Rao G, Mashkouri S, Aum D, Marcet P, Borlongan CV

Neuropsychiatric Disease and Treatment 2017, 13:585-596

Published Date: 23 February 2017

Prefrontal cortex activation during neuropsychological tasks might predict response to pharmacotherapy in patients with obsessive–compulsive disorder

Takeda T, Sumitani S, Hamatani S, Yokose Y, Shikata M, Ohmori T

Neuropsychiatric Disease and Treatment 2017, 13:577-583

Published Date: 23 February 2017

Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study

Vrbova K, Prasko J, Ociskova M, Kamaradova D, Marackova M, Holubova M, Grambal A, Slepecky M, Latalova K

Neuropsychiatric Disease and Treatment 2017, 13:567-576

Published Date: 23 February 2017

Gender differences in the association between HTR2C gene variants and suicidal behavior in a Mexican population: a case–control study

Molina-Guzman G, González-Castro TB, Hernández-Díaz Y, Tovilla-Zárate CA, Juárez-Rojop IE, Guzmán-Priego CG, Genis A, Pool García S, López-Narvaez ML, Rodriguez-Perez JM

Neuropsychiatric Disease and Treatment 2017, 13:559-566

Published Date: 22 February 2017

Assessment of poststroke mania and diagnosis

Shoaib M, Aadil M

Neuropsychiatric Disease and Treatment 2017, 13:557-558

Published Date: 21 February 2017

Validation of the Revised Illness Perception Questionnaire in Turkish epilepsy patients and the effects of earthquake experience on perception of disease

Keskin Güler S, Güler S, Gökçe Çokal B, Gunes N, Yon Mİ, Yoldas TK

Neuropsychiatric Disease and Treatment 2017, 13:551-556

Published Date: 21 February 2017

Analysis concerning nutritional behaviors in the context of the risk of orthorexia

Olejniczak D, Bugajec D, Panczyk M, Brytek-Matera A, Religioni U, Czerw A, Grąbczewska A, Juszczyk G, Jabłkowska-Górecka K, Staniszewska A

Neuropsychiatric Disease and Treatment 2017, 13:543-550

Published Date: 21 February 2017

Gene expression-based biological test for major depressive disorder: an advanced study

Watanabe S, Numata S, Iga J, Kinoshita M, Umehara H, Ishii K, Ohmori T

Neuropsychiatric Disease and Treatment 2017, 13:535-541

Published Date: 21 February 2017

Association of carotid atherosclerosis and recurrent cerebral infarction in the Chinese population: a meta-analysis

Liu J, Zhu Y, Wu Y, Liu Y, Teng Z, Hao Y

Neuropsychiatric Disease and Treatment 2017, 13:527-533

Published Date: 20 February 2017

Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population

Jiang KD, Li LJ, Wang XY, Fang MS, Shi JF, Cao QY, He JC, Wang JN, Tan WH, Hu CL

Neuropsychiatric Disease and Treatment 2017, 13:515-526

Published Date: 17 February 2017

Abnormal resting-state brain activities in patients with first-episode obsessive-compulsive disorder

Niu Q, Yang L, Song X, Chu C, Liu H, Zhang L, Li Y, Zhang X, Cheng J, Li Y

Neuropsychiatric Disease and Treatment 2017, 13:507-513

Published Date: 16 February 2017

Blood pressure and anthropometry in children treated with stimulants: a longitudinal cohort study with an individual approach

Landgren M, Nasic S, Johnson M, Lövoll T, Holmgren D, Fernell E

Neuropsychiatric Disease and Treatment 2017, 13:499-506

Published Date: 16 February 2017

Efficacy and safety of Ginkgo biloba standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial

Demarin V, Bašić Kes V, Trkanjec Z, Budišić M, Bošnjak Pašić M, Črnac P, Budinčević H

Neuropsychiatric Disease and Treatment 2017, 13:483-490

Published Date: 16 February 2017

Associations among depressive symptoms, childhood abuse, neuroticism, and adult stressful life events in the general adult population

Ono K, Takaesu Y, Nakai Y, Shimura A, Ono Y, Murakoshi A, Matsumoto Y, Tanabe H, Kusumi I, Inoue T

Neuropsychiatric Disease and Treatment 2017, 13:477-482

Published Date: 15 February 2017

Delirium after a traumatic brain injury: predictors and symptom patterns

Maneewong J, Maneeton B, Maneeton N, Vaniyapong T, Traisathit P, Sricharoen N, Srisurapanont M

Neuropsychiatric Disease and Treatment 2017, 13:459-465

Published Date: 14 February 2017

Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control

Fridman M, Banaschewski T, Sikirica V, Quintero J, Erder MH, Chen KS

Neuropsychiatric Disease and Treatment 2017, 13:443-455

Published Date: 13 February 2017

Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder

Yoshimura R, Katsuki A, Atake K, Hori H, Igata R, Konishi Y

Neuropsychiatric Disease and Treatment 2017, 13:437-441

Published Date: 14 February 2017

Abnormal whole-brain functional connectivity in patients with primary insomnia

Li C, Dong M, Yin Y, Hua K, Fu S, Jiang G

Neuropsychiatric Disease and Treatment 2017, 13:427-435

Published Date: 13 February 2017

The dynamic relationship between emotional and physical states: an observational study of personal health records

Lee YS, Jung WM, Jang H, Kim S, Chung SY, Chae Y

Neuropsychiatric Disease and Treatment 2017, 13:411-419

Published Date: 9 February 2017

Resting-state functional connectivity changes within the default mode network and the salience network after antipsychotic treatment in early-phase schizophrenia

Wang Y, Tang W, Fan X, Zhang J, Geng D, Jiang K, Zhu D, Song Z, Xiao Z, Liu D

Neuropsychiatric Disease and Treatment 2017, 13:397-406

Published Date: 7 February 2017

Risk assessment of aggressive behavior in Chinese patients with schizophrenia by fMRI and COMT gene

Tang X, Jin J, Tang Y, Cao J, Huang J

Neuropsychiatric Disease and Treatment 2017, 13:387-395

Published Date: 7 February 2017

Use of transcranial direct current stimulation for the treatment of auditory hallucinations of schizophrenia – a systematic review

Pondé PH, de Sena EP, Camprodon JA, Araújo AN, Neto MF, DiBiasi M, Baptista AF, Moura LMVR, Cosmo C

Neuropsychiatric Disease and Treatment 2017, 13:347-355

Published Date: 1 February 2017

N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients: case reports and methods for detection

Tsutsui K, Kanbayashi T, Takaki M, Omori Y, Imai Y, Nishino S, Tanaka K, Shimizu T

Neuropsychiatric Disease and Treatment 2017, 13:339-345

Published Date: 8 February 2017

Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females

Farhadi F, Vosoughi K, Shahidi GA, Delbari A, Lökk J, Fereshtehnejad SM

Neuropsychiatric Disease and Treatment 2017, 13:329-338

Published Date: 1 February 2017

The parental bonding in families of adolescents with anorexia: attachment representations between parents and offspring

Balottin L, Mannarini S, Rossi M, Rossi G, Balottin U

Neuropsychiatric Disease and Treatment 2017, 13:319-327

Published Date: 1 February 2017

The spectrum of psychosis in multiple sclerosis: a clinical case series

Gilberthorpe TG, O'Connell KE, Carolan A, Silber E, Brex PA, Sibtain NA, David AS

Neuropsychiatric Disease and Treatment 2017, 13:303-318

Published Date: 1 February 2017

The relationship between childhood trauma and adult psychosis in a UK Early Intervention Service: results of a retrospective case note study

Reeder FD, Hussain N, Rhouma A, Haddad PM, Munshi T, Naeem F, Khachatryan D, Chaudhry IB

Neuropsychiatric Disease and Treatment 2017, 13:269-273

Published Date: 8 February 2017

Role of prediabetes in stroke

Mijajlović MD, Aleksić VM, Šternić NM, Mirković MM, Bornstein NM

Neuropsychiatric Disease and Treatment 2017, 13:259-267

Published Date: 2 February 2017

Visual–spatial training efficacy in children affected by migraine without aura: a multicenter study

Precenzano F, Ruberto M, Parisi L, Salerno M, Maltese A, Gallai B, Marotta R, Lavano SM, Lavano F, Roccella M

Neuropsychiatric Disease and Treatment 2017, 13:253-258

Published Date: 27 January 2017

Efficacy of a short cognitive training program in patients with multiple sclerosis

Pérez-Martín MY, González-Platas M, Eguía-del Rio P, Croissier-Elías C, Jiménez Sosa A

Neuropsychiatric Disease and Treatment 2017, 13:245-252

Published Date: 3 February 2017

A survey of eMedia-delivered interventions for schizophrenia used in randomized controlled trials

Naeem F, Munshi T, Xiang S, Yang M, Shokraneh F, Syed Y, Ayub M, Adams CE, Farooq S

Neuropsychiatric Disease and Treatment 2017, 13:233-243

Published Date: 27 January 2017

Construct validity of the Depression and Somatic Symptoms Scale: evaluation by Mokken scale analysis

Chou YH, Lee CP, Liu CY, Hung CI

Neuropsychiatric Disease and Treatment 2017, 13:205-211

Published Date: 23 January 2017

Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study

Ifteni P, Teodorescu A, Moga MA, Pascu AM, Miclaus RS

Neuropsychiatric Disease and Treatment 2017, 13:201-204

Published Date: 23 January 2017

A possible role of the Infant/Toddler Sensory Profile in screening for autism: a proof-of-concept study in the specific sample of prematurely born children with birth weights <1,500 g

Beranova S, Stoklasa J, Dudova I, Markova D, Kasparova M, Zemankova J, Urbanek T, Talasek T, Luukka P, Hrdlicka M

Neuropsychiatric Disease and Treatment 2017, 13:191-200

Published Date: 23 January 2017

A preliminary study of Patient Dignity Inventory validation among patients hospitalized in an acute psychiatric ward

Di Lorenzo R, Cabri G, Carretti E, Galli G, Giambalvo N, Rioli G, Saraceni S, Spiga G, Del Giovane C, Ferri P

Neuropsychiatric Disease and Treatment 2017, 13:177-190

Published Date: 23 January 2017

Neuroleptic malignant syndrome: an easily overlooked neurologic emergency

Oruch R, Pryme IF, Engelsen BA, Lund A

Neuropsychiatric Disease and Treatment 2017, 13:161-175

Published Date: 16 January 2017

Evaluation of the risk factors of depressive disorders comorbid with obstructive sleep apnea

Cai LQ, Xu LY, Wei LL, Sun Y, Chen W

Neuropsychiatric Disease and Treatment 2017, 13:155-159

Published Date: 16 January 2017

Effects of paliperidone extended release on hostility among Thai patients with schizophrenia

Jariyavilas A, Thavichachart N, Kongsakon R, Chantakarn S, Arunpongpaisal S, Chantarasak V, Jaroensook P, Kittiwattanagul K, Nerapusee O

Neuropsychiatric Disease and Treatment 2017, 13:141-146

Published Date: 12 January 2017

Association of peripheral neuropathy with sleep-related breathing disorders in myotonic dystrophies

Banach M, Antczak J, Rola R

Neuropsychiatric Disease and Treatment 2017, 13:133-140

Published Date: 12 January 2017

Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study

Kongsaengdao S, Maneeton B, Maneeton N

Neuropsychiatric Disease and Treatment 2017, 13:127-132

Published Date: 10 January 2017

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial

Kishi T, Matsuda Y, Matsunaga S, Moriwaki M, Otake Y, Akamatsu K, Okochi T, Hirano S, Funahashi T, Okuda M, Tabuse H, Fujita K, Iwata N

Neuropsychiatric Disease and Treatment 2017, 13:117-125

Published Date: 6 January 2017

Cognitive profiles in bilingual children born to immigrant parents and Italian monolingual native children with specific learning disorders

Riva A, Nacinovich R, Bertuletti N, Montrasi V, Marchetti S, Neri F, Bomba M

Neuropsychiatric Disease and Treatment 2017, 13:109-116

Published Date: 30 December 2016

Risperidone improves interpersonal perception and executive function in patients with schizophrenia

Zhou Z, Zhu Y, Wang J, Zhu H

Neuropsychiatric Disease and Treatment 2017, 13:101-107

Published Date: 28 December 2016

Alterations of white matter fractional anisotropy in unmedicated obsessive–compulsive disorder

Tao J, Wang XL, Zhong ZY, Han HY, Liu S, Wen SL, Guan NH, Li LJ

Neuropsychiatric Disease and Treatment 2017, 13:69-76

Published Date: 28 December 2016

A biopsychological review of gambling disorder

Quintero GC

Neuropsychiatric Disease and Treatment 2017, 13:51-60

Published Date: 23 December 2016

Detailed course of depressive symptoms and risk for developing depression in late adolescents with subthreshold depression: a cohort study

Jinnin R, Okamoto Y, Takagaki K, Nishiyama Y, Yamamura T, Okamoto Y, Miyake Y, Takebayashi Y, Tanaka K, Sugiura Y, Shimoda H, Kawakami N, Furukawa TA, Yamawaki S

Neuropsychiatric Disease and Treatment 2017, 13:25-33

Published Date: 22 December 2016

Temperament, personality, and treatment outcome in major depression: a 6-month preliminary prospective study

Kudo Y, Nakagawa A, Wake T, Ishikawa N, Kurata C, Nakahara M, Nojima T, Mimura M

Neuropsychiatric Disease and Treatment 2017, 13:17-24

Published Date: 19 December 2016

Pioglitazone could induce remission in major depression: a meta-analysis

Colle R, de Larminat D, Rotenberg S, Hozer F, Hardy P, Verstuyft C, Fève B, Corruble E

Neuropsychiatric Disease and Treatment 2017, 13:9-16

Published Date: 19 December 2016

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial

Husain MI, Chaudhry IB, Hamirani MM, Minhas FA, Kazmi A, Hodsoll J, Haddad PM, Deakin JFW, Husain N, Young AH

Neuropsychiatric Disease and Treatment 2017, 13:1-8

Published Date: 19 December 2016

Association between the high-dose use of benzodiazepines and rehospitalization in patients with schizophrenia: a 2-year naturalistic study

Takita Y, Takaesu Y, Ono K, Futenma K, Shimura A, Murakoshi A, Komada Y, Inoue Y, Inoue T

Neuropsychiatric Disease and Treatment 2016, 12:3243-3247

Published Date: 15 December 2016

Impact of parental presence during induction of anesthesia on anxiety level among pediatric patients and their parents: a randomized clinical trial

Sadeghi A, Khaleghnejad Tabari A, Mahdavi A, Salarian S, Razavi SS

Neuropsychiatric Disease and Treatment 2016, 12:3237-3241

Published Date: 20 February 2017

Non-24-hour sleep–wake syndrome improved by low-dose valproic acid: a case report

Kurita M, Moriya T, Nishino S, Hirata E, Hirasawa N, Okubo Y, Sato T

Neuropsychiatric Disease and Treatment 2016, 12:3199-3203

Published Date: 13 December 2016

Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities

Okazaki K, Makinodan M, Yamamuro K, Takata T, Kishimoto T

Neuropsychiatric Disease and Treatment 2016, 12:3195-3198

Published Date: 14 December 2016

Neuroprotection and acidosis induced by cortical spreading depression

Kwong KK, Chan ST

Neuropsychiatric Disease and Treatment 2016, 12:3191-3194

Published Date: 12 December 2016

Associations between the mismatch-negativity component and symptom severity in children and adolescents with attention deficit/hyperactivity disorder

Yamamuro K, Ota T, Iida J, Nakanishi Y, Kishimoto N, Kishimoto T

Neuropsychiatric Disease and Treatment 2016, 12:3183-3190

Published Date: 12 December 2016

The impact of residual symptoms on relapse and quality of life among Thai depressive patients

Hiranyatheb T, Nakawiro D, Wongpakaran T, Wongpakaran N, Bookkamana P, Pinyopornpanish M, Saisavoey N, Wannarit K, Satthapisit S, Tanchakvaranont S

Neuropsychiatric Disease and Treatment 2016, 12:3175-3181

Published Date: 12 December 2016

Treadmill exercise promotes neuroprotection against cerebral ischemia–reperfusion injury via downregulation of pro-inflammatory mediators

Zhang Y, Cao RY, Jia X, Li Q, Qiao L, Yan G, Yang J

Neuropsychiatric Disease and Treatment 2016, 12:3161-3173

Published Date: 12 December 2016

Effect of dexmedetomidine on hippocampal neuron development and BDNF-TrkB signal expression in neonatal rats

Lv J, Ou W, Zou XH, Yao Y, Wu JL

Neuropsychiatric Disease and Treatment 2016, 12:3153-3159

Published Date: 9 December 2016

Baicalein improves behavioral dysfunction induced by Alzheimer’s disease in rats

Zhou L, Tan S, Shan YL, Wang YG, Cai W, Huang XH, Liao XY, Li HY, Zhang L, Zhang BJ, Lu ZQ

Neuropsychiatric Disease and Treatment 2016, 12:3145-3152

Published Date: 9 December 2016

Associations between dopamine D2 receptor gene polymorphisms and schizophrenia risk: a PRISMA compliant meta-analysis

He HR, Wu HH, Yang LH, Gao F, Fan YJ, Feng JQ, Ma XC

Neuropsychiatric Disease and Treatment 2016, 12:3129-3144

Published Date: 9 December 2016

Diminished autonomic neurocardiac function in patients with generalized anxiety disorder

Kim K, Lee S, Kim JH

Neuropsychiatric Disease and Treatment 2016, 12:3111-3118

Published Date: 8 December 2016

Age-related issues of instruments screening for autism in young children

Thomaidis L, Choleva A, Kyprianou M

Neuropsychiatric Disease and Treatment 2016, 12:3093-3095

Published Date: 5 December 2016

miR-455 inhibits neuronal cell death by targeting TRAF3 in cerebral ischemic stroke

Yao ST, Tang B, Li G, Fan RM, Cao F

Neuropsychiatric Disease and Treatment 2016, 12:3083-3092

Published Date: 5 December 2016

Global economic burden of schizophrenia: letter in response

Neil AL, Carr VJ

Neuropsychiatric Disease and Treatment 2016, 12:3069-3072

Published Date: 5 December 2016

A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders

Kishi T, Matsuda Y, Matsunaga S, Mukai T, Moriwaki M, Tabuse H, Fujita K, Iwata N

Neuropsychiatric Disease and Treatment 2016, 12:3041-3049

Published Date: 28 November 2016

Functional cortical changes in relapsing-remitting multiple sclerosis at amplitude configuration: a resting-state fMRI study

Liu H, Chen H, Wu B, Zhang TJ, Wang J, Huang KX, Song GJ, Zhan J

Neuropsychiatric Disease and Treatment 2016, 12:3031-3039

Published Date: 25 November 2016

Comparison of self-stigma and quality of life in patients with depressive disorders and schizophrenia spectrum disorders – a cross-sectional study

Holubova M, Prasko J, Matousek S, Latalova K, Marackova M, Vrbova K, Grambal A, Slepecky M, Zatkova M

Neuropsychiatric Disease and Treatment 2016, 12:3021-3030

Published Date: 24 November 2016

Self-stigma and schizophrenia: a cross-sectional study

Vrbova K, Prasko J, Holubova M, Kamaradova D, Ociskova M, Marackova M, Latalova K, Grambal A, Slepecky M, Zatkova M

Neuropsychiatric Disease and Treatment 2016, 12:3011-3020

Published Date: 24 November 2016

Factors related to depression and anxiety in adults with bronchiectasis

Özgün Niksarlioglu EY, Özkan G, Günlüoglu G, Uysal MA, Gül S, Kilic L, Yeter A, Çamsari G

Neuropsychiatric Disease and Treatment 2016, 12:3005-3010

Published Date: 23 November 2016

Evaluation of novel candidate variations and their interactions related to bipolar disorders: Analysis of GWAS data

Acikel C, Aydin Son Y, Celik C, Gul H

Neuropsychiatric Disease and Treatment 2016, 12:2997-3004

Published Date: 24 November 2016

Perceptions and impact of bipolar disorder in Japan: results of an Internet survey

Watanabe K, Harada E, Inoue T, Tanji Y, Kikuchi T

Neuropsychiatric Disease and Treatment 2016, 12:2981-2987

Published Date: 21 November 2016

Factors associated with vitamin D status of low-income, hospitalized psychiatric patients: results of a retrospective study

Bazzano AN, Littrell L, Lambert S, Roi C

Neuropsychiatric Disease and Treatment 2016, 12:2973-2980

Published Date: 15 November 2016

ADHD and Present Hedonism: time perspective as a potential diagnostic and therapeutic tool

Weissenberger S, Klicperova-Baker M, Zimbardo P, Schonova K, Akotia D, Kostal J, Goetz M, Raboch J, Ptacek R

Neuropsychiatric Disease and Treatment 2016, 12:2963-2971

Published Date: 16 November 2016

The occurrence and predictive factors of sleep paralysis in university students

Lišková M, Janečková D, Klůzová Kráčmarová L, Mladá K, Bušková J

Neuropsychiatric Disease and Treatment 2016, 12:2957-2962

Published Date: 14 November 2016

Altered spontaneous brain activity pattern in patients with high myopia using amplitude of low-frequency fluctuation: a resting-state fMRI study

Huang X, Zhou FQ, Hu YX, Xu XX, Zhou X, Zhong YL, Wang J, Wu XR

Neuropsychiatric Disease and Treatment 2016, 12:2949-2956

Published Date: 14 November 2016

Posttraumatic stress and depression in Yazidi refugees

Nasıroğlu S, Çeri V

Neuropsychiatric Disease and Treatment 2016, 12:2941-2948

Published Date: 14 November 2016

Sex differences in the course of schizophrenia across diverse regions of the world

Novick D, Montgomery W, Treuer T, Moneta MV, Haro JM

Neuropsychiatric Disease and Treatment 2016, 12:2927-2939

Published Date: 14 November 2016

Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease

Rej S, Saleem M, Herrmann N, Stefatos A, Rau A, Lanctôt KL

Neuropsychiatric Disease and Treatment 2016, 12:2913-2920

Published Date: 10 November 2016

Increased miR-132 level is associated with visual memory dysfunction in patients with depression

Liu Y, Yang X, Zhao L, Zhang J, Li T, Ma X

Neuropsychiatric Disease and Treatment 2016, 12:2905-2911

Published Date: 9 November 2016

Post-stroke dyskinesias

Nakawah MO, Lai EC

Neuropsychiatric Disease and Treatment 2016, 12:2885-2893

Published Date: 7 November 2016

The NCAN gene: schizophrenia susceptibility and cognitive dysfunction

Wang P, Cai J, Ni J, Zhang J, Tang W, Zhang C

Neuropsychiatric Disease and Treatment 2016, 12:2875-2883

Published Date: 4 November 2016

Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies

Han Y, Chen J, Zou D, Zheng P, Li Q, Wang H, Li P, Zhou X, Zhang Y, Liu Y, Xie P

Neuropsychiatric Disease and Treatment 2016, 12:2859-2867

Published Date: 3 November 2016

Effects of multiple training modalities in patients with Alzheimer’s disease: a pilot study

Tai SY, Hsu CL, Huang SW, Ma TC, Hsieh WC, Yang YH

Neuropsychiatric Disease and Treatment 2016, 12:2843-2849

Published Date: 1 November 2016

Validation of the Chinese version of Brief Assessment of Cognition in Schizophrenia

Wang LJ, Lin PY, Lee Y, Huang YC, Hsu ST, Hung CF, Chen CK, Chen YC, Wang YL, Tsai MC

Neuropsychiatric Disease and Treatment 2016, 12:2819-2826

Published Date: 31 October 2016

Beliefs and perception about mental health issues: a meta-synthesis

Choudhry FR, Mani V, Ming LC, Khan TM

Neuropsychiatric Disease and Treatment 2016, 12:2807-2818

Published Date: 31 October 2016

Psychometric properties of the self-rating organization scale with adult samples

Takeda T, Tsuji Y, Ando M

Neuropsychiatric Disease and Treatment 2016, 12:2799-2806

Published Date: 31 October 2016

Production of inflammatory cytokines, cortisol, and Aβ1-40 in elderly oral cancer patients with postoperative delirium

Sun L, Jia P, Zhang J, Zhang X, Zhang Y, Jiang H, Jiang W, Guo Y

Neuropsychiatric Disease and Treatment 2016, 12:2789-2795

Published Date: 27 October 2016

Autoimmune encephalitis in psychiatric institutions: current perspectives

Bost C, Pascual O, Honnorat J

Neuropsychiatric Disease and Treatment 2016, 12:2775-2787

Published Date: 27 October 2016

Prevalence and related factors of psychological distress among cancer inpatients using routine Distress Thermometer and Chinese Health Questionnaire screening

Chiou YJ, Chiu NM, Wang LJ, Li SH, Lee CY, Wu MK, Chen CC, Wu YS, Lee Y

Neuropsychiatric Disease and Treatment 2016, 12:2765-2773

Published Date: 25 October 2016

Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data

Solem CT, Shelbaya A, Wan Y, Deshpande CG, Alvir J, Pappadopulos E

Neuropsychiatric Disease and Treatment 2016, 12:2755-2764

Published Date: 25 October 2016

Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being

Anand E, Berggren L, Landry J, Tóth Á, Detke HC

Neuropsychiatric Disease and Treatment 2016, 12:2737-2743

Published Date: 25 October 2016

Alpha-synuclein in cutaneous small nerve fibers

Siepmann T, Illigens BM, Barlinn K

Neuropsychiatric Disease and Treatment 2016, 12:2731-2735

Published Date: 25 October 2016

Exercise is medicine for depression: even when the “pill” is small

Hallgren M, Vancampfort D, Stubbs B

Neuropsychiatric Disease and Treatment 2016, 12:2715-2721

Published Date: 25 October 2016

Self-stigma and quality of life in patients with depressive disorder: a cross-sectional study

Holubova M, Prasko J, Ociskova M, Marackova M, Grambal A, Slepecky M

Neuropsychiatric Disease and Treatment 2016, 12:2677-2687

Published Date: 19 October 2016

Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders

Prasko J, Grambal A, Kasalova P, Kamaradova D, Ociskova M, Holubova M, Vrbova K, Sigmundova Z, Latalova K, Slepecky M, Zatkova M

Neuropsychiatric Disease and Treatment 2016, 12:2659-2676

Published Date: 17 October 2016

Changes in behavior as side effects in methylphenidate treatment: review of the literature

Konrad-Bindl DS, Gresser U, Richartz BM

Neuropsychiatric Disease and Treatment 2016, 12:2635-2647

Published Date: 12 October 2016

Shortened questionnaires to assess anxiety and depression during in-hospital rehabilitation: clinical validation and cutoff scores

Bertolotti G, Moroni L, Burro R, Spanevello A, Pedretti RFE, Giorgetti G

Neuropsychiatric Disease and Treatment 2016, 12:2627-2633

Published Date: 12 October 2016

Physical activity and self-esteem: testing direct and indirect relationships associated with psychological and physical mechanisms

Zamani Sani SH, Fathirezaie Z, Brand S, Pühse U, Holsboer-Trachsler E, Gerber M, Talepasand S

Neuropsychiatric Disease and Treatment 2016, 12:2617-2625

Published Date: 12 October 2016

Managing drug-resistant epilepsy: challenges and solutions

Dalic L, Cook MJ

Neuropsychiatric Disease and Treatment 2016, 12:2605-2616

Published Date: 12 October 2016

Impact of aggression, depression, and anxiety levels on quality of life in epilepsy patients

Izci F, Fındıklı E, Camkurt MA, Tuncel D, Şahin M

Neuropsychiatric Disease and Treatment 2016, 12:2595-2603

Published Date: 13 October 2016

Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole

Peters-Strickland T, Pestreich L, Hatch A, Rohatagi S, Baker RA, Docherty JP, Markovtsova L, Raja P, Weiden PJ, Walling DP

Neuropsychiatric Disease and Treatment 2016, 12:2587-2594

Published Date: 11 October 2016

Restless leg syndrome in hospitalized psychiatric patients in Lebanon: a pilot study

Talih F, Ajaltouni J, Kobeissy F

Neuropsychiatric Disease and Treatment 2016, 12:2581-2586

Published Date: 11 October 2016

Evaluation of anxiety condition among type 1 and type 2 diabetic patients

Bulut A, Bulut A

Neuropsychiatric Disease and Treatment 2016, 12:2573-2579

Published Date: 11 October 2016

Vagus nerve stimulation balanced disrupted default-mode network and salience network in a postsurgical epileptic patient

Wang KL, Chai Q, Qiao H, Zhang JG, Liu TH, Meng FG

Neuropsychiatric Disease and Treatment 2016, 12:2561-2571

Published Date: 11 October 2016

Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder

Prasko J, Ociskova M, Grambal A, Sigmundova Z, Kasalova P, Marackova M, Holubova M, Vrbova K, Latalova K, Slepecky M

Neuropsychiatric Disease and Treatment 2016, 12:2539-2552

Published Date: 7 October 2016

Identifying predictive clinical characteristics of the treatment efficacy of mirtazapine monotherapy for major depressive disorder

Tsutsumi T, Sugawara H, Ito R, Asano M, Shimizu S, Ishigooka J, Nishimura K

Neuropsychiatric Disease and Treatment 2016, 12:2533-2538

Published Date: 5 October 2016

Impaired social cognition in anorexia nervosa patients

Hamatani S, Tomotake M, Takeda T, Kameoka N, Kawabata M, Kubo H, Tada Y, Tomioka Y, Watanabe S, Ohmori T

Neuropsychiatric Disease and Treatment 2016, 12:2527-2531

Published Date: 5 October 2016

Role of berberine in Alzheimer’s disease

Cai Z, Wang C, Yang W

Neuropsychiatric Disease and Treatment 2016, 12:2509-2520

Published Date: 3 October 2016

Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV

Tomita T, Yasui-Furukori N, Sugawara N, Ogasawara K, Katagai K, Saito H, Sawada K, Takahashi I, Nakamura K

Neuropsychiatric Disease and Treatment 2016, 12:2503-2508

Published Date: 30 September 2016

Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study

Schettino C, Dato C, Capaldo G, Sampaolo S, Di Iorio G, Melone MA

Neuropsychiatric Disease and Treatment 2016, 12:2497-2502

Published Date: 29 September 2016

Traditional Chinese medicine Yisui Tongjing relieved neural severity in experimental autoimmune neuritis rat model

Zhang E, Li M, Zhao J, Dong Y, Yang X, Huang J

Neuropsychiatric Disease and Treatment 2016, 12:2481-2487

Published Date: 29 September 2016

Melatonin in the management of perinatal hypoxic-ischemic encephalopathy: light at the end of the tunnel?

Hendaus MA, Jomha FA, Alhammadi AH

Neuropsychiatric Disease and Treatment 2016, 12:2473-2479

Published Date: 27 September 2016

A longitudinal, event-related potential pilot study of adult obsessive-compulsive disorder with 1-year follow-up

Yamamuro K, Okada K, Kishimoto N, Ota T, Iida J, Kishimoto T

Neuropsychiatric Disease and Treatment 2016, 12:2463-2471

Published Date: 26 September 2016

Self-stigma in borderline personality disorder – cross-sectional comparison with schizophrenia spectrum disorder, major depressive disorder, and anxiety disorders

Grambal A, Prasko J, Kamaradova D, Latalova K, Holubova M, Marackova M, Ociskova M, Slepecky M

Neuropsychiatric Disease and Treatment 2016, 12:2439-2448

Published Date: 22 September 2016

Mean platelet volume and red cell distribution width levels in initial evaluation of panic disorder

Asoglu M, Aslan M, Imre O, Kivrak Y, Akil O, Savik E, Buyukaslan H, Fedai U, Altındag A

Neuropsychiatric Disease and Treatment 2016, 12:2435-2438

Published Date: 22 September 2016

Delirium as a complication of the surgical intensive care

Horacek R, Krnacova B, Prasko J, Latalova K

Neuropsychiatric Disease and Treatment 2016, 12:2425-2434

Published Date: 22 September 2016

Increased frontal electroencephalogram theta amplitude in patients with anorexia nervosa compared to healthy controls

Hestad KA, Weider S, Nilsen KB, Indredavik MS, Sand T

Neuropsychiatric Disease and Treatment 2016, 12:2419-2423

Published Date: 21 September 2016

miR-370 mimic inhibits replication of Japanese encephalitis virus in glioblastoma cells

Li W, Cheng P, Nie S, Cui W

Neuropsychiatric Disease and Treatment 2016, 12:2411-2417

Published Date: 21 September 2016

Distinctive Rorschach profiles of young adults with schizophrenia and autism spectrum disorder

Kishimoto N, Yamamuro K, Iida J, Ota T, Tanaka S, Kyo M, Kimoto S, Kishimoto T

Neuropsychiatric Disease and Treatment 2016, 12:2403-2410

Published Date: 21 September 2016

Nine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology review

Feng DD, Tang T, Lin XP, Yang ZY, Yang S, Xia ZA, Wang Y, Zheng P, Wang Y, Zhang CH

Neuropsychiatric Disease and Treatment 2016, 12:2387-2402

Published Date: 20 September 2016

Varenicline improves motor and cognitive symptoms in early Huntington’s disease

McGregor AL, Dysart J, Tingle MD, Russell BR, Kydd RR, Finucane G

Neuropsychiatric Disease and Treatment 2016, 12:2381-2386

Published Date: 19 September 2016

Expanded DMPK repeats in dizygotic twins referred for diagnosis of autism versus absence of expanded DMPK repeats at screening of 330 children with autism

Musova Z, Hancarova M, Havlovicova M, Pourova R, Hrdlicka M, Kraus J, Trkova M, Stejskal D, Sedlacek Z

Neuropsychiatric Disease and Treatment 2016, 12:2367-2372

Published Date: 19 September 2016

Splitting, impulsivity, and intimate partnerships in young obese women seeking bariatric treatment

Zmolikova J, Pichlerova D, Bob P, Schückova D, Herlesova J, Weiss P

Neuropsychiatric Disease and Treatment 2016, 12:2343-2347

Published Date: 16 September 2016

The role of NMDAR antibody in the etiopathogenesis of schizophrenia

Timucin D, Ozdemir O, Parlak M

Neuropsychiatric Disease and Treatment 2016, 12:2327-2332

Published Date: 13 September 2016

Autistic traits in women with primary dysmenorrhea: a case–control study

Toy H, Hergüner A, Şimşek S, Hergüner S

Neuropsychiatric Disease and Treatment 2016, 12:2319-2325

Published Date: 12 September 2016

Alexithymia, impulsiveness, and psychopathology in nonsuicidal self-injured adolescents

Gatta M, Dal Santo F, Rago A, Spoto A, Battistella PA

Neuropsychiatric Disease and Treatment 2016, 12:2307-2317

Published Date: 12 September 2016

Prescription patterns of benzodiazepines in the Lebanese adult population: a cross-sectional study

Ramadan WH, El Khoury GM, Deeb ME, Sheikh-Taha M

Neuropsychiatric Disease and Treatment 2016, 12:2299-2305

Published Date: 6 September 2016

Insomnia in patients on hemodialysis for a short versus long duration

Tomita T, Yasui-Furukori N, Oka M, Shimizu T, Nagashima A, Mitsuhashi K, Saito H, Nakamura K

Neuropsychiatric Disease and Treatment 2016, 12:2293-2298

Published Date: 2 September 2016

The combined effect of sleep and time of day on emotion decoding from dynamic visual cues in older adults

Tsokanaki P, Moraitou D, Papantoniou G

Neuropsychiatric Disease and Treatment 2016, 12:2283-2291

Published Date: 1 September 2016

Children who screen positive for autism at 2.5 years and receive early intervention: a prospective naturalistic 2-year outcome study

Spjut Jansson B, Miniscalco C, Westerlund J, Kantzer AK, Fernell E, Gillberg C

Neuropsychiatric Disease and Treatment 2016, 12:2255-2263

Published Date: 1 September 2016

Construction of standardized Arabic questionnaires for screening neurological disorders (dementia, stroke, epilepsy, movement disorders, muscle and neuromuscular junction disorders)

El Tallawy HN, Farghaly WMA, Rageh TA, Saleh AO, Mestekawy TAH, Darwish MMM, Abd El Hamed MA, Ali AM, Mahmoud DM

Neuropsychiatric Disease and Treatment 2016, 12:2245-2253

Published Date: 30 August 2016

Psychological distress and coping in military cadre candidates

Nakkas C, Annen H, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:2237-2243

Published Date: 29 August 2016

Investigation on Internet addiction disorder in adolescents in Anhui, People’s Republic of China

Chen Y, Kang Y, Gong W, He L, Jin Y, Zhu X, Yao Y

Neuropsychiatric Disease and Treatment 2016, 12:2233-2236

Published Date: 29 August 2016

Association between sequence variations of the Mediterranean fever gene and the risk of migraine: a case–control study

Coşkun S, Varol S, Özdemir HH, Çelik SB, Balduz M, Camkurt MA, Çim A, Arslan D, Çevik MU

Neuropsychiatric Disease and Treatment 2016, 12:2225-2232

Published Date: 29 August 2016

Characteristics of binge eating disorder in relation to diagnostic criteria

Wilfley DE, Citrome L, Herman BK

Neuropsychiatric Disease and Treatment 2016, 12:2213-2223

Published Date: 29 August 2016

Late life bipolar disorder evolving into frontotemporal dementia mimic

Dols A, Krudop W, Möller C, Shulman K, Sajatovic M, Pijnenburg YAL

Neuropsychiatric Disease and Treatment 2016, 12:2207-2212

Published Date: 7 September 2016

Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer’s Disease Neuroimaging Initiative

Russo MJ, Cohen G, Chrem Mendez P, Campos J, Nahas FE, Surace EI, Vazquez S, Gustafson D, Guinjoan S, Allegri RF, Sevlever G

Neuropsychiatric Disease and Treatment 2016, 12:2199-2206

Published Date: 13 September 2016

Diffusion tensor imaging in the characterization of multiple system atrophy

Rulseh AM, Keller J, Rusz J, Syka M, Brozova H, Rusina R, Havrankova P, Zarubova K, Malikova H, Jech R, Vymazal J

Neuropsychiatric Disease and Treatment 2016, 12:2181-2187

Published Date: 26 August 2016

Confirmation of the factorial structure of the Japanese short version of the TEMPS-A in psychiatric patients and general adults

Nakato Y, Inoue T, Nakagawa S, Kitaichi Y, Kameyama R, Wakatsuki Y, Kitagawa K, Omiya Y, Kusumi I

Neuropsychiatric Disease and Treatment 2016, 12:2173-2179

Published Date: 25 August 2016

Olfactory functioning in early multiple sclerosis: Sniffin’ Sticks Test study

Batur Caglayan HZ, Irkec C, Nazliel B, Akyol Gurses A, Capraz I

Neuropsychiatric Disease and Treatment 2016, 12:2143-2147

Published Date: 26 August 2016

The use of the Psychiatric Electroencephalography Evaluation Registry (PEER) to personalize pharmacotherapy

Iosifescu DV, Neborsky RJ, Valuck RJ

Neuropsychiatric Disease and Treatment 2016, 12:2131-2142

Published Date: 25 August 2016

Brain tissue partial pressure of oxygen predicts the outcome of severe traumatic brain injury under mild hypothermia treatment

Sun H, Zheng M, Wang Y, Diao Y, Zhao W, Wei Z

Neuropsychiatric Disease and Treatment 2016, 12:2125-2129

Published Date: 24 August 2016

Disruptive mood dysregulation disorder: current insights

Baweja R, Mayes SD, Hameed U, Waxmonsky JG

Neuropsychiatric Disease and Treatment 2016, 12:2115-2124

Published Date: 24 August 2016

Mood disorders in the elderly: prevalence, functional impact, and management challenges

Valiengo LCL, Stella F, Forlenza OV

Neuropsychiatric Disease and Treatment 2016, 12:2105-2114

Published Date: 24 August 2016

Forensic reporting of a case of sexual abuse broadcast on periscope

Nasıroğlu S, Çimen İD

Neuropsychiatric Disease and Treatment 2016, 12:2073-2075

Published Date: 19 August 2016

Mental health care use in medically unexplained and explained physical symptoms: findings from a general population study

van Eck van der Sluijs JF, ten Have M, Rijnders CA, van Marwijk HWJ, de Graaf R, van der Feltz-Cornelis CM

Neuropsychiatric Disease and Treatment 2016, 12:2063-2072

Published Date: 16 August 2016

Mean platelet volume in bipolar disorder: the search for an ideal biomarker

Mert DG, Terzi H

Neuropsychiatric Disease and Treatment 2016, 12:2057-2062

Published Date: 16 August 2016

The interactive effects of ketamine and magnesium upon depressive-like pathology

Razmjou S, Litteljohn D, Rudyk C, Syed S, Clarke M, Pentz R, Dwyer Z, Hayley S

Neuropsychiatric Disease and Treatment 2016, 12:2049-2056

Published Date: 8 September 2016

Evaluation and follow-up of cognitive functions in patients with minor stroke and transient ischemic attack

Deniz Ç, Çelik Y, Özdemir Gültekin T, Baran GE, Deniz Ç, Asil T

Neuropsychiatric Disease and Treatment 2016, 12:2039-2048

Published Date: 16 August 2016

Higher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity

Ozcan ME, Ince B, Karadeli HH, Gedikbasi A, Asil T, Altinoz MA

Neuropsychiatric Disease and Treatment 2016, 12:2033-2038

Published Date: 16 August 2016

HIV- and AIDS-associated neurocognitive functioning in Zambia – a perspective based on differences between the genders

Kabuba N, Menon JA, Franklin Jr DR, Heaton RK, Hestad KA

Neuropsychiatric Disease and Treatment 2016, 12:2021-2028

Published Date: 11 August 2016

Microstructural changes of whole brain in patients with comitant strabismus: evidence from a diffusion tensor imaging study

Huang X, Li HJ, Zhang Y, Peng DC, Hu PH, Zhong YL, Zhou FQ, Shao Y

Neuropsychiatric Disease and Treatment 2016, 12:2007-2014

Published Date: 12 August 2016

Two-year prognosis after residential treatment for patients with alcohol dependence: three chief guidelines for sobriety in Japan

Cho T, Negoro H, Saka Y, Morikawa M, Kishimoto T

Neuropsychiatric Disease and Treatment 2016, 12:1983-1991

Published Date: 5 August 2016

Exercise is medicine for patients with major depressive disorders : but only if the “pill” is taken!

Gerber M, Holsboer-Trachsler E, Pühse U, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:1977-1981

Published Date: 5 August 2016

Brief behavioral treatment for patients with treatment-resistant insomnia

Wang J, Wei Q, Wu X, Zhong Z, Li G

Neuropsychiatric Disease and Treatment 2016, 12:1967-1975

Published Date: 4 August 2016

Stress, anxiety, and depression among parents of children with autism spectrum disorder in Oman: a case–control study

Al-Farsi OA, Al-Farsi YM, Al-Sharbati MM, Al-Adawi S

Neuropsychiatric Disease and Treatment 2016, 12:1943-1951

Published Date: 4 August 2016

Cycloid psychoses in the psychosis spectrum: evidence for biochemical differences with schizophrenia

van de Kerkhof NW, Fekkes D, van der Heijden FM, Hoogendijk WJ, Stöber G, Egger JI, Verhoeven WM

Neuropsychiatric Disease and Treatment 2016, 12:1927-1933

Published Date: 2 August 2016

Discriminating poststroke depression from stroke by nuclear magnetic resonance spectroscopy-based metabonomic analysis

Xiao J, Zhang J, Sun D, Wang L, Yu L, Wu H, Wang D, Qiu X

Neuropsychiatric Disease and Treatment 2016, 12:1919-1925

Published Date: 2 August 2016

Pain perception: predictive value of sex, depression, anxiety, somatosensory amplification, obesity, and age

Kivrak Y, Kose-Ozlece H, Ustundag MF, Asoglu M

Neuropsychiatric Disease and Treatment 2016, 12:1913-1918

Published Date: 1 August 2016

A study of patients with aggressive multiple sclerosis at disease onset

Kaunzner UW, Kumar G, Askin G, Gauthier SA, Nealon NN, Vartanian T, Perumal JS

Neuropsychiatric Disease and Treatment 2016, 12:1907-1912

Published Date: 1 August 2016

Altered regional homogeneity in patients with unilateral acute open globe injury: a resting-state functional MRI study

Huang X, Li HJ, Ye L, Zhang Y, Wei R, Zhong YL, Peng DC, Shao Y

Neuropsychiatric Disease and Treatment 2016, 12:1901-1906

Published Date: 1 August 2016

Clinical characteristics of patients with benign nonlesional temporal lobe epilepsy

Kim J, Kim SH, Lim SC, Kim W, Shon YM

Neuropsychiatric Disease and Treatment 2016, 12:1887-1891

Published Date: 28 July 2016

Post-stroke emotional incontinence or bipolar disorder?

Mnif L, Sellami R, Masmoudi J

Neuropsychiatric Disease and Treatment 2016, 12:1883-1885

Published Date: 29 July 2016

Depression and pain: testing of serial multiple mediators

Wongpakaran T, Wongpakaran N, Tanchakvaranont S, Bookkamana P, Pinyopornpanish M, Wannarit K, Satthapisit S, Nakawiro D, Hiranyatheb T, Thongpibul K

Neuropsychiatric Disease and Treatment 2016, 12:1849-1860

Published Date: 25 July 2016

Association between obesity and the brain-derived neurotrophic factor gene polymorphism Val66Met in individuals with bipolar disorder in Mexican population

Morales-Marín ME, Genis-Mendoza AD, Tovilla-Zarate CA, Lanzagorta N, Escamilla M, Nicolini H

Neuropsychiatric Disease and Treatment 2016, 12:1843-1848

Published Date: 25 July 2016

Update on schizophrenia and bipolar disorder: focus on cariprazine

Roberts RJ, Findlay LJ, El-Mallakh PL, El-Mallakh RS

Neuropsychiatric Disease and Treatment 2016, 12:1837-1842

Published Date: 25 July 2016

Long-term administration of escitalopram in patients with social anxiety disorder in Japan

Asakura S, Hayano T, Hagino A, Koyama T

Neuropsychiatric Disease and Treatment 2016, 12:1817-1825

Published Date: 22 July 2016

Subgrouping of risky behaviors among Iranian college students: a latent class analysis

Safiri S, Rahimi-Movaghar A, Yunesian M, Sadeghi-Bazargani H, Shamsipour M, Mansournia MA, Fotouhi A

Neuropsychiatric Disease and Treatment 2016, 12:1809-1816

Published Date: 22 July 2016

The major risk factors for delirium in a clinical setting

Kim H, Chung S, Joo YH, Lee JS

Neuropsychiatric Disease and Treatment 2016, 12:1787-1793

Published Date: 21 July 2016

Association of brain-derived neurotrophic factor and nerve growth factor gene polymorphisms with susceptibility to migraine

Coskun S, Varol S, Ozdemir HH, Agacayak E, Aydın B, Kapan O, Camkurt MA, Tunc S, Cevik MU

Neuropsychiatric Disease and Treatment 2016, 12:1779-1785

Published Date: 19 July 2016

Zika virus challenges for neuropsychiatry

Simões e Silva AC, Moreira JM, Romanelli RMC, Teixeira AL

Neuropsychiatric Disease and Treatment 2016, 12:1747-1760

Published Date: 14 July 2016

ESSENCE-Q – a first clinical validation study of a new screening questionnaire for young children with suspected neurodevelopmental problems in south Japan

Hatakenaka Y, Fernell E, Sakaguchi M, Ninomiya H, Fukunaga I, Gillberg C

Neuropsychiatric Disease and Treatment 2016, 12:1739-1746

Published Date: 14 July 2016

Involvement of upregulation of miR-210 in a rat epilepsy model

Chen L, Zheng H, Zhang S

Neuropsychiatric Disease and Treatment 2016, 12:1731-1737

Published Date: 13 July 2016

Evaluation of oxidant, antioxidant, and S100B levels in patients with conversion disorder

Büyükaslan H, Kandemir SB, Asoğlu M, Kaya H, Gökdemir MT, Karababa İF, Güngörmez F, Kılıçaslan F, Şavik E

Neuropsychiatric Disease and Treatment 2016, 12:1725-1729

Published Date: 13 July 2016

Cortical spreading depression produces a neuroprotective effect activating mitochondrial uncoupling protein-5

Viggiano E, Monda V, Messina A, Moscatelli F, Valenzano A, Tafuri D, Cibelli G, De Luca B, Messina G, Monda M

Neuropsychiatric Disease and Treatment 2016, 12:1705-1710

Published Date: 11 July 2016

A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts

Dell’Osso L, Del Grande C, Gesi C, Carmassi C, Musetti L

Neuropsychiatric Disease and Treatment 2016, 12:1687-1703

Published Date: 11 July 2016

Autism spectrum disorder in adults: diagnosis, management, and health services development

Murphy CM, Wilson CE, Robertson DM, Ecker C, Daly EM, Hammond N, Galanopoulos A, Dud I, Murphy DG, McAlonan GM

Neuropsychiatric Disease and Treatment 2016, 12:1669-1686

Published Date: 7 July 2016

Historical evolution of the concept of anorexia nervosa and relationships with orthorexia nervosa, autism, and obsessive-compulsive spectrum

Dell'Osso L, Abelli M, Carpita B, Pini S, Castellini G, Carmassi C, Ricca V

Neuropsychiatric Disease and Treatment 2016, 12:1651-1660

Published Date: 7 July 2016

Age at diagnosis of autism spectrum disorders: is there an association with socioeconomic status and family self-education about autism?

Hrdlicka M, Vacova M, Oslejskova H, Gondzova V, Vadlejchova I, Kocourkova J, Koutek J, Dudova I

Neuropsychiatric Disease and Treatment 2016, 12:1639-1644

Published Date: 6 July 2016

Risk-factor differences for nonsuicidal self-injury and suicide attempts in Mexican psychiatric patients

Fresán A, Camarena B, González-Castro TB, Tovilla-Zárate CA, Juárez-Rojop IE, López-Narváez L, González-Ramón AE, Hernández-Díaz Y

Neuropsychiatric Disease and Treatment 2016, 12:1631-1637

Published Date: 5 July 2016

5-HTR1A and 5-HTR2A genetic polymorphisms and SSRI antidepressant response in depressive Chinese patients

Dong ZQ, Li XR, He L, He G, Yu T, Sun XL

Neuropsychiatric Disease and Treatment 2016, 12:1623-1629

Published Date: 4 July 2016

Effects of Astragalus polysaccharides on memory impairment in a diabetic rat model

Dun C, Liu J, Qiu F, Wu X, Wang Y, Zhao Y, Gu P

Neuropsychiatric Disease and Treatment 2016, 12:1617-1621

Published Date: 1 July 2016

Measuring illness insight in patients with alcohol-related cognitive dysfunction using the Q8 questionnaire: a validation study

Walvoort SJW, van der Heijden PT, Kessels RPC, Egger JIM

Neuropsychiatric Disease and Treatment 2016, 12:1609-1615

Published Date: 1 July 2016

Prediction of population with Alzheimer's disease in the European Union using a system dynamics model

Tomaskova H, Kuhnova J, Cimler R, Dolezal O, Kuca K

Neuropsychiatric Disease and Treatment 2016, 12:1589-1598

Published Date: 30 June 2016

Parkinson's disease managing reversible neurodegeneration [Corrigendum]

Hinz M, Stein A, Cole T, McDougall B, Westaway M

Neuropsychiatric Disease and Treatment 2016, 12:1587-1588

Published Date: 28 June 2016

Cortisol awakening response in drug-naïve panic disorder

Jakuszkowiak-Wojten K, Landowski J, Wiglusz MS, Cubała WJ

Neuropsychiatric Disease and Treatment 2016, 12:1581-1585

Published Date: 27 June 2016

Mental toughness, sleep disturbances, and physical activity in patients with multiple sclerosis compared to healthy adolescents and young adults

Sadeghi Bahmani D, Gerber M, Kalak N, Lemola S, Clough PJ, Calabrese P, Shaygannejad V, Pühse U, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:1571-1579

Published Date: 27 June 2016

Unmet needs of bipolar disorder patients

Hajda M, Prasko J, Latalova K, Hruby R, Ociskova M, Holubova M, Kamaradova D, Mainerova B

Neuropsychiatric Disease and Treatment 2016, 12:1561-1570

Published Date: 24 June 2016

Cognitive status in patients with multiple sclerosis in Lanzarote

Pérez-Martín MY, Eguia-del Rio P, González-Platas M, Jiménez-Sosa A

Neuropsychiatric Disease and Treatment 2016, 12:1553-1559

Published Date: 30 June 2016

Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients

Ociskova M, Prasko J, Latalova K, Kamaradova D, Grambal A

Neuropsychiatric Disease and Treatment 2016, 12:1539-1551

Published Date: 24 June 2016

Aggression in autism spectrum disorder: presentation and treatment options

Fitzpatrick SE, Srivorakiat L, Wink LK, Pedapati EV, Erickson CA

Neuropsychiatric Disease and Treatment 2016, 12:1525-1538

Published Date: 23 June 2016

Effect of adjuvant sleep hygiene psychoeducation and lorazepam on depression and sleep quality in patients with major depressive disorders: results from a randomized three-arm intervention

Rahimi A, Ahmadpanah M, Shamsaei F, Cheraghi F, Sadeghi Bahmani D, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:1507-1515

Published Date: 22 June 2016

A door-to-door survey to estimate the prevalence of Parkinsonism in Pakistan

Khan S, Nabi G, Naeem M, Ali L, Silburn PA, Mellick GD

Neuropsychiatric Disease and Treatment 2016, 12:1499-1506

Published Date: 21 June 2016

Comparison of treatment outcomes in severe personality disorder patients with or without substance use disorders: a 36-month prospective pragmatic follow-up study

Lana F, Sánchez-Gil C, Adroher ND, Pérez V, Feixas G, Martí-Bonany J, Torrens M

Neuropsychiatric Disease and Treatment 2016, 12:1477-1487

Published Date: 21 June 2016

Characterizing sexual function in patients with generalized anxiety disorder: a pooled analysis of three vilazodone studies

Clayton AH, Durgam S, Tang X, Chen C, Ruth A, Gommoll C

Neuropsychiatric Disease and Treatment 2016, 12:1467-1476

Published Date: 21 June 2016

Psychometric properties of the Spanish version of the Clinical Outcomes in Routine Evaluation – Outcome Measure

Trujillo A, Feixas G, Bados A, García-Grau E, Salla M, Medina JC, Montesano A, Soriano J, Medeiros-Ferreira L, Cañete J, Corbella S, Grau A, Lana F, Evans C

Neuropsychiatric Disease and Treatment 2016, 12:1457-1466

Published Date: 21 June 2016

Altered lower leg muscle activation patterns in patients with cerebral palsy during cycling on an ergometer

Alves-Pinto A, Blumenstein T, Turova V, Lampe R

Neuropsychiatric Disease and Treatment 2016, 12:1445-1456

Published Date: 17 June 2016

The causes of new-onset epilepsy and seizures in the elderly

Liu S, Yu W, Lü Y

Neuropsychiatric Disease and Treatment 2016, 12:1425-1434

Published Date: 17 June 2016

Body integrity identity disorder crosses culture: case reports in the Japanese and Chinese literature

Blom RM, Vulink NC, van der Wal SJ, Nakamae T, Tan Z, Derks EM, Denys D

Neuropsychiatric Disease and Treatment 2016, 12:1419-1423

Published Date: 16 June 2016

Anterior cingulate hyperactivations during negative emotion processing among men with schizophrenia and a history of violent behavior

Tikàsz A, Potvin S, Lungu O, Joyal CC, Hodgins S, Mendrek A, Dumais A

Neuropsychiatric Disease and Treatment 2016, 12:1397-1410

Published Date: 15 June 2016

Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression

Zincir S, Öztürk P, Bilgen AE, İzci F, Yükselir C

Neuropsychiatric Disease and Treatment 2016, 12:1389-1396

Published Date: 15 June 2016

Early diagnosis and Early Start Denver Model intervention in autism spectrum disorders delivered in an Italian Public Health System service

Devescovi R, Monasta L, Mancini A, Bin M, Vellante V, Carrozzi M, Colombi C

Neuropsychiatric Disease and Treatment 2016, 12:1379-1384

Published Date: 14 June 2016

Abnormal spontaneous regional brain activity in primary insomnia: a resting-state functional magnetic resonance imaging study

Li C, Ma XF, Dong MS, Yin Y, Hua KL, Li M, Li CH, Zhan WF, Li C, Jiang GH

Neuropsychiatric Disease and Treatment 2016, 12:1371-1378

Published Date: 14 June 2016

The effect of ApoE e4 on blood pressure in patients with and without depression

Hestad KA, Engedal K, Whist JE, Farup PG

Neuropsychiatric Disease and Treatment 2016, 12:1365-1370

Published Date: 14 June 2016

Volumetric brain abnormalities in polysubstance use disorder patients

Noyan CO, Kose S, Nurmedov S, Metin B, Darcin AE, Dilbaz N

Neuropsychiatric Disease and Treatment 2016, 12:1355-1363

Published Date: 13 June 2016

Bilateral internal carotid artery dissection associated with prior syphilis: a case report and review of the literature

Marangi A, Moretto G, Cappellari M, Micheletti N, Tomelleri G, Bovi P

Neuropsychiatric Disease and Treatment 2016, 12:1351-1354

Published Date: 10 June 2016

Randomized controlled trials – a matter of design

Spieth PM, Kubasch AS, Penzlin AI, Illigens BM, Barlinn K, Siepmann T

Neuropsychiatric Disease and Treatment 2016, 12:1341-1349

Published Date: 10 June 2016

Investigating analgesic and psychological factors associated with risk of postpartum depression development: a case–control study

Suhitharan T, Pham TPT, Chen H, Assam PN, Sultana R, Han NLR, Tan EC, Sng BL

Neuropsychiatric Disease and Treatment 2016, 12:1333-1339

Published Date: 9 June 2016

Cognitive behavioral therapy for depression in Japanese Parkinson's disease patients: a pilot study

Shinmei I, Kobayashi K, Oe Y, Takagishi Y, Kanie A, Ito M, Takebayashi Y, Murata M, Horikoshi M, Dobkin RD

Neuropsychiatric Disease and Treatment 2016, 12:1319-1331

Published Date: 8 June 2016

The current state of physical activity and exercise programs in German-speaking, Swiss psychiatric hospitals: results from a brief online survey

Brand S, Colledge F, Beeler N, Pühse U, Kalak N, Sadeghi Bahmani D, Mikoteit T, Holsboer-Trachsler E, Gerber M

Neuropsychiatric Disease and Treatment 2016, 12:1309-1317

Published Date: 3 June 2016

Altered intrinsic regional brain spontaneous activity in patients with comitant strabismus: a resting-state functional MRI study

Huang X, Li SH, Zhou FQ, Zhang Y, Zhong YL, Cai FQ, Shao Y, Zeng XJ

Neuropsychiatric Disease and Treatment 2016, 12:1303-1308

Published Date: 3 June 2016

Chronic depression treated successfully with novel taping therapy: a new approach to the treatment of depression

Han CH, Hwang HS, Lee YJ, Lee SN, Abanes JJ, Lee BH

Neuropsychiatric Disease and Treatment 2016, 12:1281-1286

Published Date: 1 June 2016

Comparison of clinical features between primary and drug-induced sleep-related eating disorder

Komada Y, Takaesu Y, Matsui K, Nakamura M, Nishida S, Kanno M, Usui A, Inoue Y

Neuropsychiatric Disease and Treatment 2016, 12:1275-1280

Published Date: 26 May 2016

Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study

Beyazyüz M, Küfeciler T, Bulut L, Ünsal C, Albayrak Y, Akyol ES, Baykal S, Kuloglu M, Hashimoto K

Neuropsychiatric Disease and Treatment 2016, 12:1261-1268

Published Date: 23 May 2016

Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy

Tambucci R, Basti C, Maresca M, Coppola G, Verrotti A

Neuropsychiatric Disease and Treatment 2016, 12:1251-1260

Published Date: 23 May 2016

Low-dose aripiprazole for refractory burning mouth syndrome

Umezaki Y, Takenoshita M, Toyofuku A

Neuropsychiatric Disease and Treatment 2016, 12:1229-1231

Published Date: 19 May 2016

A review of executive function deficits in autism spectrum disorder and attention-deficit/hyperactivity disorder

Craig F, Margari F, Legrottaglie AR, Palumbi R, de Giambattista C, Margari L

Neuropsychiatric Disease and Treatment 2016, 12:1191-1202

Published Date: 12 May 2016

Efficacy and motor complications of original and generic levodopa in Parkinson's disease treatment

Kasemsap N, Onsanit S, Chiewthanakul P, Kongbunkiat K, Tanking C, Vorasoot N, Sawanyawisuth K, Tiamkao S

Neuropsychiatric Disease and Treatment 2016, 12:1185-1189

Published Date: 11 May 2016

The role of psychiatrists in diagnosing conversion disorder: a mixed-methods analysis

Kanaan RA, Armstrong D, Wessely S

Neuropsychiatric Disease and Treatment 2016, 12:1181-1184

Published Date: 11 May 2016

Clinical usefulness of hemoencephalography beyond the neurofeedback

Serra-Sala M, Timoneda-Gallart C, Pérez-Álvarez F

Neuropsychiatric Disease and Treatment 2016, 12:1173-1180

Published Date: 11 May 2016

The impact of synapsin III gene on the neurometabolite level alterations after single-dose methylphenidate in attention-deficit hyperactivity disorder patients

Başay Ö, Kabukcu Basay B, Alacam H, Ozturk O, Buber A, Gorucu Yilmaz S, Kıroğlu Y, Erdal ME, Herken H

Neuropsychiatric Disease and Treatment 2016, 12:1141-1149

Published Date: 10 May 2016

The prevalence and risk factors of stroke in patients with chronic schizophrenia

Liang Y, Huang J, Tian J, Cao Y, Zhang G, Wang C, Cao Y, Li J

Neuropsychiatric Disease and Treatment 2016, 12:1131-1134

Published Date: 9 May 2016

Possible sertraline-induced extrapyramidal adverse effects in an adolescent

Wang LF, Huang JW, Shan SY, Ding JH, Lai JB, Xu Y, Hu SH

Neuropsychiatric Disease and Treatment 2016, 12:1127-1129

Published Date: 6 May 2016

Cognitive deficits in patients with obsessive–compulsive disorder – electroencephalography correlates

Kamaradova D, Hajda M, Prasko J, Taborsky J, Grambal A, Latalova K, Ociskova M, Brunovsky M, Hlustik P

Neuropsychiatric Disease and Treatment 2016, 12:1119-1125

Published Date: 6 May 2016

Spectrum of epilepsy – prevalence, impact, and treatment gap: an epidemiological study from Al-Quseir, Egypt

El-Tallawy HN, Farghaly WM, Rageh TA, Shehata GA, Metwally NA, Badry R, Sayed MA, Abdelwarith AM, Kandil MR, Hamed MA, Mohamed KO, Tohamy AM

Neuropsychiatric Disease and Treatment 2016, 12:1111-1118

Published Date: 12 May 2016

Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review

Treuer T, Méndez L, Montgomery W, Wu S

Neuropsychiatric Disease and Treatment 2016, 12:1061-1083

Published Date: 3 May 2016

Risk factors for pneumonia among patients with Parkinson's disease: a Taiwan nationwide population-based study

Chang YP, Yang CJ, Hu KF, Chao AC, Chang YH, Hsieh KP, Tsai JH, Ho PS, Lim SY

Neuropsychiatric Disease and Treatment 2016, 12:1037-1046

Published Date: 27 April 2016

Anxiety and depression in patients with head and neck cancer: 6-month follow-up study

Wu YS, Lin PY, Chien CY, Fang FM, Chiu NM, Hung CF, Lee Y, Chong MY

Neuropsychiatric Disease and Treatment 2016, 12:1029-1036

Published Date: 27 April 2016

Investigation of PON1 activity and MDA levels in patients with epilepsy not receiving antiepileptic treatment

Dönmezdil N, Çevik MU, Özdemir HH, Taşin M

Neuropsychiatric Disease and Treatment 2016, 12:1013-1017

Published Date: 22 April 2016

Protective effects of L-glutamine against toxicity of deltamethrin in the cerebral tissue

Varol S, Özdemir HH, Çevik MU, Altun Y, Ibiloğlu I, Ekinci A, Ibiloğlu AO, Balduz M, Arslan D, Tekin R, Aktar F, Aluçlu MU

Neuropsychiatric Disease and Treatment 2016, 12:1005-1011

Published Date: 21 April 2016

Sense of alexithymia in patients with anxiety disorders comorbid with recurrent urticaria

Ogłodek EA, Szota AM, Just MJ, Araszkiewicz A, Szromek AR

Neuropsychiatric Disease and Treatment 2016, 12:995-1004

Published Date: 21 April 2016

The correlation between stress and economic crisis: a systematic review

Mucci N, Giorgi G, Roncaioli M, Fiz Perez J, Arcangeli G

Neuropsychiatric Disease and Treatment 2016, 12:983-993

Published Date: 21 April 2016

Diagnostic pitfalls in a young Romanian ranger with an acute psychotic episode

Nagy EE, Rácz A, Urbán E, Terhes G, Berki T, Horváth E, Georgescu AM, Zaharia-Kézdi IE

Neuropsychiatric Disease and Treatment 2016, 12:961-967

Published Date: 3 May 2016

Medication management during electroconvulsant therapy

Zolezzi M

Neuropsychiatric Disease and Treatment 2016, 12:931-939

Published Date: 19 April 2016

Olig1 expression pattern in neural cells during rat spinal cord development

Qi Q, Zhang Y, Shen L, Wang R, Zhou J, Lü H, Hu J

Neuropsychiatric Disease and Treatment 2016, 12:909-916

Published Date: 18 April 2016

Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia

Alosaimi FD, Alhabbad AA, Abalhassan MF, Fallata EO, Alzain NM, Alassiry MZ, Haddad BA

Neuropsychiatric Disease and Treatment 2016, 12:897-907

Published Date: 19 April 2016

Shen-Qi-Jie-Yu-Fang exerts effects on a rat model of postpartum depression by regulating inflammatory cytokines and CD4+CD25+ regulatory T cells

Li JY, Zhao RZ, Li XL, Sun WJ, Qu M, Tang QS, Yang XK, Zhang SJ

Neuropsychiatric Disease and Treatment 2016, 12:883-896

Published Date: 15 April 2016

Fear of falling: efficacy of virtual reality associated with serious games in elderly people

Levy F, Leboucher P, Rautureau G, Komano O, Millet B, Jouvent R

Neuropsychiatric Disease and Treatment 2016, 12:877-881

Published Date: 15 April 2016

Olfactory dysfunction in Alzheimer’s disease

Zou YM, Lu D, Liu LP, Zhang HH, Zhou YY

Neuropsychiatric Disease and Treatment 2016, 12:869-875

Published Date: 15 April 2016

Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia

Urban-Kowalczyk M, Śmigielski J, Strzelecki D

Neuropsychiatric Disease and Treatment 2016, 12:863-868

Published Date: 15 April 2016

Altered intra- and interregional synchronization in relapsing–remitting multiple sclerosis: a resting-state fMRI study

Wu L, Zhang Y, Zhou F, Gao L, He L, Zeng X, Gong H

Neuropsychiatric Disease and Treatment 2016, 12:853-862

Published Date: 15 April 2016

Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder

Medhasi S, Pasomsub E, Vanwong N, Ngamsamut N, Puangpetch A, Chamnanphon M, Hongkaew Y, Limsila P, Pinthong D, Sukasem C

Neuropsychiatric Disease and Treatment 2016, 12:843-851

Published Date: 13 April 2016

Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine

Guerdjikova AI, Mori N, Casuto LS, McElroy SL

Neuropsychiatric Disease and Treatment 2016, 12:833-841

Published Date: 18 April 2016

The influence of childhood abuse, adult life events, and affective temperaments on the well-being of the general, nonclinical adult population

Kanai Y, Takaesu Y, Nakai Y, Ichiki M, Sato M, Matsumoto Y, Ishikawa J, Ono Y, Murakoshi A, Tanabe H, Kusumi I, Inoue T

Neuropsychiatric Disease and Treatment 2016, 12:823-832

Published Date: 12 April 2016

Patients with depression display cytokine levels in serum and cerebrospinal fluid similar to patients with diffuse neurological symptoms without a defined diagnosis

Hestad KA, Engedal K, Whist JE, Aukrust P, Farup PG, Mollnes TE, Ueland T

Neuropsychiatric Disease and Treatment 2016, 12:817-822

Published Date: 13 April 2016

Relationship between quality of life and restless legs syndrome among a community-dwelling population in Japan

Kubo K, Sugawara N, Kaneda A, Takahashi I, Nakamura K, Nakaji S, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2016, 12:809-815

Published Date: 12 April 2016

Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients

Novick D, Montgomery W, Aguado J, Peng XM, Haro JM

Neuropsychiatric Disease and Treatment 2016, 12:795-800

Published Date: 11 April 2016

Suicidal behavior and self-harm in girls with eating disorders

Koutek J, Kocourkova J, Dudova I

Neuropsychiatric Disease and Treatment 2016, 12:787-793

Published Date: 11 April 2016

Virtual reality for the treatment of posttraumatic disorders

Moraes TM, de Andrade AF, Paiva WS

Neuropsychiatric Disease and Treatment 2016, 12:785-786

Published Date: 7 April 2016

Does amantadine induce acute psychosis? A case report and literature review

Xu WJ, Wei N, Xu Y, Hu SH

Neuropsychiatric Disease and Treatment 2016, 12:781-783

Published Date: 6 April 2016

Positron emission tomography in patients with psychogenic non-epileptic seizures

McGonigal A, Arthuis M, Micoulaud-Franchi JA, Bartolomei F, Guedj E

Neuropsychiatric Disease and Treatment 2016, 12:777-778

Published Date: 5 April 2016

Parkinson’s disease managing reversible neurodegeneration

Hinz M, Stein A, Cole T, McDougall B, Westaway M

Neuropsychiatric Disease and Treatment 2016, 12:763-775

Published Date: 5 April 2016

A meta-synthesis on parenting a child with autism

Ooi KL, Ong YS, Jacob SA, Khan TM

Neuropsychiatric Disease and Treatment 2016, 12:745-762

Published Date: 5 April 2016

Demographic variables, clinical aspects, and medicolegal implications in a population of patients with adjustment disorder

Anastasia A, Colletti C, Cuoco V, Quartini A, Urso S, Rinaldi R, Bersani G

Neuropsychiatric Disease and Treatment 2016, 12:737-743

Published Date: 1 April 2016

Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review

Fornaro M, De Berardis D, Koshy AS, Perna G, Valchera A, Vancampfort D, Stubbs B

Neuropsychiatric Disease and Treatment 2016, 12:719-735

Published Date: 31 March 2016

Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report

Zhang B, Zhao Y, Liu J, Li L, Shan J, Zhao D, Yan C

Neuropsychiatric Disease and Treatment 2016, 12:713-717

Published Date: 29 March 2016

A family-oriented therapy program for youths with substance abuse: long-term outcomes related to relapse and academic or social status

Wang LJ, Lu SF, Chong MY, Chou WJ, Hsieh YL, Tsai TN, Chen C, Lee YH

Neuropsychiatric Disease and Treatment 2016, 12:699-706

Published Date: 30 March 2016

Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia

Cheng MF, Gu HY, Zheng LR, Wang HL, Zhong ZY, Wen SL

Neuropsychiatric Disease and Treatment 2016, 12:695-697

Published Date: 29 March 2016

Brain-derived neurotrophic factor modulates immune reaction in mice with peripheral nerve xenotransplantation

Yu X, Lu L, Liu Z, Yang T, Gong X, Ning Y, Jiang Y

Neuropsychiatric Disease and Treatment 2016, 12:685-694

Published Date: 29 March 2016

The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease

Yanartas O, Kani HT, Bicakci E, Kilic I, Banzragch M, Acikel C, Atug O, Kuscu K, Imeryuz N, Akin H

Neuropsychiatric Disease and Treatment 2016, 12:673-683

Published Date: 24 March 2016

Quality of life and parental styles assessed by adolescents suffering from inflammatory bowel diseases and their parents

Jelenova D, Prasko J, Ociskova M, Latalova K, Karaskova E, Hruby R, Kamaradova D, Mihal V

Neuropsychiatric Disease and Treatment 2016, 12:665-672

Published Date: 23 March 2016

Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function

Takeyoshi K, Kurita M, Nishino S, Teranishi M, Numata Y, Sato T, Okubo Y

Neuropsychiatric Disease and Treatment 2016, 12:641-649

Published Date: 15 March 2016

Cognitive behavioral therapy in pharmacoresistant obsessive–compulsive disorder

Vyskocilova J, Prasko J, Sipek J

Neuropsychiatric Disease and Treatment 2016, 12:625-639

Published Date: 14 March 2016

Effects of intracerebral hemorrhage on 5-hydroxymethylcytosine modification in mouse brains

Tang YL, Han S, Asakawa T, Luo YH, Han X, Xiao BG, Dong Q, Wang L

Neuropsychiatric Disease and Treatment 2016, 12:617-624

Published Date: 15 March 2016

No association between BDNFVal66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population

Umehara H, Numata S, Kinoshita M, Watanabe S, Nakaaki S, Sumitani S, Ohmori T

Neuropsychiatric Disease and Treatment 2016, 12:611-615

Published Date: 11 March 2016

Identification of a seasonal pattern to brain metastases

Sakellakis M, Koutras A, Pittaka M, Kardamakis D, Kalofonou M, Kalofonos HP, Spyropoulou D

Neuropsychiatric Disease and Treatment 2016, 12:609-610

Published Date: 7 March 2016

Validity and test–retest reliability of the Persian version of the Montgomery–Asberg Depression Rating Scale

Ahmadpanah M, Sheikhbabaei M, Haghighi M, Roham F, Jahangard L, Akhondi A, Sadeghi Bahmani D, Bajoghli H, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:603-607

Published Date: 7 March 2016

Occurrence of ADHD in parents of ADHD children in a clinical sample

Starck M, Grünwald J, Schlarb AA

Neuropsychiatric Disease and Treatment 2016, 12:581-588

Published Date: 3 March 2016

Attention deficit hyperactivity disorder and disordered eating behaviors: links, risks, and challenges faced

Ptacek R, Stefano GB, Weissenberger S, Akotia D, Raboch J, Papezova H, Domkarova L, Stepankova T, Goetz M

Neuropsychiatric Disease and Treatment 2016, 12:571-579

Published Date: 3 March 2016

Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy–tolerability pilot study

Petrò E, Ruffini E, Cappuccio M, Guerini V, Belotti G, Fascendini S, Licini C, Marcassa C

Neuropsychiatric Disease and Treatment 2016, 12:559-569

Published Date: 2 March 2016

The noradrenergic paradox: implications in the management of depression and anxiety

Montoya A, Bruins R, Katzman MA, Blier P

Neuropsychiatric Disease and Treatment 2016, 12:541-557

Published Date: 1 March 2016

Assistive technologies for managing language disorders in dementia

Klimova B, Maresova P, Kuca K

Neuropsychiatric Disease and Treatment 2016, 12:533-540

Published Date: 29 February 2016

Association between sociodemographic characteristics and anxiety levels of violence-exposed patients admitted to emergency clinic

Hocagil H, Izci F, Hocagil AC, Findikli E, Korkmaz S, Koc MI

Neuropsychiatric Disease and Treatment 2016, 12:511-516

Published Date: 26 February 2016

Intelligence quotient discrepancy indicates levels of motor competence in preschool children at risk for developmental delays

Yu TY, Chen KL, Chou W, Yang SH, Kung SC, Lee YC, Tung LC

Neuropsychiatric Disease and Treatment 2016, 12:501-510

Published Date: 26 February 2016

Suvorexant: a promising, novel treatment for insomnia

Lee-Iannotti JK, Parish JM

Neuropsychiatric Disease and Treatment 2016, 12:491-495

Published Date: 25 February 2016

Medical management of epileptic seizures: challenges and solutions

Sarma AK, Khandker N, Kurczewski L, Brophy GM

Neuropsychiatric Disease and Treatment 2016, 12:467-485

Published Date: 24 February 2016

A voxel-based morphometric study of age- and sex-related changes in white matter volume in the normal aging brain

Liu H, Wang L, Geng Z, Zhu Q, Song Z, Chang R, Lv H

Neuropsychiatric Disease and Treatment 2016, 12:453-465

Published Date: 24 February 2016

Detection of hyperphosphorylated tau protein and α-synuclein in spinal cord of patients with Alzheimer’s disease

Guo YJ, Wang LN, Zhu MW, Zhang HH, Hu YZ, Han ZT, Liu J, Zhao WQ, Wang DX

Neuropsychiatric Disease and Treatment 2016, 12:445-452

Published Date: 26 February 2016

Attitudes toward metabolic adverse events among patients with schizophrenia in Japan

Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Matsuda H, Suzuki Y, Minami Y, Ozeki Y, Okamoto K, Sagae T, Someya T

Neuropsychiatric Disease and Treatment 2016, 12:427-436

Published Date: 24 February 2016

Intractable restless legs syndrome: role of prolonged-release oxycodone–naloxone

de Biase S, Valente M, Gigli GL

Neuropsychiatric Disease and Treatment 2016, 12:417-425

Published Date: 23 February 2016

The investigation of factors related to suicide attempts in Southeastern Turkey

Okan Ibiloglu A, Atli A, Demir S, Gunes M, Kaya MC, Bulut M, Sir A

Neuropsychiatric Disease and Treatment 2016, 12:407-416

Published Date: 23 February 2016

An Internet-based program for depression using activity and physiological sensors: efficacy, expectations, satisfaction, and ease of use

Botella C, Mira A, Moragrega I, García-Palacios A, Bretón-López J, Castilla D, Riera López del Amo A, Soler C, Molinari G, Quero S, Guillén-Botella V, Miralles I, Nebot S, Serrano B, Majoe D, Alcañiz M, Baños RM

Neuropsychiatric Disease and Treatment 2016, 12:393-406

Published Date: 23 February 2016

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia

Novick D, Montgomery W, Haro JM, Moneta MV, Zhu G, Yue L, Hong J, Dueñas H, Brugnoli R

Neuropsychiatric Disease and Treatment 2016, 12:383-392

Published Date: 23 February 2016

DSM-5 PTSD and posttraumatic stress spectrum in Italian emergency personnel: correlations with work and social adjustment

Carmassi C, Gesi C, Simoncini M, Favilla L, Massimetti G, Olivieri MC, Conversano C, Santini M, Dell’Osso L

Neuropsychiatric Disease and Treatment 2016, 12:375-381

Published Date: 18 February 2016

Global economic burden of schizophrenia: a systematic review

Chong HY, Teoh SL, Wu DBC, Kotirum S, Chiou CF, Chaiyakunapruk N

Neuropsychiatric Disease and Treatment 2016, 12:357-373

Published Date: 16 February 2016

Sexual dysfunction, mood, anxiety, and personality disorders in female patients with fibromyalgia

Kayhan F, Küçük A, Satan Y, İlgün E, Arslan S, İlik F

Neuropsychiatric Disease and Treatment 2016, 12:349-355

Published Date: 16 February 2016

Traumatic brain injury-induced sleep disorders

Viola-Saltzman M, Musleh C

Neuropsychiatric Disease and Treatment 2016, 12:339-348

Published Date: 15 February 2016

Preliminary report of improved sleep quality in patients with dry eye disease after initiation of topical therapy

Ayaki M, Toda I, Tachi N, Negishi K, Tsubota K

Neuropsychiatric Disease and Treatment 2016, 12:329-337

Published Date: 16 February 2016

Strategies to improve anxiety and depression in patients with COPD: a mental health perspective

Tselebis A, Pachi A, Ilias I, Kosmas E, Bratis D, Moussas G, Tzanakis N

Neuropsychiatric Disease and Treatment 2016, 12:297-328

Published Date: 9 February 2016

Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges

Williams AE, Giust JM, Kronenberger WG, Dunn DW

Neuropsychiatric Disease and Treatment 2016, 12:287-296

Published Date: 9 February 2016

Recruiting for research studies using online public advertisements examples from research in affective disorders

Wise T, Arnone D, Marwood L, Zahn R, Lythe KE, Young AH

Neuropsychiatric Disease and Treatment 2016, 12:279-285

Published Date: 5 February 2016

Chronic organophosphate-induced neuropsychiatric disorder: a case report

Ghimire SR, Parajuli S

Neuropsychiatric Disease and Treatment 2016, 12:275-277

Published Date: 4 February 2016

Depot-medication compliance for patients with psychotic disorders: the importance of illness insight and treatment motivation

Noordraven EL, Wierdsma AI, Blanken P, Bloemendaal AFT, Mulder CL

Neuropsychiatric Disease and Treatment 2016, 12:269-274

Published Date: 3 February 2016

Neuroleptic-induced deficit syndrome in bipolar disorder with psychosis

Ueda S, Sakayori T, Omori A, Fukuta H, Kobayashi T, Ishizaka K, Saijo T, Okubo Y

Neuropsychiatric Disease and Treatment 2016, 12:265-268

Published Date: 2 February 2016

Electroencephalogram characteristics in patients with chronic fatigue syndrome

Wu T, Qi X, Su Y, Teng J, Xu X

Neuropsychiatric Disease and Treatment 2016, 12:241-249

Published Date: 28 January 2016

Mania following ketamine abuse

Lu YY, Lin CH, Lane HY

Neuropsychiatric Disease and Treatment 2016, 12:237-239

Published Date: 27 January 2016

Examining Dark Triad traits in relation to mental toughness and physical activity in young adults

Sabouri S, Gerber M, Sadeghi Bahmani D, Lemola S, Clough PJ, Kalak N, Shamsi M, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:229-235

Published Date: 27 January 2016

cAMP/PKA/CREB/GLT1 signaling involved in the antidepressant-like effects of phosphodiesterase 4D inhibitor (GEBR-7b) in rats

Liu X, Guo H, Sayed MDSOM, Lu Y, Yang T, Zhou D, Chen Z, Wang H, Wang C, Xu J

Neuropsychiatric Disease and Treatment 2016, 12:219-227

Published Date: 21 January 2016

A 5-year retrospective study of demographic, anamnestic, and clinical factors related to psychiatric hospitalizations of adolescent patients

Di Lorenzo R, Cimino N, Di Pietro E, Pollutri G, Neviani V, Ferri P

Neuropsychiatric Disease and Treatment 2016, 12:191-201

Published Date: 18 January 2016

Psychogenic nonepileptic seizures as a manifestation of psychological distress associated with undiagnosed autism spectrum disorder

Miyawaki D, Iwakura Y, Seto T, Kusaka H, Goto A, Okada Y, Asada N, Yanagihara E, Inoue K

Neuropsychiatric Disease and Treatment 2016, 12:185-189

Published Date: 18 January 2016

The crossroads of anxiety: distinct neurophysiological maps for different symptomatic groups

Gerez M, Suárez E, Serrano C, Castanedo L, Tello A

Neuropsychiatric Disease and Treatment 2016, 12:159-175

Published Date: 18 January 2016

Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt

El-Tallawy HN, Farghaly WM, Badry R, Metwally NA, Shehata GA, Rageh TA, El Hamed MA, Kandil MR

Neuropsychiatric Disease and Treatment 2016, 12:155-158

Published Date: 13 January 2016

Higher emotional intelligence is related to lower test anxiety among students

Ahmadpanah M, Keshavarz M, Haghighi M, Jahangard L, Bajoghli H, Sadeghi Bahmani D, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:133-136

Published Date: 12 January 2016

Synesthetic associations and psychosensory symptoms of temporal epilepsy

Neckar M, Bob P

Neuropsychiatric Disease and Treatment 2016, 12:109-112

Published Date: 11 January 2016

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder

Harada E, Shirakawa O, Satoi Y, Marangell LB, Escobar R

Neuropsychiatric Disease and Treatment 2016, 12:89-97

Published Date: 11 January 2016

Optimal management of ADHD in older adults

Torgersen T, Gjervan B, Lensing MB, Rasmussen K

Neuropsychiatric Disease and Treatment 2016, 12:79-87

Published Date: 8 January 2016

Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review

Karson C, Duffy RA, Eramo A, Nylander AG, Offord SJ

Neuropsychiatric Disease and Treatment 2016, 12:57-67

Published Date: 6 January 2016

Affective network and default mode network in depressive adolescents with disruptive behaviors

Kim SM, Park SY, Kim YI, Son YD, Chung US, Min KJ, Han DH

Neuropsychiatric Disease and Treatment 2016, 12:49-56

Published Date: 31 December 2015

Computer task performance by subjects with Duchenne muscular dystrophy

Malheiros SRP, da Silva TD, Favero FM, de Abreu LC, Fregni F, Ribeiro DC, de Mello Monteiro CB

Neuropsychiatric Disease and Treatment 2016, 12:41-48

Published Date: 30 December 2015

Influence of hypothyroidism on renal function of lithium-treated patients

Lozano R, Marín R, Santacruz MJ

Neuropsychiatric Disease and Treatment 2016, 12:25-27

Published Date: 23 December 2015

Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses

Bortolato B, Miskowiak KW, Köhler CA, Vieta E, Carvalho AF

Neuropsychiatric Disease and Treatment 2015, 11:3111-3125

Published Date: 17 December 2015

Cerebrospinal fluid biomarkers for Alzheimer’s disease: the role of apolipoprotein E genotype, age, and sex

Mehrabian S, Alexopoulos P, Ortner M, Traykov L, Grimmer T, Kurz A, Förstl H, Bickel H, Diehl-Schmid J

Neuropsychiatric Disease and Treatment 2015, 11:3105-3110

Published Date: 17 December 2015

Lack of tolerable treatment options for patients with schizophrenia

Citrome L, Eramo A, Francois C, Duffy R, Legacy SN, Offord SJ, Krasa HB, Johnston SS, Guiraud-Diawara A, Kamat SA, Rohman P

Neuropsychiatric Disease and Treatment 2015, 11:3095-3104

Published Date: 16 December 2015

Functional connectivity of paired default mode network subregions in primary insomnia

Nie X, Shao Y, Liu SY, Li HJ, Wan AL, Nie S, Peng DC, Dai XJ

Neuropsychiatric Disease and Treatment 2015, 11:3085-3093

Published Date: 16 December 2015

Disturbed spontaneous brain-activity pattern in patients with optic neuritis using amplitude of low-frequency fluctuation: a functional magnetic resonance imaging study

Huang X, Cai FQ, Hu PH, Zhong YL, Zhang Y, Wei R , Pei CG, Zhou FQ, Shao Y

Neuropsychiatric Disease and Treatment 2015, 11:3075-3083

Published Date: 16 December 2015

Altered intrinsic regional spontaneous brain activity in patients with optic neuritis: a resting-state functional magnetic resonance imaging study

Shao Y, Cai FQ, Zhong YL, Huang X, Zhang Y, Hu PH, Pei CG, Zhou FQ, Zeng XJ

Neuropsychiatric Disease and Treatment 2015, 11:3065-3073

Published Date: 11 December 2015

The effects of motivation feedback in patients with severe mental illness: a cluster randomized controlled trial

Jochems EC, van der Feltz-Cornelis CM, van Dam A, Duivenvoorden HJ, Mulder CL

Neuropsychiatric Disease and Treatment 2015, 11:3049-3064

Published Date: 11 December 2015

Coping strategies and quality of life in schizophrenia: cross-sectional study

Holubova M, Prasko J, Hruby R, Kamaradova D, Ociskova M, Latalova K, Grambal A

Neuropsychiatric Disease and Treatment 2015, 11:3041-3048

Published Date: 10 December 2015

Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study

Hashimoto T, Sakurai D, Oda Y, Hasegawa T, Kanahara N, Sasaki T, Komatsu H, Takahashi J, Oiwa T, Sekine Y, Watanabe H, Iyo M

Neuropsychiatric Disease and Treatment 2015, 11:3031-3040

Published Date: 10 December 2015

Severe arrhythmia induced by orally disintegrating aripiprazole tablets (Bosiqing®): a case report

Shao Q, Quan W, Jia X, Chen J, Ma S, Zhang X

Neuropsychiatric Disease and Treatment 2015, 11:3019-3021

Published Date: 9 December 2015

Asenapine for bipolar disorder

Scheidemantel T, Korobkova I, Rej S, Sajatovic M

Neuropsychiatric Disease and Treatment 2015, 11:3007-3017

Published Date: 4 December 2015

A review of cognitive conflicts research: a meta-analytic study of prevalence and relation to symptoms

Montesano A, López-González MA, Saúl LA, Feixas G

Neuropsychiatric Disease and Treatment 2015, 11:2997-3006

Published Date: 4 December 2015

Psychological changes in alcohol-dependent patients during a residential rehabilitation program

Giorgi I, Ottonello M, Vittadini G, Bertolotti G,

Neuropsychiatric Disease and Treatment 2015, 11:2989-2996

Published Date: 7 December 2015

Risk of seizures in transcranial magnetic stimulation: a clinical review to inform consent process focused on bupropion

Dobek CE, Blumberger DM, Downar J, Daskalakis ZJ, Vila-Rodriguez F

Neuropsychiatric Disease and Treatment 2015, 11:2975-2987

Published Date: 30 November 2015

Profile of brivaracetam and its potential in the treatment of epilepsy

Ferlazzo E, Russo E, Mumoli L, Sueri C, Gasparini S, Palleria C, Labate A, Gambardella A, De Sarro G, Aguglia U

Neuropsychiatric Disease and Treatment 2015, 11:2967-2973

Published Date: 30 November 2015

Long-term effect of early-life stress from earthquake exposure on working memory in adulthood

Li N, Wang Y, Zhao X, Gao Y, Song M, Yu L, Wang L, Li N, Chen Q, Li Y, Cai J, Wang X

Neuropsychiatric Disease and Treatment 2015, 11:2959-2965

Published Date: 26 November 2015

Japanese version of the Munich Parasomnia Screening: translation and linguistic validation of a screening instrument for parasomnias and nocturnal behaviors

Komada Y, Breugelmans R, Fulda S, Nakano S, Watanabe A, Noda C, Nishida S, Inoue Y

Neuropsychiatric Disease and Treatment 2015, 11:2953-2958

Published Date: 25 November 2015

Comparative efficacy, acceptability, and tolerability of dexmethylphenidate versus placebo in child and adolescent ADHD: a meta-analysis of randomized controlled trials

Maneeton N, Maneeton B, Woottiluk P, Suttajit S, Likhitsathian S, Charnsil C, Srisurapanont M

Neuropsychiatric Disease and Treatment 2015, 11:2943-2952

Published Date: 25 November 2015

The association between the subjective memory complaints scale and depressive state and cognitive impairment: a factor analysis

Tomita T, Yasui-Furukori N, Sugawara N, Takahashi I, Sawada K, Nakamura K

Neuropsychiatric Disease and Treatment 2015, 11:2935-2941

Published Date: 23 November 2015

Relationship between remnant hippocampus and amygdala and memory outcomes after stereotactic surgery for mesial temporal lobe epilepsy

Malikova H, Kramska L, Vojtech Z, Sroubek J, Lukavsky J, Liscak R

Neuropsychiatric Disease and Treatment 2015, 11:2927-2933

Published Date: 19 November 2015

Serum endocan levels in women with restless legs syndrome

Celik K, Cikrikcioglu MA, Halac G, Kilic E, Ayhan S, Ozaras N, Yildiz K, Yildiz RS, Zorlu M, Karatoprak C, Cakirca M, Kiskac M

Neuropsychiatric Disease and Treatment 2015, 11:2919-2925

Published Date: 19 November 2015

Prefrontocerebellar transcranial direct current stimulation increases amplitude and decreases latency of P3b component in patients with euthymic bipolar disorder

Bersani FS, Minichino A, Fattapposta F, Bernabei L, Spagnoli F, Mannarelli D, Francesconi M, Pauletti C, Corrado A, Vergnani L, Taddei I, Biondi M, Delle Chiaie R

Neuropsychiatric Disease and Treatment 2015, 11:2913-2917

Published Date: 19 November 2015

Atomoxetine treatment may decrease striatal dopaminergic transporter availability after 8 weeks: pilot SPECT report of three cases

Akay AP, Kaya GC, Baykara B, Demir Y, Ozek H, Alsen S, Eren MS, Emiroglu NI, Ertay T, Ozturk Y, Miral S, Durak H, Tufan E

Neuropsychiatric Disease and Treatment 2015, 11:2909-2912

Published Date: 19 November 2015

Association between insulin and executive functioning in alcohol dependence: a pilot study

Han C, Bae H, Won SD, Lim J, Kim DJ

Neuropsychiatric Disease and Treatment 2015, 11:2903-2908

Published Date: 16 November 2015

Paroxetine ameliorates changes in hippocampal energy metabolism in chronic mild stress-exposed rats

Khedr LH, Nassar NN, El-Denshary ES, Abdel-tawab AM

Neuropsychiatric Disease and Treatment 2015, 11:2887-2901

Published Date: 13 November 2015

Memantine for the treatment of frontotemporal dementia: a meta-analysis

Kishi T, Matsunaga S, Iwata N

Neuropsychiatric Disease and Treatment 2015, 11:2883-2885

Published Date: 12 November 2015

The ability of early changes in motivation to predict later antidepressant treatment response

Gorwood P, Vaiva G, Corruble E, Llorca PM, Baylé FJ, Courtet P

Neuropsychiatric Disease and Treatment 2015, 11:2875-2882

Published Date: 11 November 2015

The impact of nonmotor symptoms on quality of life in patients with Parkinson's disease in Taiwan

Liu WM, Lin RJ, Yu RL, Tai CH, Lin CH, Wu RM

Neuropsychiatric Disease and Treatment 2015, 11:2865-2873

Published Date: 11 November 2015

Early stages of pediatric bipolar disorder: retrospective analysis of a Czech inpatient sample

Goetz M, Novak T, Vesela M, Hlavka Z, Brunovsky M, Povazan M, Ptacek R, Sebela A

Neuropsychiatric Disease and Treatment 2015, 11:2855-2864

Published Date: 4 November 2015

Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease

Cui F, Zhu WJ, Zhou ZB, Ren Y, Li YF, Li M, Huo YY, Huang XS

Neuropsychiatric Disease and Treatment 2015, 11:2847-2854

Published Date: 3 November 2015

In vitro screening of major neurotransmitter systems possibly involved in the mechanism of action of antibodies to S100 protein in released-active form

Gorbunov EA, Ertuzun IA, Kachaeva EV, Tarasov SA, Epstein OI

Neuropsychiatric Disease and Treatment 2015, 11:2837-2846

Published Date: 3 November 2015

Double encephalitis with herpes simplex virus type II and cytomegalovirus in an elder Chinese: a case report

Xue C, Chen S, Lin Q, Zhou H, Huang C, Lin J, Xie W, Chen K, Zhou D, Ma W, Ma F, Xu H

Neuropsychiatric Disease and Treatment 2015, 11:2833-2836

Published Date: 2 November 2015

Neurological soft signs might be endophenotype candidates for patients with deficit syndrome schizophrenia

Albayarak Y, Akyol ES, Beyazyüz M, Baykal S, Kuloglu M

Neuropsychiatric Disease and Treatment 2015, 11:2825-2831

Published Date: 29 October 2015

Reliability and validity of the Thai self-report version of the Yale–Brown Obsessive–Compulsive Scale-Second Edition

Hiranyatheb T, Saipanish R, Lotrakul M, Prasertchai R, Ketkaew W, Jullagate S, Udomsubpayakul U, Kusalaruk P

Neuropsychiatric Disease and Treatment 2015, 11:2817-2824

Published Date: 28 October 2015

The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan

Kudo S, Tomita T, Sugawara N, Sato Y, Ishioka M, Tsuruga K, Nakagami T, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2015, 11:2811-2816

Published Date: 28 October 2015

Connectomics in psychiatric research: advances and applications

Cao M, Wang Z, He Y

Neuropsychiatric Disease and Treatment 2015, 11:2801-2810

Published Date: 29 October 2015

Association study of sepiapterin reductase gene promoter polymorphisms with schizophrenia in a Han Chinese population

Fu JW, Ma GD, Mai H, Luo XD, Yin JW, Chen Q, Lin ZX, Tao H, Li Y, Cui LL, Li Z, Lin JD, Zhao B, Li KS

Neuropsychiatric Disease and Treatment 2015, 11:2793-2799

Published Date: 28 October 2015

Efficacy of physical activity counseling plus sleep restriction therapy on the patients with chronic insomnia

Wang J, Yin G, Li G, Liang W, Wei Q

Neuropsychiatric Disease and Treatment 2015, 11:2771-2778

Published Date: 23 October 2015

Electroencephalography signatures of attention-deficit/hyperactivity disorder: clinical utility

Alba G, Pereda E, Mañas S, Méndez LD, González A, González JJ

Neuropsychiatric Disease and Treatment 2015, 11:2755-2769

Published Date: 22 October 2015

Epidemiological support for genetic variability at hypothalamic–pituitary–adrenal axis and serotonergic system as risk factors for major depression

Ching-López A, Cervilla J, Rivera M, Molina E, McKenney K, Ruiz-Perez I, Rodríguez-Barranco M, Gutiérrez B

Neuropsychiatric Disease and Treatment 2015, 11:2743-2754

Published Date: 22 October 2015

Frequency of anemia in chronic psychiatry patients

Korkmaz S, Yıldız S, Korucu T, Gundogan B, Sunbul ZE, Korkmaz H, Atmaca M

Neuropsychiatric Disease and Treatment 2015, 11:2737-2741

Published Date: 22 October 2015

Neuropsychological and neuroimaging markers in prediction of cognitive impairment after ischemic stroke: a prospective follow-up study

Mehrabian S, Raycheva M, Petrova N, Janyan A, Petrova M, Traykov L

Neuropsychiatric Disease and Treatment 2015, 11:2711-2719

Published Date: 16 October 2015

Motivation for everyday social participation in cognitively able individuals with autism spectrum disorder

Chen YW, Bundy AC, Cordier R, Chien YL, Einfeld SL

Neuropsychiatric Disease and Treatment 2015, 11:2699-2709

Published Date: 15 October 2015

Neurobehavioral burden of multiple sclerosis with nanotheranostics

Sriramoju B, Kanwar RK, Kanwar JR

Neuropsychiatric Disease and Treatment 2015, 11:2675-2689

Published Date: 15 October 2015

Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a retrospective chart review

Nguyen L, Marshalek PJ, Weaver CB, Cramer KJ, Pollard SE, Matsumoto RR

Neuropsychiatric Disease and Treatment 2015, 11:2667-2673

Published Date: 14 October 2015

Altered regional homogeneity of spontaneous brain activity in idiopathic trigeminal neuralgia

Wang Y, Zhang X, Guan Q, Wan L, Yi Y, Liu CF

Neuropsychiatric Disease and Treatment 2015, 11:2659-2666

Published Date: 13 October 2015

Aripiprazole: from pharmacological profile to clinical use

Di Sciascio G, Riva MA

Neuropsychiatric Disease and Treatment 2015, 11:2635-2647

Published Date: 13 October 2015

Increased mean platelet volume in patients with panic disorder

Kokacya MH, Copoglu US, Kivrak Y, Ari M, Sahpolat M, Ulutas KT

Neuropsychiatric Disease and Treatment 2015, 11:2629-2633

Published Date: 13 October 2015

Heart rate variability biofeedback in patients with alcohol dependence: a randomized controlled study

Penzlin AI, Siepmann T, Illigens BMW, Weidner K, Siepmann M

Neuropsychiatric Disease and Treatment 2015, 11:2619-2627

Published Date: 9 October 2015

Predictors of trauma in bank employee robbery victims

Mucci N, Giorgi G, Fiz Perez J, Iavicoli I, Arcangeli G

Neuropsychiatric Disease and Treatment 2015, 11:2605-2612

Published Date: 7 October 2015

Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer’s Disease Neuroimaging Initiative)

Harris P, Fernandez Suarez M, Surace EI, Chrem Méndez P, Martín ME, Clarens MF, Tapajóz F, Russo MJ, Campos J, Guinjoan SM, Sevlever G, Allegri RF

Neuropsychiatric Disease and Treatment 2015, 11:2599-2604

Published Date: 7 October 2015

Clinical correlates of complicated grief among individuals with acute coronary syndromes

Pini S, Gesi C, Abelli M, Cardini A, Lari L, Felice F, Di Stefano R, Mazzotta G, Bovenzi F, Bertoli D, Borelli L, Michi P, Oligeri C, Balbarini A, Manicavasagar V

Neuropsychiatric Disease and Treatment 2015, 11:2583-2589

Published Date: 7 October 2015

Variation of the default mode network with altered alertness levels induced by propofol

Liu XY, Li HD, Luo F, Zhang L, Han RQ, Wang BG

Neuropsychiatric Disease and Treatment 2015, 11:2573-2581

Published Date: 7 October 2015

Electroconvulsive therapy treatment in patients with somatic symptom and related disorders

Leong KW, Tham JCW, Scamvougeras A, Vila-Rodriguez F

Neuropsychiatric Disease and Treatment 2015, 11:2565-2572

Published Date: 6 October 2015

Effect of depressive symptoms on the length of hospital stay among patients hospitalized for acute stroke in Japan

Sugawara N, Metoki N, Hagii J, Saito S, Shiroto H, Tomita T, Yasujima M, Okumura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2015, 11:2551-2556

Published Date: 5 October 2015

Psychogenic non-epileptic seizures: so-called psychiatric comorbidity and underlying defense mechanisms

Beghi M, Beffa Negrini P, Perin C, Peroni F, Magaudda A, Cerri C, Cornaggia CM

Neuropsychiatric Disease and Treatment 2015, 11:2519-2527

Published Date: 30 September 2015

Depressogenic medications and other risk factors for depression among Polish patients with epilepsy

Bosak M, Turaj W, Dudek D, Siwek M, Szczudlik A

Neuropsychiatric Disease and Treatment 2015, 11:2509-2517

Published Date: 30 September 2015

A meta-analysis of lipid peroxidation markers in major depression

Mazereeuw G, Herrmann N, Andreazza AC, Khan MM, Lanctôt KL

Neuropsychiatric Disease and Treatment 2015, 11:2479-2491

Published Date: 29 September 2015

Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains?

Suttajit S, Arunpongpaisal S, Srisurapanont M, Thavichachart N, Kongsakon R, Chantakarn S, Chantarasak V, Jariyavilas A, Jaroensook P, Kittiwattanagul K, Nerapusee O

Neuropsychiatric Disease and Treatment 2015, 11:2471-2477

Published Date: 29 September 2015

Metric qualities of the cognitive behavioral assessment for outcome evaluation to estimate psychological treatment effects

Bertolotti G, Michielin P, Vidotto G, Sanavio E, Bottesi G, Bettinardi O, Zotti AM

Neuropsychiatric Disease and Treatment 2015, 11:2449-2460

Published Date: 24 September 2015

First-time admissions for opioid treatment: cross-sectional and descriptive study of new opioid users seeking treatment

Flórez G, López-Durán A, Triñanes Y, Osorio J, Fraga J, Fernández JM, Becoña E, Arrojo M

Neuropsychiatric Disease and Treatment 2015, 11:2431-2440

Published Date: 24 September 2015

Linking emotional distress to unhealthy sleep duration: analysis of the 2009 National Health Interview Survey

Seixas AA, Nunes JV, Airhihenbuwa CO, Williams NJ, Pandi-Perumal SR, James CC, Jean-Louis G

Neuropsychiatric Disease and Treatment 2015, 11:2425-2430

Published Date: 25 September 2015

Anatomical and functional brain abnormalities in unmedicated major depressive disorder

Yang X, Ma X, Li M, Liu Y, Zhang J, Huang B, Zhao L, Deng W, Li T, Ma X

Neuropsychiatric Disease and Treatment 2015, 11:2415-2423

Published Date: 18 September 2015

Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab

Dubey D, Cano CA, Stuve O

Neuropsychiatric Disease and Treatment 2015, 11:2405-2414

Published Date: 18 September 2015

An innovative intervention for the treatment of cognitive impairment–Emisymmetric bilateral stimulation improves cognitive functions in Alzheimer’s disease and mild cognitive impairment: an open-label study

Guerriero F, Botarelli E, Mele G, Polo L, Zoncu D, Renati P, Sgarlata C, Rollone M, Ricevuti G, Maurizi N, Francis M, Rondanelli M, Perna S, Guido D, Mannu P

Neuropsychiatric Disease and Treatment 2015, 11:2391-2404

Published Date: 18 September 2015

Preliminary findings on the reliability and validity of the Cantonese Birmingham Cognitive Screen in patients with acute ischemic stroke

Pan X, Chen H, Bickerton WL, Lau JKL, Kong APH, Rotshtein P, Guo A, Hu J, Humphreys GW

Neuropsychiatric Disease and Treatment 2015, 11:2377-2390

Published Date: 16 September 2015

Prediction by data mining, of suicide attempts in Korean adolescents: a national study

Bae SM, Lee SA, Lee SH

Neuropsychiatric Disease and Treatment 2015, 11:2367-2375

Published Date: 16 September 2015

Alzheimer's disease and its treatment costs: case study in the Czech Republic

Mohelska H, Maresova P, Valis M, Kuca K

Neuropsychiatric Disease and Treatment 2015, 11:2349-2354

Published Date: 11 September 2015

Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients

Camardese G, Leone B, Serrani R, Walstra C, Di Nicola M, Della Marca G, Bria P, Janiri L

Neuropsychiatric Disease and Treatment 2015, 11:2331-2338

Published Date: 9 September 2015

Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity

Veauthier C, Gaede G, Radbruch H, Sieb JP, Wernecke KD, Paul F

Neuropsychiatric Disease and Treatment 2015, 11:2323-2329

Published Date: 9 September 2015

Identification of two novel mutations, PSEN1 E280K and PRNP G127S, in a Malaysian family

Ch’ng GS, An SSA, Bae SO, Bagyinszky E, Kim SY

Neuropsychiatric Disease and Treatment 2015, 11:2315-2322

Published Date: 8 September 2015

Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study

Mazereeuw G, Herrmann N, Xu H, Blanchard AP, Figeys D, Oh PI, Bennett SAL, Lanctôt KL

Neuropsychiatric Disease and Treatment 2015, 11:2309-2314

Published Date: 4 September 2015

Value of F-wave studies on the electrodiagnosis of carpal tunnel syndrome

Alemdar M

Neuropsychiatric Disease and Treatment 2015, 11:2279-2286

Published Date: 31 August 2015

Prefronto–cerebellar transcranial direct current stimulation improves visuospatial memory, executive functions, and neurological soft signs in patients with euthymic bipolar disorder

Minichino A, Bersani FS, Bernabei L, Spagnoli F, Vergnani L, Corrado A, Taddei I, Biondi M, Delle Chiaie R

Neuropsychiatric Disease and Treatment 2015, 11:2265-2270

Published Date: 28 August 2015

Addiction profile in probation practices in Turkey: 5-year data analysis

Yazici AB, Yazici E, Akkisi Kumsar N, Erol A

Neuropsychiatric Disease and Treatment 2015, 11:2259-2263

Published Date: 27 August 2015

Neutrophil-lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy

Demir S, Atli A, Bulut M, İbiloğlu AO, Güneş M, Kaya MC, Demirpençe Ö, Sır A

Neuropsychiatric Disease and Treatment 2015, 11:2253-2258

Published Date: 27 August 2015

The impact of the duration of an untreated episode on improvement of depression and somatic symptoms

Hung CI, Yu NW, Liu CY, Wu KY, Yang CH

Neuropsychiatric Disease and Treatment 2015, 11:2245-2252

Published Date: 27 August 2015

Serum 25-hydroxyvitamin D predicts cognitive performance in adults

Darwish H, Zeinoun P, Ghusn H, Khoury B, Tamim H, Khoury SJ

Neuropsychiatric Disease and Treatment 2015, 11:2217-2223

Published Date: 25 August 2015

The association between sleep patterns and overweight/obesity in Chinese children: a cross-sectional study

Zhang B, Hao YL, Zhou JY, Jia FJ, Li XL, Tang Y, Zheng HR

Neuropsychiatric Disease and Treatment 2015, 11:2209-2216

Published Date: 24 August 2015

Epidemiology and clinical presentation of stroke in Upper Egypt (desert area)

El Tallawy HN, Farghaly WM, Badry R, Hamdy NA, Shehata GA, Rageh TA, Metwally NA, Hassan EM, Elsayed SS, Yehia MA, Soliman WT

Neuropsychiatric Disease and Treatment 2015, 11:2177-2183

Published Date: 21 August 2015

Psychiatric symptoms and leptin in obese patients who were bariatric surgery candidates

Changchien TC, Tai CM, Huang CK, Chien CC, Yen YC

Neuropsychiatric Disease and Treatment 2015, 11:2153-2158

Published Date: 19 August 2015

Lurasidone for the treatment of bipolar depression: an evidence-based review

Franklin R, Zorowitz S, Corse AK, Widge AS, Deckersbach T

Neuropsychiatric Disease and Treatment 2015, 11:2143-2152

Published Date: 19 August 2015

Employment and the associated impact on quality of life in people diagnosed with schizophrenia

Bouwmans C, de Sonneville C, Mulder CL, Hakkaart-van Roijen L

Neuropsychiatric Disease and Treatment 2015, 11:2125-2142

Published Date: 18 August 2015

Misophonia: current perspectives

Cavanna AE, Seri S

Neuropsychiatric Disease and Treatment 2015, 11:2117-2123

Published Date: 18 August 2015

Childhood adversities and laboratory pain perception

Pieritz K, Rief W, Euteneuer F

Neuropsychiatric Disease and Treatment 2015, 11:2109-2116

Published Date: 19 August 2015

Autophagy dysfunction upregulates beta-amyloid peptides via enhancing the activity of γ-secretase complex

Cai Z, Zhou Y, Liu Z, Ke Z, Zhao B

Neuropsychiatric Disease and Treatment 2015, 11:2091-2099

Published Date: 17 August 2015

The structural equation analysis of childhood abuse, adult stressful life events, and temperaments in major depressive disorders and their influence on refractoriness

Toda H, Inoue T, Tsunoda T, Nakai Y, Tanichi M, Tanaka T, Hashimoto N, Nakato Y, Nakagawa S, Kitaichi Y, Mitsui N, Boku S, Tanabe H, Nibuya M, Yoshino A, Kusumi I

Neuropsychiatric Disease and Treatment 2015, 11:2079-2090

Published Date: 12 August 2015

Poor mental health status and aggression are associated with poor driving behavior among male traffic offenders

Abdoli N, Farnia V, Delavar A, Esmaeili A, Dortaj F, Farrokhi N, Karami M, Shakeri J, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2015, 11:2071-2078

Published Date: 11 August 2015

Mental health status, aggression, and poor driving distinguish traffic offenders from non-offenders but health status predicts driving behavior in both groups

Abdoli N, Farnia V, Delavar A, Esmaeili A, Dortaj F, Farrokhi N, Karami M, Shakeri J, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2015, 11:2063-2070

Published Date: 10 August 2015

Adult attention-deficit hyperactivity disorder, risky behaviors, and motorcycle injuries: a case-control study

Sadeghi-Bazargani H, Abedi L, Mahini M, Amiri S, Khorasani-Zavareh D

Neuropsychiatric Disease and Treatment 2015, 11:2049-2054

Published Date: 7 August 2015

Relationship between cognitive insight and subjective quality of life in outpatients with schizophrenia

Kim JH, Lee S, Han AY, Kim K, Lee J

Neuropsychiatric Disease and Treatment 2015, 11:2041-2048

Published Date: 7 August 2015

Relationship between cobalamin deficiency and delirium in elderly patients undergoing cardiac surgery

Sevuk U, Baysal E, Ay N, Altas Y, Altindag R, Yaylak B, Alp V, Demirtas E

Neuropsychiatric Disease and Treatment 2015, 11:2033-2039

Published Date: 7 August 2015

Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms

Urban-Kowalczyk M, Pigońska J, Śmigielski J

Neuropsychiatric Disease and Treatment 2015, 11:2023-2031

Published Date: 6 August 2015

Rare and very rare adverse effects of clozapine

De Fazio P, Gaetano R, Caroleo M, Cerminara G, Maida F, Bruno A, Muscatello MR, Jaén Moreno MJ, Russo E, Segura-García C

Neuropsychiatric Disease and Treatment 2015, 11:1995-2003

Published Date: 6 August 2015

The cost reduction in hospitalization associated with paliperidone palmitate in the People’s Republic of China, Korea, and Malaysia

Chiou CF, Wang BCM, Caldwell R, Furnback W, Lee JS, Kothandaraman N, Lee SK, Wang J, Zhang F

Neuropsychiatric Disease and Treatment 2015, 11:1989-1994

Published Date: 5 August 2015

Case-control association study of ABCB1 gene and major depressive disorder in a local Chinese Han population

Xie WW, Zhang L, Wu RR, Yu Y, Zhao JP, Li LH

Neuropsychiatric Disease and Treatment 2015, 11:1967-1971

Published Date: 4 August 2015

Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder

Zhang XF, Wu L, Wan DJ, Liu RZ, Dong Z, Chen M, Yu SY

Neuropsychiatric Disease and Treatment 2015, 11:1957-1965

Published Date: 4 August 2015

Animal models of obsessive–compulsive disorder: utility and limitations

Alonso P, López-Solà C, Real E, Segalàs C, Menchón JM

Neuropsychiatric Disease and Treatment 2015, 11:1939-1955

Published Date: 4 August 2015

Piano training in youths with hand motor impairments after damage to the developing brain

Lampe R, Thienel A, Mitternacht J, Blumenstein T, Turova V, Alves-Pinto A

Neuropsychiatric Disease and Treatment 2015, 11:1929-1938

Published Date: 3 August 2015

A family-oriented treatment program for youths with ketamine abuse and their caregivers: a pilot study in Taiwan

Wang LJ, Lu SF, Chou WJ, Chong MY, Wang YH, Hsieh YL, Lee YH, Chen C

Neuropsychiatric Disease and Treatment 2015, 11:1921-1927

Published Date: 31 July 2015

Impact of aerobic exercise on sleep and motor skills in children with autism spectrum disorders – a pilot study

Brand S, Jossen S, Holsboer-Trachsler E, Pühse U, Gerber M

Neuropsychiatric Disease and Treatment 2015, 11:1911-1920

Published Date: 5 August 2015

Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice

Dell’Osso B, Albert U, Atti AR, Carmassi C, Carrà G, Cosci F, Del Vecchio V, Di Nicola M, Ferrari S, Goracci A, Iasevoli F, Luciano M, Martinotti G, Nanni MG, Nivoli A, Pinna F, Poloni N, Pompili M, Sampogna G, Tarricone I, Tosato S, Volpe U, Fiorillo A

Neuropsychiatric Disease and Treatment 2015, 11:1885-1909

Published Date: 30 July 2015

Disturbed spontaneous brain activity pattern in patients with primary angle-closure glaucoma using amplitude of low-frequency fluctuation: a fMRI study

Huang X, Zhong YL, Zeng XJ, Zhou F, Liu XH, Hu PH, Pei CG, Shao Y, Dai XJ

Neuropsychiatric Disease and Treatment 2015, 11:1877-1883

Published Date: 29 July 2015

Differential effects of dopamine-directed treatments on cognition

Ashby FG, Valentin VV, von Meer SS

Neuropsychiatric Disease and Treatment 2015, 11:1859-1875

Published Date: 29 July 2015

Association between toll-like receptor 4 expression and symptoms of major depressive disorder

Wu MK, Huang TL, Huang KW, Huang YL, Hung YY

Neuropsychiatric Disease and Treatment 2015, 11:1853-1857

Published Date: 30 July 2015

Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia

Oda Y, Kanahara N, Kimura H, Watanabe H, Hashimoto K, Iyo M

Neuropsychiatric Disease and Treatment 2015, 11:1845-1851

Published Date: 29 July 2015

Pituitary dysfunction following traumatic brain injury: clinical perspectives

Tanriverdi F, Kelestimur F

Neuropsychiatric Disease and Treatment 2015, 11:1835-1843

Published Date: 27 July 2015

Altered blood oxygen level-dependent signal variability in chronic post-traumatic stress disorder during symptom provocation

Ke J, Zhang L, Qi R, Xu Q, Li W, Hou C, Zhong Y, Zhang Z, He Z, Li L, Lu G

Neuropsychiatric Disease and Treatment 2015, 11:1805-1815

Published Date: 23 July 2015

Markers of neurodevelopmental impairments in early-onset psychosis

Petruzzelli MG, Margari L, Craig F, Campa MG, Martinelli D, Pastore A, Simone M, Margari F

Neuropsychiatric Disease and Treatment 2015, 11:1793-1798

Published Date: 20 July 2015

Effects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic study

Albert U, De Cori D, Aguglia A, Barbaro F, Lanfranco F, Bogetto F, Maina G

Neuropsychiatric Disease and Treatment 2015, 11:1785-1791

Published Date: 20 July 2015

Individual correlates of self-stigma in patients with anxiety disorders with and without comorbidities

Ociskova M, Prasko J, Kamaradova D, Grambal A, Sigmundova Z

Neuropsychiatric Disease and Treatment 2015, 11:1767-1779

Published Date: 17 July 2015

Role of apolipoprotein E in neurodegenerative diseases

Giau VV, Bagyinszky E, An SS, Kim SY

Neuropsychiatric Disease and Treatment 2015, 11:1723-1737

Published Date: 16 July 2015

Stress, anxiety, and depression among medical students in a multiethnic setting

Kulsoom B, Afsar NA

Neuropsychiatric Disease and Treatment 2015, 11:1713-1722

Published Date: 16 July 2015

Attitudes of psychiatrists toward obsessive–compulsive disorder patients

Kusalaruk P, Saipanish R, Hiranyatheb T

Neuropsychiatric Disease and Treatment 2015, 11:1703-1711

Published Date: 15 July 2015

Microribonucleic acid dysregulations in children and adolescents with obsessive–compulsive disorder

Kandemir H, Erdal ME, Selek S, İzci Ay Ö, Karababa İF, Ay ME, Kandemir SB, Yılmaz ŞG, Ekinci S, Taşdelen B, Bayazit H

Neuropsychiatric Disease and Treatment 2015, 11:1695-1701

Published Date: 14 July 2015

Relationship between apathy and tumor location, size, and brain edema in patients with intracranial meningioma

Peng Y, Shao C, Gong Y, Wu X, Tang W, Shi S

Neuropsychiatric Disease and Treatment 2015, 11:1685-1693

Published Date: 13 July 2015

Differences in maladaptive schemas between patients suffering from chronic and acute posttraumatic stress disorder and healthy controls

Ahmadian A, Mirzaee J, Omidbeygi M, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2015, 11:1677-1684

Published Date: 10 July 2015

Early-onset anorexia nervosa in girls with Asperger syndrome

Dudova I, Kocourkova J, Koutek J

Neuropsychiatric Disease and Treatment 2015, 11:1639-1643

Published Date: 2 July 2015

The reduction of volume and fiber bundle connections in the hippocampus of EGR3 transgenic schizophrenia rats

Ma E, Song T, Zhang H, Lu J, Wang L, Zhao Q, Guo R, Li M, Ma G, Lu G, Li K

Neuropsychiatric Disease and Treatment 2015, 11:1625-1638

Published Date: 1 July 2015

Jumping to conclusions in schizophrenia

Evans SL, Averbeck BB, Furl N

Neuropsychiatric Disease and Treatment 2015, 11:1615-1624

Published Date: 1 July 2015

Epidemiological investigation of 264 sporadic cases of ruptured cerebral aneurysm at a single institution in southwest China

Liu H, Zhang TJ, Jiao S, Li BG, Guan J, Wang YX

Neuropsychiatric Disease and Treatment 2015, 11:1609-1614

Published Date: 1 July 2015

Diagnostic and treatment challenges in traumatic brain injury patients with severe neuropsychiatric symptoms: insights into psychiatric practice

Lauterbach MD, Notarangelo PL, Nichols SJ, Lane KS, Koliatsos VE

Neuropsychiatric Disease and Treatment 2015, 11:1601-1607

Published Date: 1 July 2015

Clinical utility of brain stimulation modalities following traumatic brain injury: current evidence

Li S, Zaninotto AL, Neville IS, Paiva WS, Nunn D, Fregni F

Neuropsychiatric Disease and Treatment 2015, 11:1573-1586

Published Date: 30 June 2015

Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines

Jeong JH, Lee JG, Kim MD, Sohn IK, Shim SH, Wang HR, Woo YS, Jon DI, Seo JS, Shin YC, Min KJ, Yoon BH, Bahk WM

Neuropsychiatric Disease and Treatment 2015, 11:1561-1571

Published Date: 26 June 2015

Transcranial magnetic stimulation for the treatment of major depression

Janicak PG, Dokucu ME

Neuropsychiatric Disease and Treatment 2015, 11:1549-1560

Published Date: 26 June 2015

The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia

Nakagawa R, Ohnishi T, Kobayashi H, Wakamatsu A, Tanimura A, Morita K, Yamaoka T, Usui H, Ogawa Y, Fujino A, Yoshizawa K

Neuropsychiatric Disease and Treatment 2015, 11:1511-1521

Published Date: 22 June 2015

Validity and reliability of the Turkish version of CRAFFT Substance Abuse Screening Test among adolescents

Kandemir H, Aydemir Ö, Ekinci S, Selek S, Kandemir SB, Bayazit H

Neuropsychiatric Disease and Treatment 2015, 11:1505-1509

Published Date: 22 June 2015

Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia

Pawelczyk T, Szymanska B, Grancow-Grabka M, Kotlicka-Antczak M, Pawelczyk A

Neuropsychiatric Disease and Treatment 2015, 11:1493-1503

Published Date: 22 June 2015

Quetiapine mitigates the ethanol-induced oxidative stress in brain tissue, but not in the liver, of the rat

Han JH, Tian HZ, Lian YY, Yu Y, Lu CB, Li XM, Zhang RL, Xu H

Neuropsychiatric Disease and Treatment 2015, 11:1473-1482

Published Date: 15 June 2015

Focus group reflections on the current and future state of cognitive assessment tools in geriatric health care

Whitehead JC, Gambino SA, Richter JD, Ryan JD

Neuropsychiatric Disease and Treatment 2015, 11:1455-1466

Published Date: 12 June 2015

An exploratory study of the association between SORL1 polymorphisms and sporadic Alzheimer’s disease in the Han Chinese population

Zhang F, Liu X, Wang B, Cheng Z, Zhao X, Zhu J, Wang D, Wang Y, Dong A, Li P, Jin C

Neuropsychiatric Disease and Treatment 2015, 11:1443-1448

Published Date: 12 June 2015

Anti-N-methyl-d-aspartate receptor encephalitis in a patient with a 7-year history of being diagnosed as schizophrenia: complexities in diagnosis and treatment

Huang C, Kang Y, Zhang B, Li B, Qiu C, Liu S, Ren H, Yang Y, Liu X, Li T, Guo W

Neuropsychiatric Disease and Treatment 2015, 11:1437-1442

Published Date: 11 June 2015

Undertreatment of human immunodeficiency virus in psychiatric inpatients: a cross-sectional study of seroprevalence and associated factors

Gonzalez-Torres MA, Salazar MA, Imaz M, Inchausti L, Ibañez B, Fernandez-Rivas A, Pastor J, Anguiano B, Muñoz P, Ruiz E, Oraa R, Bustamante S, Alvarez de Eulate S, Cisterna R

Neuropsychiatric Disease and Treatment 2015, 11:1421-1426

Published Date: 11 June 2015

Psychiatric symptoms in glioma patients: from diagnosis to management

Boele FW, Rooney AG, Grant R, Klein M

Neuropsychiatric Disease and Treatment 2015, 11:1413-1420

Published Date: 10 June 2015

Cognitive impairment in generalized anxiety disorder revealed by event-related potential N270

Yang Y, Zhang X, Zhu Y, Dai Y, Liu T, Wang Y

Neuropsychiatric Disease and Treatment 2015, 11:1405-1411

Published Date: 3 June 2015

Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population

Otsuka I, Watanabe Y, Hishimoto A, Boku S, Mouri K, Shiroiwa K, Okazaki S, Nunokawa A, Shirakawa O, Someya T, Sora I

Neuropsychiatric Disease and Treatment 2015, 11:1381-1393

Published Date: 2 June 2015

Predictors of quality of life among individuals with schizophrenia

Suttajit S, Pilakanta S

Neuropsychiatric Disease and Treatment 2015, 11:1371-1379

Published Date: 28 May 2015

Attitudes and beliefs of patients with chronic depression toward antidepressants and depression

Jacob SA, Ab Rahman AF, Hassali MA

Neuropsychiatric Disease and Treatment 2015, 11:1339-1347

Published Date: 27 May 2015

Ranitidine reduced levodopa-induced dyskinesia by remodeling neurochemical changes in hemiparkinsonian model of rats

Shi H, Yang X, Zhao H, Zhang S, Zu J, Zhang W, Shen X, Cui G, Hua F, Yan C

Neuropsychiatric Disease and Treatment 2015, 11:1331-1337

Published Date: 27 May 2015

Brain in flames – animal models of psychosis: utility and limitations

Mattei D, Schweibold R, Wolf SA

Neuropsychiatric Disease and Treatment 2015, 11:1313-1329

Published Date: 27 May 2015

Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial

Kang RY, He Y, Yan YX, Li ZW, Wu YQ, Guo XJ, Liang ZG, Jiang J

Neuropsychiatric Disease and Treatment 2015, 11:1307-1311

Published Date: 27 May 2015

Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis

De Hert M, Eramo A, Landsberg W, Kostic D, Tsai LF, Baker RA

Neuropsychiatric Disease and Treatment 2015, 11:1299-1306

Published Date: 27 May 2015

Being parents with epilepsy: thoughts on its consequences and difficulties affecting their children

Gauffin H, Flensner G, Landtblom AM

Neuropsychiatric Disease and Treatment 2015, 11:1291-1298

Published Date: 27 May 2015

The interventional effects of loving-kindness meditation on positive emotions and interpersonal interactions

He X, Shi W, Han X, Wang N, Zhang N, Wang X

Neuropsychiatric Disease and Treatment 2015, 11:1273-1277

Published Date: 25 May 2015

Comprehensive family therapy: an effective approach for cognitive rehabilitation in schizophrenia

Cai J, Zhu Y, Zhang W, Wang Y, Zhang C

Neuropsychiatric Disease and Treatment 2015, 11:1247-1253

Published Date: 21 May 2015

Efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage

Li YQ, Fang W, Tao L, Li M, Yang YL, Gao YF, Ge SN, Gao L, Zhang B, Li ZH, Zhou W, Wang BL, Li LH

Neuropsychiatric Disease and Treatment 2015, 11:1231-1238

Published Date: 19 May 2015

The relationship of psychological trauma with trichotillomania and skin picking

Özten E, Hızlı Sayar G, Eryılmaz G, Kağan G, Işık S, Karamustafalıoğlu O

Neuropsychiatric Disease and Treatment 2015, 11:1203-1210

Published Date: 15 May 2015

Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders

Ociskova M, Prasko J, Kamaradova D, Grambal A, Kasalova P, Sigmundova Z, Latalova K, Vrbova K

Neuropsychiatric Disease and Treatment 2015, 11:1191-1201

Published Date: 15 May 2015

Wearing-off in Parkinson’s disease: neuropsychological differences between on and off periods

Caillava-Santos F, Margis R, Rieder CR

Neuropsychiatric Disease and Treatment 2015, 11:1175-1180

Published Date: 13 May 2015

Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder

Lamberti M, Italiano D, Guerriero L, D’Amico G, Siracusano R, Ingrassia M, Germanò E, Calabrò MP, Spina E, Gagliano A

Neuropsychiatric Disease and Treatment 2015, 11:1169-1174

Published Date: 8 May 2015

Ataxia with Parkinsonism and dystonia after intentional inhalation of liquefied petroleum gas

Godani M, Canavese F, Migliorini S, Del Sette M

Neuropsychiatric Disease and Treatment 2015, 11:1157-1159

Published Date: 6 May 2015

Depressive disorders co-existing with Addison–Biermer anemia – case report

Just MJ, Kozakiewicz M

Neuropsychiatric Disease and Treatment 2015, 11:1145-1148

Published Date: 30 April 2015

Association between anxiety and hypertension: a systematic review and meta-analysis of epidemiological studies

Pan Y, Cai W, Cheng Q, Dong W, An T, Yan J

Neuropsychiatric Disease and Treatment 2015, 11:1121-1130

Published Date: 22 April 2015

Dietary patterns and schizophrenia: a comparison with healthy controls

Tsuruga K, Sugawara N, Sato Y, Saito M, Furukori H, Nakagami T, Nakamura K, Takahashi I, Nakaji S, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2015, 11:1115-1120

Published Date: 22 April 2015

Posterior reversible encephalopathy syndrome in a woman with focal segmental glomerulosclerosis

Chowdhary M, Kabbani AA, Tobey D, Hope TD

Neuropsychiatric Disease and Treatment 2015, 11:1111-1114

Published Date: 21 April 2015

Factors associated with poor discharge status in patients with status epilepticus at Khon Kaen hospital

Chiewthanakul P, Noppaklao P, Sawanyawisuth K, Tiamkao S

Neuropsychiatric Disease and Treatment 2015, 11:1097-1101

Published Date: 20 April 2015

Comorbid personality disorders among patients with depression

Wongpakaran N, Wongpakaran T, Boonyanaruthee V, Pinyopornpanish M, Intaprasert S

Neuropsychiatric Disease and Treatment 2015, 11:1091-1096

Published Date: 17 April 2015

Catha edulis chewing effects on treatment of paranoid schizophrenic patients

Kotb El-Sayed MI, Amin HK

Neuropsychiatric Disease and Treatment 2015, 11:1067-1076

Published Date: 15 April 2015

Current perspectives on deep brain stimulation for severe neurological and psychiatric disorders

Kocabicak E, Temel Y, Höllig A, Falkenburger B, Tan SK

Neuropsychiatric Disease and Treatment 2015, 11:1051-1066

Published Date: 9 April 2015

Prevalence of distorted body image in young Koreans and its association with age, sex, body weight status, and disordered eating behaviors

Hong SC, Jung YE, Kim MD, Lee CI, Hyun MY, Bahk WM, Yoon BH, Lee KH

Neuropsychiatric Disease and Treatment 2015, 11:1043-1049

Published Date: 9 April 2015

Social cognitive and neurocognitive deficits in inpatients with unilateral thalamic lesions — pilot study

Wilkos E, Brown TJ, Slawinska K, Kucharska KA

Neuropsychiatric Disease and Treatment 2015, 11:1031-1038

Published Date: 10 April 2015

Activation of mTOR: a culprit of Alzheimer’s disease?

Cai Z, Chen G, He W, Xiao M, Yan LJ

Neuropsychiatric Disease and Treatment 2015, 11:1015-1030

Published Date: 9 April 2015

Possible association between moderate intellectual disability and weight gain in valproic acid–treated patients with epilepsy

Tanamachi Y, Saruwatari J, Noai M, Kamihashi R, Soraoka H, Yoshimori Y, Ogusu N, Oniki K, Yasui-Furukori N, Ishitsu T, Nakagawa K

Neuropsychiatric Disease and Treatment 2015, 11:1007-1014

Published Date: 7 April 2015

“Recovery” from the diagnosis of autism – and then?

Barnevik Olsson M, Westerlund J, Lundström S, Giacobini M, Fernell E, Gillberg C

Neuropsychiatric Disease and Treatment 2015, 11:999-1005

Published Date: 7 April 2015

Factors associated with group bullying and psychopathology in elementary school students using child-welfare facilities

Kim JW, Lee K, Lee YS, Han DH, Min KJ, Song SH, Park GN, Lee JY, Kim JO

Neuropsychiatric Disease and Treatment 2015, 11:991-998

Published Date: 7 April 2015

Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People’s Republic of China

Wu J, He XN, Liu L, Ye W, Montgomery W, Xue HB, McCombs JS

Neuropsychiatric Disease and Treatment 2015, 11:983-990

Published Date: 7 April 2015

Neuromodulation and antenatal depression: a review

Kim DR, Snell JL, Ewing GC, O’Reardon J

Neuropsychiatric Disease and Treatment 2015, 11:975-982

Published Date: 7 April 2015

Psychosurgery for stuttering

Durand E, Weil AG, Lévêque M

Neuropsychiatric Disease and Treatment 2015, 11:963-965

Published Date: 2 April 2015

Catatonia in Down syndrome; a treatable cause of regression

Ghaziuddin N, Nassiri A, Miles JH

Neuropsychiatric Disease and Treatment 2015, 11:941-949

Published Date: 2 April 2015

Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data

Kuwabara H, Saito Y, Mahlich J

Neuropsychiatric Disease and Treatment 2015, 11:935-940

Published Date: 1 April 2015

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East

Alkhadhari S, Al Zain N, Darwish T, Khan S, Okasha T, Ramy H, Tadros TM

Neuropsychiatric Disease and Treatment 2015, 11:915-924

Published Date: 1 April 2015

A cross-sectional study on perception of stigma by Chinese schizophrenia patients [Retraction]

Ren ZB, Wang HQ, Feng B, Gu CY, Ma YC, Chen H, Li BL, Liu LY

Neuropsychiatric Disease and Treatment 2015, 11:895-896

Published Date: 1 April 2015

High prevalence of sleep and mood disorders in dry eye patients: survey of 1,000 eye clinic visitors

Ayaki M, Kawashima M, Negishi K, Tsubota K

Neuropsychiatric Disease and Treatment 2015, 11:889-894

Published Date: 31 March 2015

Aripiprazole-associated tic in a schizophrenia patient

Guo X, Lu D, Jiang Y

Neuropsychiatric Disease and Treatment 2015, 11:873-874

Published Date: 30 March 2015

Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome

Akyol ES, Albayrak Y, Beyazyüz M, Aksoy N, Kuloglu M, Hashimoto K

Neuropsychiatric Disease and Treatment 2015, 11:865-872

Published Date: 30 March 2015

Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study

Gutiérrez-Fernández J, Luna del Castillo JD, Mañanes-González S, Carrillo-Ávila JA, Gutiérrez B, Cervilla JA, Sorlózano-Puerto A

Neuropsychiatric Disease and Treatment 2015, 11:843-852

Published Date: 27 March 2015

Effects of prolonged head-down bed rest on working memory

Liu Q, Zhou R, Zhao X, Oei TPS

Neuropsychiatric Disease and Treatment 2015, 11:835-842

Published Date: 26 March 2015

Neurofibromatosis type 1 and attention deficit hyperactivity disorder: a case study and literature review

Miguel CS, Chaim-Avancini TM, Silva MA, Louzã MR

Neuropsychiatric Disease and Treatment 2015, 11:815-821

Published Date: 25 March 2015

Forehead carbuncle with intractable headache

Chou PY, Chen YC, Huang P

Neuropsychiatric Disease and Treatment 2015, 11:793-795

Published Date: 20 March 2015

Neuroinflammatory responses to traumatic brain injury

Paiva WS, Correia AD, Marie SK

Neuropsychiatric Disease and Treatment 2015, 11:773-776

Published Date: 19 March 2015

Optimal management of night eating syndrome: challenges and solutions

Kucukgoncu S, Midura M, Tek C

Neuropsychiatric Disease and Treatment 2015, 11:751-760

Published Date: 19 March 2015

Effects of a selective educational system on fatigue, sleep problems, daytime sleepiness, and depression among senior high school adolescents in Taiwan

Chen TY, Chou YC, Tzeng NS, Chang HA, Kuo SC, Pan PY, Yeh YW, Yeh CB, Mao WC

Neuropsychiatric Disease and Treatment 2015, 11:741-750

Published Date: 19 March 2015

Red cell distribution width and neurological scoring systems in acute stroke patients

Kara H, Degirmenci S, Bayir A, Ak A, Akinci M, Dogru A, Akyurek F, Kayis SA

Neuropsychiatric Disease and Treatment 2015, 11:733-739

Published Date: 18 March 2015

The influence of comorbid personality disorders on recovery from depression

Wongpakaran T, Wongpakaran N, Boonyanaruthee V, Pinyopornpanish M, Intaprasert S

Neuropsychiatric Disease and Treatment 2015, 11:725-732

Published Date: 16 March 2015

Association between pain severity, depression severity, and use of health care services in Japan: results of a nationwide survey

Vietri J, Otsubo T, Montgomery W, Tsuji T, Harada E

Neuropsychiatric Disease and Treatment 2015, 11:675-683

Published Date: 13 March 2015

Impact of incarceration in Nazi concentration camps on multimorbidity of former prisoners

Jablonski RK, Leszek J, Rosińczuk J, Uchmanowicz I, Panaszek B

Neuropsychiatric Disease and Treatment 2015, 11:669-674

Published Date: 11 March 2015

Efficacy, safety, and impact on hospitalizations of paliperidone palmitate in recent-onset schizophrenia

Zhang F, Si T, Chiou CF, Harris AWF, Kim CY, Jahagirdar P, Ascher S

Neuropsychiatric Disease and Treatment 2015, 11:657-668

Published Date: 11 March 2015

A retrospective study to assess resource utilization in patients with cervical dystonia in the United Kingdom

Raluy-Callado M, Gabriel S, Dinet J, Wang M, Wasiak R

Neuropsychiatric Disease and Treatment 2015, 11:647-655

Published Date: 9 March 2015

Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia

Masopust J, Andrýs C, Bažant J, Vyšata O, Kuca K, Vališ M

Neuropsychiatric Disease and Treatment 2015, 11:619-623

Published Date: 6 March 2015

Buprenorphine, methadone, and morphine treatment during pregnancy: behavioral effects on the offspring in rats

Chen HH, Chiang YC, Yuan ZF, Kuo CC, Lai MD, Hung TW, Ho IK, Chen ST

Neuropsychiatric Disease and Treatment 2015, 11:609-618

Published Date: 6 March 2015

Changes in proinflammatory cytokines and white matter in chronically stressed rats

Yang P, Gao Z, Zhang H, Fang Z, Wu C, Xu H, Huang QJ

Neuropsychiatric Disease and Treatment 2015, 11:597-607

Published Date: 6 March 2015

Quality of life of patients with schizophrenia treated in foster home care and in outpatient treatment

Mihanović M, Restek-Petrović B, Bogović A, Ivezić E, Bodor D, Požgain I

Neuropsychiatric Disease and Treatment 2015, 11:585-595

Published Date: 5 March 2015

Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia

Frydecka D, Misiak B, Pawlak-Adamska E, Karabon L, Tomkiewicz A, Sedlaczek P, Kiejna A, Beszłej JA

Neuropsychiatric Disease and Treatment 2015, 11:575-584

Published Date: 5 March 2015

Impaired mitochondrial energy metabolism as a novel risk factor for selective onset and progression of dementia in oldest-old subjects

Zhao W, Wang J, Varghese M, Ho L, Mazzola P, Haroutunian V, Katsel PL, Gibson GE, Levine S, Dubner L, Pasinetti GM

Neuropsychiatric Disease and Treatment 2015, 11:565-574

Published Date: 5 March 2015

Is it possible to use highly realistic virtual reality in the elderly? A feasibility study with image-based rendering

Benoit M, Guerchouche R, Petit PD, Chapoulie E, Manera V, Chaurasia G, Drettakis G, Robert P

Neuropsychiatric Disease and Treatment 2015, 11:557-563

Published Date: 3 March 2015

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia

Ranjbar F, Sadeghi-Bazargani H, Niari Khams P, Arfaie A, Salari A, Farahbakhsh M

Neuropsychiatric Disease and Treatment 2015, 11:549-555

Published Date: 2 March 2015

Cattle encephalon glycoside and ignotin injection improves cognitive impairment in APPswe/PS1dE9 mice used as multitarget anti-Alzheimer’s drug candidates

Gao Y, Hu YZ, Li RS, Han ZT, Geng Y, Xia Z, Du WJ, Liu LX, Zhang HH, Wang LN

Neuropsychiatric Disease and Treatment 2015, 11:537-548

Published Date: 27 February 2015

Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study

Strzelecki D, Szyburska J, Kotlicka-Antczak M, Kałużyńska O

Neuropsychiatric Disease and Treatment 2015, 11:533-536

Published Date: 27 February 2015

Toward an online cognitive and emotional battery to predict treatment remission in depression

Gordon E, Rush AJ, Palmer DM, Braund TA, Rekshan W

Neuropsychiatric Disease and Treatment 2015, 11:517-531

Published Date: 26 February 2015

Korean Medication Algorithm Project for Bipolar Disorder: third revision

Woo YS, Lee JG, Jeong JH, Kim MD, Sohn IK, Shim SH, Jon DI, Seo JS, Shin YC, Min KJ, Yoon BH, Bahk WM

Neuropsychiatric Disease and Treatment 2015, 11:493-506

Published Date: 26 February 2015

A case-control proton magnetic resonance spectroscopy study confirms cerebellar dysfunction in benign adult familial myoclonic epilepsy

Long L, Song Y, Zhang L, Hu C, Gong J, Xu L, Long H, Zhou L, Zhang Y, Zhang Y, Xiao B

Neuropsychiatric Disease and Treatment 2015, 11:485-491

Published Date: 25 February 2015

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers

Ishioka M, Yasui-Furukori N, Sugawara N, Furukori H, Kudo S, Nakamura K

Neuropsychiatric Disease and Treatment 2015, 11:477-484

Published Date: 24 February 2015

Coexistence of anxiety sensitivity and psychiatric comorbidities in patients with chronic tinnitus

Gül Aİ, Özkırış M, Aydın R, Şimşek G, Saydam L

Neuropsychiatric Disease and Treatment 2015, 11:413-418

Published Date: 19 February 2015

Untreated depression in the first trimester of pregnancy leads to postpartum depression: high rates from a natural follow-up study

Yazici E, Kirkan TS, Aslan PA, Aydin N, Yazici AB

Neuropsychiatric Disease and Treatment 2015, 11:405-411

Published Date: 19 February 2015

The clinical basis of orthorexia nervosa: emerging perspectives

Koven NS, Abry AW

Neuropsychiatric Disease and Treatment 2015, 11:385-394

Published Date: 18 February 2015

One-year follow-up in patients with brainstem infarction due to large-artery atherothrombosis

Kolukısa M, Ozdemir Gültekin T, Eryigit Baran G, Aralasmak A, Kocaman G, Gürsoy AE, Asil T

Neuropsychiatric Disease and Treatment 2015, 11:379-384

Published Date: 18 February 2015

Neurosyphilis with psychotic symptoms and Parkinsonism in a young girl

Yin L, Zou S, Huang Y

Neuropsychiatric Disease and Treatment 2015, 11:375-377

Published Date: 16 February 2015

MRI-guided stereotactic amygdalohippocampectomy: a single center experience

Vojtěch Z, Malíková H, Krámská L, Liščák R, Vladyka V

Neuropsychiatric Disease and Treatment 2015, 11:359-374

Published Date: 11 February 2015

Psychopathology, symptoms of attention-deficit/hyperactivity disorder, and risk factors in juvenile offenders

Margari F, Craig F, Margari L, Matera E, Lamanna AL, Lecce PA, La Tegola D, Carabellese F

Neuropsychiatric Disease and Treatment 2015, 11:343-352

Published Date: 10 February 2015

Common psychocutaneous disorders in children

Chiriac A, Brzezinski P, Pinteala T, Chiriac AE, Foia L

Neuropsychiatric Disease and Treatment 2015, 11:333-337

Published Date: 9 February 2015

Medium-to-high prevalence of screening-detected parkinsonism in the urban area of Tehran, Iran: data from a community-based door-to-door study

Fereshtehnejad SM, Shafieesabet M, Rahmani A, Delbari A, Lökk J

Neuropsychiatric Disease and Treatment 2015, 11:321-332

Published Date: 5 February 2015

Diffuse cerebral vasospasm after resection of schwannoma: a case report

Qi J,Zhang LW, Jia W, Zhang JT, Wu Z

Neuropsychiatric Disease and Treatment 2015, 11:317-320

Published Date: 5 February 2015

Neuroprotective strategies against calpain-mediated neurodegeneration

Yildiz-Unal A, Korulu S, Karabay A

Neuropsychiatric Disease and Treatment 2015, 11:297-310

Published Date: 5 February 2015

Adjunct effect of music therapy on cognition in Alzheimer’s disease in Taiwan: a pilot study

Li CH, Liu CK, Yang YH, Chou MC, Chen CH, Lai CL

Neuropsychiatric Disease and Treatment 2015, 11:291-296

Published Date: 4 February 2015

Increased expression of retinoic acid-induced gene 1 in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression

Haybaeck J, Postruznik M, Miller CL, Dulay JR, Llenos IC, Weis S

Neuropsychiatric Disease and Treatment 2015, 11:279-289

Published Date: 4 February 2015

Increased risk of posterior circulation infarcts among ischemic stroke patients with cervical spondylosis

Chen CC, Chung CY, Lee TH, Chang WH, Tang SF, Pei YC

Neuropsychiatric Disease and Treatment 2015, 11:273-278

Published Date: 3 February 2015

Perfectionism related to self-reported insomnia severity, but not when controlled for stress and emotion regulation

Brand S, Kirov R, Kalak N, Gerber M, Pühse U, Lemola S, Correll CU, Cortese S, Meyer T, Holsboer-Trachsler E

Neuropsychiatric Disease and Treatment 2015, 11:263-271

Published Date: 3 February 2015

Neural correlates of delusional infestation responding to aripiprazole monotherapy: a case report

Ponson L, Andersson F, El-Hage W

Neuropsychiatric Disease and Treatment 2015, 11:257-261

Published Date: 2 February 2015

Neuroinflammation in Alzheimer’s disease

Zhang FJ, Jiang LL

Neuropsychiatric Disease and Treatment 2015, 11:243-256

Published Date: 30 January 2015

The association of post-stroke anhedonia with salivary cortisol levels and stroke lesion in hippocampal/parahippocampal region

Terroni L, Amaro Jr E, Iosifescu DV, Mattos P, Yamamoto FI, Tinone G, Conforto AB, Sobreiro MFM, Guajardo VD, De Lucia MC, Moreira AC, Scaff M, Leite CC, Fraguas R

Neuropsychiatric Disease and Treatment 2015, 11:233-242

Published Date: 3 February 2015

Dilemma of prescribing aripiprazole under the Taiwan health insurance program: a descriptive study

Hsu YC, Chou YC, Chang HA, Kao YC, Huang SY, Tzeng NS

Neuropsychiatric Disease and Treatment 2015, 11:225-232

Published Date: 27 January 2015

Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study

Novick D, Hong J, Montgomery W, Dueñas H, Gado M, Haro JM

Neuropsychiatric Disease and Treatment 2015, 11:197-205

Published Date: 22 January 2015

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone

Hongkaew Y, Ngamsamut N, Puangpetch A, Vanwong N, Srisawasdi P, Chamnanphon M, Chamkrachchangpada B, Tan-kam T, Limsila P, Sukasem C

Neuropsychiatric Disease and Treatment 2015, 11:191-196

Published Date: 22 January 2015

The role of family therapy in the management of schizophrenia: challenges and solutions

Caqueo-Urízar A, Rus-Calafell M, Urzúa A, Escudero J, Gutiérrez-Maldonado J

Neuropsychiatric Disease and Treatment 2015, 11:145-151

Published Date: 14 January 2015

Acute effects of single and multiple level thoracic manipulations on chronic mechanical neck pain: a randomized controlled trial

Puntumetakul R, Suvarnnato T, Werasirirat P, Uthaikhup S, Yamauchi J, Boucaut R

Neuropsychiatric Disease and Treatment 2015, 11:137-144

Published Date: 12 January 2015

Levomilnacipran for the treatment of major depressive disorder: a review

Asnis GA, Henderson MA

Neuropsychiatric Disease and Treatment 2015, 11:125-135

Published Date: 9 January 2015

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan

Harada E, Schacht A, Koyama T, Marangell LB, Tsuji T, Escobar R

Neuropsychiatric Disease and Treatment 2015, 11:115-123

Published Date: 12 January 2015

Association between subjective actual sleep duration, subjective sleep need, age, body mass index, and gender in a large sample of young adults

Kalak N, Brand S, Beck J, Holsboer-Trachsler E, Wollmer MA

Neuropsychiatric Disease and Treatment 2015, 11:107-113

Published Date: 9 January 2015

Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities

Lozano D, Gonzales-Portillo GS, Acosta S, de la Pena I, Tajiri N, Kaneko Y, Borlongan CV

Neuropsychiatric Disease and Treatment 2015, 11:97-106

Published Date: 8 January 2015

The impact of internalizing symptoms on autistic traits in adolescents with restrictive anorexia nervosa

Calderoni S, Fantozzi P, Balboni G, Pagni V, Franzoni E, Apicella F, Narzisi A, Maestro S, Muratori F

Neuropsychiatric Disease and Treatment 2015, 11:75-85

Published Date: 5 January 2015

Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia

Sicras-Mainar A, Maurino J, Ruiz-Beato E, Navarro-Artieda R

Neuropsychiatric Disease and Treatment 2015, 11:51-57

Published Date: 30 December 2014

A study of safety and tolerability of rotatory vestibular input for preschool children

Su WC, Lin CK, Chang SC

Neuropsychiatric Disease and Treatment 2015, 11:41-49

Published Date: 31 December 2014

Clinical preference for factors in treatment of geriatric depression

Riepe MW

Neuropsychiatric Disease and Treatment 2015, 11:25-31

Published Date: 22 December 2014

Cerebellar cryptococcosis characterized by a space-occupying lesion in an immunocompetent non-HIV patient

Liu BX, Dai XJ, Liu H, Gong HH, Wang YX, Zhang LL

Neuropsychiatric Disease and Treatment 2015, 11:21-24

Published Date: 19 December 2014

Exploring the risk-factor association between depression and incident stroke: a systematic review and meta-analysis

Barlinn K, Kepplinger J, Puetz V, Illigens BM, Bodechtel U, Siepmann T

Neuropsychiatric Disease and Treatment 2015, 11:1-14

Published Date: 18 December 2014

Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo

Yanik ME, Erfan G, Albayrak Y, Aydin M, Kulac M, Kuloglu M

Neuropsychiatric Disease and Treatment 2014, 10:2361-2367

Published Date: 12 December 2014

Single event-related changes in cerebral oxygenated hemoglobin using word game in schizophrenia

Fujiki R, Morita K, Sato M, Yamashita Y, Kato Y, Ishii Y, Shoji Y, Uchimura N

Neuropsychiatric Disease and Treatment 2014, 10:2353-2360

Published Date: 11 December 2014

Parkinson’s disease-associated melanin steal

Hinz M, Stein A, Cole T

Neuropsychiatric Disease and Treatment 2014, 10:2331-2337

Published Date: 10 December 2014

Association of Per3 length polymorphism with bipolar I disorder and schizophrenia

Karthikeyan R, Marimuthu G, Ramasubramanian C, Arunachal G, BaHammam AS, Spence DW, Cardinali DP, Brown GM, Pandi-Perumal SR

Neuropsychiatric Disease and Treatment 2014, 10:2325-2330

Published Date: 9 December 2014

Plasma levels of 3-methoxy-4-hydroxyphenylglycol are associated with microstructural changes within the cerebellum in the early stage of first-episode schizophrenia: a longitudinal VBM study

Nishimura J, Kakeda S, Abe O, Yoshimura R, Watanabe K, Goto N, Hori H, Sato T, Takao H, Kabasawa H, Nakamura J, Korogi Y

Neuropsychiatric Disease and Treatment 2014, 10:2315-2323

Published Date: 8 December 2014

Remediation of context-processing deficits in schizophrenia: preliminary data with ambiguous sentences

Besche-Richard C, Terrien S, Lesgourgues M, Béchiri-Payet C, Gierski F, Limosin F

Neuropsychiatric Disease and Treatment 2014, 10:2307-2312

Published Date: 3 December 2014

Possible association between phantom vibration syndrome and occupational burnout

Chen CP, Wu CC, Chang LR, Lin YH

Neuropsychiatric Disease and Treatment 2014, 10:2307-2314

Published Date: 4 December 2014

Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke

Amiri-Nikpour MR, Nazarbaghi S, Ahmadi-Salmasi B, Mokari T, Tahamtan U, Rezaei Y

Neuropsychiatric Disease and Treatment 2014, 10:2299-2306

Published Date: 3 December 2014

The clinical psychologist and the management of inpatient pain: a small case series

Childs SR, Casely EM, Kuehler BM, Ward S, Halmshaw CL, Thomas SE, Goodall ID, Bantel C

Neuropsychiatric Disease and Treatment 2014, 10:2291-2297

Published Date: 2 December 2014

Increasing dependency of older people in nursing homes is associated with need for dental treatments

Zenthöfer A, Rammelsberg P, Cabrera T, Hassel AJ

Neuropsychiatric Disease and Treatment 2014, 10:2285-2290

Published Date: 2 December 2014

Posttraumatic stress symptoms, dissociation, and alexithymia in an Italian sample of flood victims

Craparo G, Gori A, Mazzola E, Petruccelli I, Pellerone M, Rotondo G

Neuropsychiatric Disease and Treatment 2014, 10:2281-2284

Published Date: 28 November 2014

Cluster headache as a first manifestation of multiple sclerosis: case report and literature review

Mijajlović MD, Aleksić VM, Čovičković Šternić NM

Neuropsychiatric Disease and Treatment 2014, 10:2269-2274

Published Date: 25 November 2014

Rehabilitation for a child with recalcitrant anti-N-methyl-D-aspartate receptor encephalitis: case report and literature review

Guo YH, Kuan TS, Hsieh PC, Lien WC, Chang CK, Lin YC

Neuropsychiatric Disease and Treatment 2014, 10:2263-2267

Published Date: 24 November 2014

Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions

Koppel J, Greenwald BS

Neuropsychiatric Disease and Treatment 2014, 10:2253-2262

Published Date: 24 November 2014

Foix-Chavany-Marie syndrome in a 17-year-old female with congenital cytomegalovirus infection

Conforti R, Capasso R, Capaldo G, Dato C, Saracino D, Di Iorio G, Melone MA

Neuropsychiatric Disease and Treatment 2014, 10:2249-2252

Published Date: 20 November 2014

Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigation

Dennis BB, Samaan MC, Bawor M, Paul J, Plater C, Pare G, Worster A, Varenbut M, Daiter J, Marsh DC, Desai D, Thabane L, Samaan Z

Neuropsychiatric Disease and Treatment 2014, 10:2239-2247

Published Date: 19 November 2014

A comparative study of 43 patients with mirror-like intracranial aneurysms: risk factors, treatment, and prognosis

Wang R, Zhang D, Zhao JZ, Wang S, Zhao YL, Niu HC

Neuropsychiatric Disease and Treatment 2014, 10:2231-2237

Published Date: 19 November 2014

Bereavement and behavioral changes as risk factors for cognitive decline in adults with Down syndrome

Fonseca LM, Oliveira MC, Guilhoto LM, Cavalheiro EA, Bottino CM

Neuropsychiatric Disease and Treatment 2014, 10:2209-2219

Published Date: 17 November 2014

Comparison of three screening tests for autism in preterm children with birth weights less than 1,500 grams

Dudova I, Markova D, Kasparova M, Zemankova J, Beranova S, Urbanek T, Hrdlicka M

Neuropsychiatric Disease and Treatment 2014, 10:2201-2208

Published Date: 17 November 2014

Below and beyond the recognition of emotional facial expressions in alcohol dependence: from basic perception to social cognition

D’Hondt F, Campanella S, Kornreich C, Philippot P, Maurage P

Neuropsychiatric Disease and Treatment 2014, 10:2177-2182

Published Date: 18 November 2014

Posttraumatic epilepsy: current and emerging treatment options

Paiva WS, Mello LE

Neuropsychiatric Disease and Treatment 2014, 10:2159-2161

Published Date: 13 November 2014

Decreased serum level of NGF in alcohol-dependent patients with declined executive function

Bae H, Ra Y, Han C, Kim DJ

Neuropsychiatric Disease and Treatment 2014, 10:2153-2157

Published Date: 13 November 2014

Severe agitation in severe early-onset Alzheimer’s disease resolves with ECT

Aksay SS, Hausner L, Frölich L, Sartorius A

Neuropsychiatric Disease and Treatment 2014, 10:2147-2151

Published Date: 13 November 2014

Acute intermittent porphyria caused by novel mutation in HMBS gene, misdiagnosed as cholecystitis

Alfadhel M, Saleh N, Alenazi H, Baffoe-Bonnie H

Neuropsychiatric Disease and Treatment 2014, 10:2135-2137

Published Date: 12 November 2014

Association of BDNF Val66Met polymorphism with HPA and SAM axis reactivity to psychological and physical stress

Tsuru J, Tanaka Y, Ishitobi Y, Maruyama Y, Inoue A, Kawano A, Ikeda R, Ando T, Oshita H, Aizawa S, Masuda K, Higuma H, Kanehisa M, Ninomiya T, Akiyoshi J

Neuropsychiatric Disease and Treatment 2014, 10:2123-2133

Published Date: 11 November 2014

A prospective naturalistic study of antidepressant-induced jitteriness/anxiety syndrome

Harada T, Inada K, Yamada K, Sakamoto K, Ishigooka J

Neuropsychiatric Disease and Treatment 2014, 10:2115-2121

Published Date: 10 November 2014

Age-associated decrease in global DNA methylation in patients with major depression

Tseng PT, Lin PY, Lee Y, Hung CF, Lung FW, Chen CS, Chong MY

Neuropsychiatric Disease and Treatment 2014, 10:2105-2114

Published Date: 10 November 2014

Psychiatric comorbidities in patients with major depressive disorder

Thaipisuttikul P, Ittasakul P, Waleeprakhon P, Wisajun P, Jullagate S

Neuropsychiatric Disease and Treatment 2014, 10:2097-2103

Published Date: 10 November 2014

Iron deficiency and cognitive functions

Jáuregui-Lobera I

Neuropsychiatric Disease and Treatment 2014, 10:2087-2095

Published Date: 10 November 2014

Can low brain-derived neurotrophic factor levels be a marker of the presence of depression in obese women?

Celik Guzel E, Bakkal E, Guzel S, Eroglu HE, Acar A, Kuçukyalcin V, Topcu B

Neuropsychiatric Disease and Treatment 2014, 10:2079-2086

Published Date: 5 November 2014

Social cognition and its relationship to functional outcomes in patients with sustained acquired brain injury

Ubukata S, Tanemura R, Yoshizumi M, Sugihara G, Murai T, Ueda K

Neuropsychiatric Disease and Treatment 2014, 10:2061-2068

Published Date: 3 November 2014

Spinal cord demyelination combined with hyperhomocysteinemia: a case report

Hao MM, Zhang Y, Hou SX, Chen YL, Shi M, Zhao G, Deng YC

Neuropsychiatric Disease and Treatment 2014, 10:2057-2059

Published Date: 3 November 2014

Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report

Noda Y, Daskalakis ZJ, Downar J, Croarkin PE, Fitzgerald PB, Blumberger DM

Neuropsychiatric Disease and Treatment 2014, 10:2049-2055

Published Date: 31 October 2014

Factors associated with adherence to medication among depressed patients from Saudi Arabia: a cross-sectional study

Al Jumah K, Hassali MA, Al Qhatani D, El Tahir K

Neuropsychiatric Disease and Treatment 2014, 10:2031-2037

Published Date: 28 October 2014

Parental bonding and attitudes toward suicide among medical college students in Japan

Hashimoto K, Sugawara N, Tanaka O, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2014, 10:2015-2020

Published Date: 23 October 2014

Elongation of pulse width as an augmentation strategy in electroconvulsive therapy

Kawashima H, Suwa T, Murai T, Yoshioka R

Neuropsychiatric Disease and Treatment 2014, 10:2009-2014

Published Date: 23 October 2014

Nothing to smile about

Luca M, Luca A, Grasso CMAV, Calandra C

Neuropsychiatric Disease and Treatment 2014, 10:1999-2008

Published Date: 23 October 2014

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]

Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM

Neuropsychiatric Disease and Treatment 2014, 10:1997-1998

Published Date: 20 October 2014

Brain structural abnormalities in behavior therapy-resistant obsessive-compulsive disorder revealed by voxel-based morphometry

Hashimoto N, Nakaaki S, Kawaguchi A, Sato J, Kasai H, Nakamae T, Narumoto J, Miyata J, Furukawa TA, Mimura M

Neuropsychiatric Disease and Treatment 2014, 10:1987-1996

Published Date: 20 October 2014

Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia

Kikuchi YS, Sato W, Ataka K, Yagisawa K, Omori Y, Kanbayashi T, Shimizu T

Neuropsychiatric Disease and Treatment 2014, 10:1973-1978

Published Date: 15 October 2014

Cortisol levels and sleep patterns in infants with orofacial clefts undergoing surgery

Mueller AA, Kalak N, Schwenzer-Zimmerer K, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2014, 10:1965-1972

Published Date: 15 October 2014

Neuropsychiatric symptoms and celiac disease

Urban-Kowalczyk M, Śmigielski J, Gmitrowicz A

Neuropsychiatric Disease and Treatment 2014, 10:1961-1964

Published Date: 14 October 2014

Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics

Adam UU, Husain N, Haddad PM, Munshi T, Tariq F, Naeem F, Chaudhry IB

Neuropsychiatric Disease and Treatment 2014, 10:1953-1959

Published Date: 14 October 2014

Alexithymia in parents and adolescent anorexic daughters: comparing the responses to TSIA and TAS-20 scales

Balottin L, Nacinovich R, Bomba M, Mannarini S

Neuropsychiatric Disease and Treatment 2014, 10:1941-1951

Published Date: 9 October 2014

Violent victimization of adult patients with severe mental illness: a systematic review

Latalova K, Kamaradova D, Prasko J

Neuropsychiatric Disease and Treatment 2014, 10:1925-1939

Published Date: 9 October 2014

EMSAM (deprenyl patch): how a promising antidepressant was underutilized

Asnis GM, Henderson MA

Neuropsychiatric Disease and Treatment 2014, 10:1911-1923

Published Date: 6 October 2014

Diagnosing pseudobulbar affect in traumatic brain injury

Engelman W, Hammond FM, Malec JF

Neuropsychiatric Disease and Treatment 2014, 10:1903-1910

Published Date: 7 October 2014

Anxiety and depression levels in prepubertal obese children: a case-control study

Esposito M, Gallai B, Roccella M, Marotta R, Lavano F, Lavano SM, Mazzotta G, Bove D, Sorrentino M, Precenzano F, Carotenuto M

Neuropsychiatric Disease and Treatment 2014, 10:1897-1902

Published Date: 3 October 2014

Prevalence of stress in junior doctors during their internship training: a cross-sectional study of three Saudi medical colleges’ hospitals

Abdulghani HM, Irshad M, Al Zunitan MA, Al Sulihem AA, Al Dehaim MA, Al Esefir WA, Al Rabiah AM, Kameshki RN, Alrowais NA, Sebiany A, Haque S

Neuropsychiatric Disease and Treatment 2014, 10:1879-1886

Published Date: 25 September 2014

Towards a framework for treatment effectiveness in schizophrenia

Juckel G, de Bartolomeis A, Gorwood P, Mosolov S, Pani L, Rossi A, Sanjuan J

Neuropsychiatric Disease and Treatment 2014, 10:1867-1878

Published Date: 24 September 2014

Early prediction of blonanserin response in Japanese patients with schizophrenia

Kishi T, Matsuda Y, Fujita K, Iwata N

Neuropsychiatric Disease and Treatment 2014, 10:1861-1866

Published Date: 23 September 2014

Development and validation of the Pictorial Cognitive Screening Inventory for illiterate people with dementia

Park S, Park SE, Kim MJ, Jung HY, Choi JS, Park KH, Kim I, Lee JY

Neuropsychiatric Disease and Treatment 2014, 10:1837-1845

Published Date: 23 September 2014

Kynurenine and depressive symptoms in a poststroke population

Bensimon K, Herrmann N, Swardfager W, Yi H, Black SE, Gao FQ, Snaiderman A, Lanctôt KL

Neuropsychiatric Disease and Treatment 2014, 10:1827-1835

Published Date: 22 September 2014

A multidimensional risk factor model for suicide attempts in later life

Chan SMS, Chiu FKH, Lam CWL, Wong SMC, Conwell Y

Neuropsychiatric Disease and Treatment 2014, 10:1807-1817

Published Date: 18 September 2014

Sleep and cognitive problems in patients with attention-deficit hyperactivity disorder

Lee HK, Jeong JH, Kim NY, Park MH, Kim TW, Seo HJ, Lim HK, Hong SC, Han JH

Neuropsychiatric Disease and Treatment 2014, 10:1799-1805

Published Date: 17 September 2014

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder

Aoki A, Ishiguro S, Watanabe T, Ueda M, Hayashi Y, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K

Neuropsychiatric Disease and Treatment 2014, 10:1793-1798

Published Date: 18 September 2014

Attention-deficit/hyperactivity disorder in postsecondary students

Nugent K, Smart W

Neuropsychiatric Disease and Treatment 2014, 10:1781-1791

Published Date: 26 September 2014

Modulation of the GABAergic pathway for the treatment of fragile X syndrome

Lozano R, Hare EB, Hagerman RJ

Neuropsychiatric Disease and Treatment 2014, 10:1769-1779

Published Date: 16 September 2014

Reversible brain atrophy and cognitive impairment in an adolescent Japanese patient with primary adrenal Cushing’s syndrome

Ohara N, Suzuki H, Suzuki A, Kaneko M, Ishizawa M, Furukawa K, Abe T, Matsubayashi Y, Yamada T, Hanyu O, Shimohata T, Sone H

Neuropsychiatric Disease and Treatment 2014, 10:1763-1767

Published Date: 15 September 2014

No change in N-acetyl aspartate in first episode of moderate depression after antidepressant treatment: 1H magnetic spectroscopy study of left amygdala and left dorsolateral prefrontal cortex

Bajs Janović M, Kalember P, Janović Š, Hrabač P, Folnegović Grošić P, Grošić V, Radoš M, Henigsberg N

Neuropsychiatric Disease and Treatment 2014, 10:1753-1762

Published Date: 17 September 2014

Cognitive assessments for the early diagnosis of dementia after stroke

Al-Qazzaz NK, Ali SH, Ahmad SA, Islam S

Neuropsychiatric Disease and Treatment 2014, 10:1743-1751

Published Date: 12 September 2014

Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions

Okamoto H, Iyo M, Ueda K, Han C, Hirasaki Y, Namiki T

Neuropsychiatric Disease and Treatment 2014, 10:1727-1742

Published Date: 12 September 2014

The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects – a preliminary study

Ishioka M, Sugawara N, Kaneda A, Okubo N, Iwane K, Takahashi I, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2014, 10:1721-1725

Published Date: 11 September 2014

Association between smoking and cognitive impairment in multiple sclerosis

Özcan ME, İnce B, Bingöl A, Ertürk S, Altınöz MA, Karadeli HH, Koçer A, Asil T

Neuropsychiatric Disease and Treatment 2014, 10:1715-1719

Published Date: 10 September 2014

Validity and clinical utilization of the Chinese version of the Gotland Male Depression Scale at a men’s health polyclinic

Chu CL, Chen Y, Jiang KH, Chen JL, Lee CP, Chau YL, Chen CY

Neuropsychiatric Disease and Treatment 2014, 10:1707-1714

Published Date: 10 September 2014

Animal models of epilepsy: use and limitations

Kandratavicius L, Balista PA, Lopes-Aguiar C, Ruggiero RN, Umeoka EH, Garcia-Cairasco N, Bueno-Junior LS, Leite JP

Neuropsychiatric Disease and Treatment 2014, 10:1693-1705

Published Date: 9 September 2014

Cognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessment

Al-Qazzaz NK, Ali SH, Ahmad SA, Islam S, Mohamad K

Neuropsychiatric Disease and Treatment 2014, 10:1677-1691

Published Date: 9 September 2014

Vitamin B12, folate, and homocysteine levels in patients with obsessive–compulsive disorder

Türksoy N, Bilici R, Yalçıner A, Özdemir YÖ, Örnek I, Tufan AE, Kara A

Neuropsychiatric Disease and Treatment 2014, 10:1671-1675

Published Date: 9 September 2014

Decreased mean platelet volume in panic disorder

Göğçegöz Gül I, Eryılmaz G, Özten E, Hızlı Sayar G

Neuropsychiatric Disease and Treatment 2014, 10:1665-1669

Published Date: 4 September 2014

Risk of epilepsy in patients with systemic lupus erythematosus – a retrospective cohort study

Tsai JD, Lin CL, Lin CC, Sung FC, Lue KH

Neuropsychiatric Disease and Treatment 2014, 10:1635-1643

Published Date: 2 September 2014

Yokukansan and its ingredients as possible treatment options for schizophrenia

Yu CH, Ishii R, Yu SC, Takeda M

Neuropsychiatric Disease and Treatment 2014, 10:1629-1634

Published Date: 1 September 2014

A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan

Tsuruga K, Sugawara N, Yasui-Furukori N, Takahashi I, Tsuchimine S, Kaneda A, Nakaji S, Nakamura K

Neuropsychiatric Disease and Treatment 2014, 10:1621-1627

Published Date: 30 August 2014

Aggression, impulsivity, and suicide risk in benign chronic pain patients – a cross-sectional study

Margari F, Lorusso M, Matera E, Pastore A, Zagaria G, Bruno F, Puntillo F, Margari L

Neuropsychiatric Disease and Treatment 2014, 10:1613-1620

Published Date: 2 September 2014

Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection

Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU

Neuropsychiatric Disease and Treatment 2014, 10:1605-1611

Published Date: 30 August 2014

Motivation for treatment in patients with substance use disorder: personal volunteering versus legal/familial enforcement

Bilici R, Yazici E, Tufan AE, Mutlu E, İzci F, Ugurlu GK

Neuropsychiatric Disease and Treatment 2014, 10:1599-1604

Published Date: 30 August 2014

Hepatotoxicity induced by clozapine: a case report and review of literature

Wu Chou AI, Lu ML, Shen WW

Neuropsychiatric Disease and Treatment 2014, 10:1585-1587

Published Date: 26 August 2014

Influence of patient characteristics on care time in patients hospitalized with schizophrenia

Sugibayashi Y, Yoshimura K, Yamauchi K, Inagaki A, Ikegami N

Neuropsychiatric Disease and Treatment 2014, 10:1577-1584

Published Date: 25 August 2014

Biological differences between melancholic and nonmelancholic depression subtyped by the CORE measure

Spanemberg L, Caldieraro MA, Vares EA, Wollenhaupt-Aguiar B, Kauer-Sant’Anna M, Kawamoto SY, Galvão E, Parker G, Fleck MP

Neuropsychiatric Disease and Treatment 2014, 10:1523-1531

Published Date: 19 August 2014

Diagnostic and therapeutic utility of neuroimaging in depression: an overview

Wise T, Cleare AJ, Herane A, Young AH, Arnone D

Neuropsychiatric Disease and Treatment 2014, 10:1509-1522

Published Date: 19 August 2014

Genetic influence on methadone treatment outcomes in patients undergoing methadone maintenance treatment for opioid addiction: a pilot study

Samaan Z, Bawor M, Dennis BB, Plater C, Varenbut M, Daiter J, Worster A, Marsh DC, Tan C, Desai D, Thabane L, Pare G

Neuropsychiatric Disease and Treatment 2014, 10:1503-1508

Published Date: 19 August 2014

Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire Thai version

Waleeprakhon P, Ittasakul P, Lotrakul M, Wisajun P, Jullagate S, Ketter TA

Neuropsychiatric Disease and Treatment 2014, 10:1497-1502

Published Date: 18 August 2014

A retrospective analysis focusing on a group of patients with dual diagnosis treated by both mental health and substance use services

Di Lorenzo R, Galliani A, Guicciardi A, Landi G, Ferri P

Neuropsychiatric Disease and Treatment 2014, 10:1479-1488

Published Date: 11 August 2014

Post-traumatic epilepsy: current and emerging treatment options

Szaflarski JP, Nazzal Y, Dreer LE

Neuropsychiatric Disease and Treatment 2014, 10:1469-1477

Published Date: 11 August 2014

High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke

Kara H, Akinci M, Degirmenci S, Bayir A, Ak A, Nayman A, Unlu A, Akyurek F, Sivri M

Neuropsychiatric Disease and Treatment 2014, 10:1451-1457

Published Date: 6 August 2014

Examining the relationship between adherence and satisfaction with antidepressant treatment

Aljumah K, Ahmad Hassali A, AlQhatani S

Neuropsychiatric Disease and Treatment 2014, 10:1433-1438

Published Date: 4 August 2014

Sleep quality changes in insomniacs and non-insomniacs after acute altitude exposure and its relationship with acute mountain sickness

Tang XG, Zhang JH, Gao XB, Li QN, Li JB, Yu J, Qin J, Huang L

Neuropsychiatric Disease and Treatment 2014, 10:1423-1432

Published Date: 31 July 2014

The relationship between insight and subjective experience in schizophrenia

Kako Y, Ito K, Hashimoto N, Toyoshima K, Shimizu Y, Mitsui N, Fujii Y, Tanaka T, Kusumi I

Neuropsychiatric Disease and Treatment 2014, 10:1415-1422

Published Date: 29 July 2014

Caregiver burden and coping strategies in caregivers of patients with Alzheimer’s disease

Iavarone A, Ziello AR, Pastore F, Fasanaro AM, Poderico C

Neuropsychiatric Disease and Treatment 2014, 10:1407-1413

Published Date: 29 July 2014

Perspectives on perceived stigma and self-stigma in adult male patients with depression

Latalova K, Kamaradova D, Prasko J

Neuropsychiatric Disease and Treatment 2014, 10:1399-1405

Published Date: 29 July 2014

Cognitive dysfunction in pediatric multiple sclerosis

Suppiej A, Cainelli E

Neuropsychiatric Disease and Treatment 2014, 10:1385-1392

Published Date: 23 July 2014

Reduced brain resting-state network specificity in infants compared with adults

Wylie KP, Rojas DC, Ross RG, Hunter SK, Maharajh K, Cornier M-A, Tregellas JR

Neuropsychiatric Disease and Treatment 2014, 10:1349-1359

Published Date: 21 July 2014

A cross-sectional study on perception of stigma by Chinese schizophrenia patients [Expression of concern]

Ren ZB, Wang HQ, Feng B, Gu CY, Ma YC, Chen H, Li BL, Liu LY

Neuropsychiatric Disease and Treatment 2014, 10:1333-1334

Published Date: 18 July 2014

Dimensional assessment of DSM-5 social anxiety symptoms among university students and its relationship with functional impairment

Dell’Osso L, Abelli M, Pini S, Carlini M, Carpita B, Macchi E, Gorrasi F, Mengali F, Tognetti R, Massimetti G

Neuropsychiatric Disease and Treatment 2014, 10:1325-1332

Published Date: 16 July 2014

Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study

Zhu W, Zhang Z, Qi J, Liu F, Chen J, Zhao J, Guo X

Neuropsychiatric Disease and Treatment 2014, 10:1317-1323

Published Date: 14 July 2014

Sensory disturbances, inhibitory deficits, and the P50 wave in schizophrenia

Vlcek P, Bob P, Raboch J

Neuropsychiatric Disease and Treatment 2014, 10:1309-1315

Published Date: 14 July 2014

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensland MD, Ascher-Svanum H

Neuropsychiatric Disease and Treatment 2014, 10:1287-1296

Published Date: 10 July 2014

Eye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer’s disease

Pereira ML, Camargo MVZA, Aprahamian I, Forlenza OV

Neuropsychiatric Disease and Treatment 2014, 10:1273-1285

Published Date: 9 July 2014

Cerebral palsy in Al-Quseir City, Egypt: prevalence, subtypes, and risk factors

El-Tallawy HN, Farghaly WMA, Shehata GA, Rageh TA, Metwally NA, Badry R, Sayed MAM, Abd El Hamed M, Abd-Elwarth A, Kandil MR

Neuropsychiatric Disease and Treatment 2014, 10:1267-1272

Published Date: 8 July 2014

The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study

Grošić V, Folnegović Grošić P, Kalember P, Bajs Janović M, Radoš M, Mihanović M, Henigsberg N

Neuropsychiatric Disease and Treatment 2014, 10:1243-1253

Published Date: 7 July 2014

Investigation of health anxiety and its related factors in nursing students

Zhang Y, Zhao Y, Mao S, Li G, Yuan Y

Neuropsychiatric Disease and Treatment 2014, 10:1223-1234

Published Date: 7 July 2014

Quantification of functional abilities in Rett syndrome: a comparison between stages III and IV

Monteiro CBM, Savelsbergh GJP, Smorenburg ARP, Graciani Z, Torriani-Pasin C, de Abreu LC, Valenti VE, Kok F

Neuropsychiatric Disease and Treatment 2014, 10:1213-1222

Published Date: 3 July 2014

Sleep duration and subjective psychological well-being in adolescence: a longitudinal study in Switzerland and Norway

Kalak N, Lemola S, Brand S, Holsboer–Trachsler E, Grob A

Neuropsychiatric Disease and Treatment 2014, 10:1199-1207

Published Date: 3 July 2014

The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression

Dannehl K, Rief W, Schwarz MJ, Hennings A, Riemer S, Selberdinger V, Stapf T, Euteneuer F

Neuropsychiatric Disease and Treatment 2014, 10:1191-1197

Published Date: 28 June 2014

COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study

Hayashi K, Yoshimura R, Kakeda S, Kishi T, Abe O, Umene-Nakano W, Katsuki A, Hori H, Ikenouchi-Sugita A, Watanabe K, Ide S, Ueda I, Moriya J, Iwata N, Korogi Y, Kubicki M, Nakamura J

Neuropsychiatric Disease and Treatment 2014, 10:1183-1190

Published Date: 25 June 2014

Brain meningioma with initial manifestation similar to cervical radiculopathy: a case report

Huang YH, Hong CZ, Wu WT, Li KT, Chou LW

Neuropsychiatric Disease and Treatment 2014, 10:1175-1181

Published Date: 25 June 2014

Improvement of verbal fluency in patients with diffuse brain injury over time

Zaninotto AL, Guirado VM, Baldivia B, Núñez MD, Amorim RL, Teixeira MJ, Lucia MC, Andrade AF, Paiva WS

Neuropsychiatric Disease and Treatment 2014, 10:1155-1160

Published Date: 24 June 2014

A failure to confirm the effectiveness of a brief group psychoeducational program for mothers of children with high-functioning pervasive developmental disorders: a randomized controlled pilot trial

Suzuki M, Yamada A, Watanabe N, Akechi T, Katsuki F, Nishiyama T, Imaeda M, Miyachi T, Otaki K, Mitsuda Y, Ota A, Furukawa TA

Neuropsychiatric Disease and Treatment 2014, 10:1141-1153

Published Date: 30 June 2014

Association of dopamine D1 receptor gene polymorphism with schizophrenia: a meta-analysis

Pan YQ, Yao J, Wang BJ

Neuropsychiatric Disease and Treatment 2014, 10:1133-1139

Published Date: 20 June 2014

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection

Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H

Neuropsychiatric Disease and Treatment 2014, 10:1125-1131

Published Date: 20 June 2014

Sleeping well with cancer: a systematic review of cognitive behavioral therapy for insomnia in cancer patients

Garland SN, Johnson JA, Savard J, Gehrman P, Perlis M, Carlson L, Campbell T

Neuropsychiatric Disease and Treatment 2014, 10:1113-1124

Published Date: 18 June 2014

Amantadine and cognitive flexibility: decision making in Parkinson's patients with severe pathological gambling and other impulse control disorders

Cera N, Bifolchetti S, Martinotti G, Gambi F, Sepede G, Onofrj M, Di Giannantonio M, Thomas A

Neuropsychiatric Disease and Treatment 2014, 10:1093-1101

Published Date: 17 June 2014

Analysis of the cumulative effect of schizophrenia-related single nucleotide polymorphisms

Lozano R, Marín R, Freire I, Santacruz MJ, Pascual-García A

Neuropsychiatric Disease and Treatment 2014, 10:1079-1080

Published Date: 12 June 2014

Tackling nonadherence in psychiatric disorders: current opinion

Farooq S, Naeem F

Neuropsychiatric Disease and Treatment 2014, 10:1069-1077

Published Date: 12 June 2014

Towards Horizon 2020: challenges and advances for clinical mental health research – outcome of an expert survey

van der Feltz-Cornelis CM, van Os J, Knappe S, Schumann G, Vieta E, Wittchen HU, Lewis SW, Elfeddali I, Wahlbeck K, Linszen D, Obradors-Tarragó C, Haro JM

Neuropsychiatric Disease and Treatment 2014, 10:1057-1068

Published Date: 27 June 2014

Neurophysiological correlates of response inhibition predict relapse in detoxified alcoholic patients: some preliminary evidence from event-related potentials

Petit G, Cimochowska A, Kornreich C, Hanak C, Verbanck P, Campanella S

Neuropsychiatric Disease and Treatment 2014, 10:1025-1037

Published Date: 9 June 2014

Factors associated with antenatal depression in pregnant Korean females: the effect of bipolarity on depressive symptoms

Park CM, Seo HJ, Jung YE, Kim MD, Hong SC, Bahk WM, Yoon BH, Hur MH, Song JM

Neuropsychiatric Disease and Treatment 2014, 10:1017-1023

Published Date: 9 June 2014

Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both a-synucleinopathy and tauopathy

Moretti DV, Binetti G, Zanetti O, Frisoni GB

Neuropsychiatric Disease and Treatment 2014, 10:1003-1009

Published Date: 5 June 2014

Perceiving “ghost” images: a unique case of visual allesthesia with hemianopsia in mitochondrial disease

Murakami H, Ichikawa H, Sugimoto A, Futamura A, Shimizu Y, Sugie M, Miller MW, Kawamura M

Neuropsychiatric Disease and Treatment 2014, 10:999-1002

Published Date: 5 June 2014

Determining a diagnostic cut-off on the Teate Depression Inventory

Balsamo M, Saggino A

Neuropsychiatric Disease and Treatment 2014, 10:987-995

Published Date: 3 June 2014

Effect of calligraphy training on hyperarousal symptoms for childhood survivors of the 2008 China earthquakes

Zhu Z, Wang R, Kao HSR, Zong Y, Liu Z, Tang S, Xu M, Liu ICY, Lam SPW

Neuropsychiatric Disease and Treatment 2014, 10:977-985

Published Date: 3 June 2014

Epileptic and cognitive changes in children with cerebral palsy: an Egyptian study

El-Tallawy HN, Farghaly WMA, Shehata GA, Badry R, Rageh TA

Neuropsychiatric Disease and Treatment 2014, 10:971-975

Published Date: 29 May 2014

Nonepileptic seizures under levetiracetam therapy: a case report of forced normalization process

Anzellotti F, Franciotti R, Zhuzhuni H, D’Amico A, Thomas A, Onofrj M

Neuropsychiatric Disease and Treatment 2014, 10:959-964

Published Date: 23 May 2014

Possible association between vitamin D deficiency and restless legs syndrome

Oran M, Unsal C, Albayrak Y, Tulubas F, Oguz K, Avci O, Turgut N, Alp R, Gurel A

Neuropsychiatric Disease and Treatment 2014, 10:953-958

Published Date: 21 May 2014

Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?

Fornaro M, Bandini F, Cestari L, Cordano C, Ogliastro C, Albano C, De Berardis D, Martino M, Escelsior A, Rocchi G, Fornaro P, De Pasquale C

Neuropsychiatric Disease and Treatment 2014, 10:907-914

Published Date: 20 May 2014

Neuropathic sensory symptoms: association with pain and psychological factors

Shaygan M, Böger A, Kröner-Herwig B

Neuropsychiatric Disease and Treatment 2014, 10:897-906

Published Date: 20 May 2014

Psychometric evaluation of the Sheehan Disability Scale in adult patients with attention-deficit/hyperactivity disorder

Coles T, Coon C, DeMuro C, McLeod L, Gnanasakthy A

Neuropsychiatric Disease and Treatment 2014, 10:887-895

Published Date: 19 May 2014

Temperament, character traits, and alexithymia in patients with panic disorder

Izci F, Gültekin BK, Saglam S, Koc MI, Zincir SB, Atmaca M

Neuropsychiatric Disease and Treatment 2014, 10:879-885

Published Date: 16 May 2014

Second case report of successful electroconvulsive therapy for a patient with schizophrenia and severe hemophilia A

Saito N, Shioda K, Nisijima K, Kobayashi T, Kato S

Neuropsychiatric Disease and Treatment 2014, 10:865-867

Published Date: 16 May 2014

Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review

Xue HBH, Liu L, Zhang H, Montgomery W, Treuer T

Neuropsychiatric Disease and Treatment 2014, 10:841-864

Published Date: 16 May 2014

Nerve growth factor variations in patients with mood disorders: no changes in eight weeks of clinical treatment

Liu X, Zhang T, He S, Hong B, Peng D, Su H, Li F, Tang Y, Lin Z, Fang Y, Jiang K

Neuropsychiatric Disease and Treatment 2014, 10:835-840

Published Date: 15 May 2014

Social phobia in Parkinson’s disease: Prevalence and risk factors

Gultekin BK, Ozdilek B, Bestepe EE

Neuropsychiatric Disease and Treatment 2014, 10:829-834

Published Date: 21 May 2014

Latent class analysis on internet and smartphone addiction in college students

Mok JY, Choi SW, Kim DJ, Choi JS, Lee J, Ahn H, Choi EJ, Song WY

Neuropsychiatric Disease and Treatment 2014, 10:817-828

Published Date: 20 May 2014

The association between suicide risk and self-esteem in Japanese university students with major depressive episodes of major depressive disorder

Mitsui N, Asakura S, Shimizu Y, Fujii Y, Toyomaki A, Kako Y, Tanaka T, Kitagawa N, Inoue T, Kusumi I

Neuropsychiatric Disease and Treatment 2014, 10:811-816

Published Date: 15 May 2014

Risk factors for an anxiety disorder comorbidity among Thai patients with bipolar disorder: results from the Thai Bipolar Disorder Registry

Paholpak S, Kongsakon R, Pattanakumjorn W, Kanokvut R, Wongsuriyadech W, Srisurapanont M

Neuropsychiatric Disease and Treatment 2014, 10:803-810

Published Date: 15 May 2014

Factors associated with body image distortion in Korean adolescents

Hyun MY, Jung YE, Kim MD, Kwak YS, Hong SC, Bahk WM, Yoon BH, Yoon HW, Yoo B

Neuropsychiatric Disease and Treatment 2014, 10:797-802

Published Date: 13 May 2014

The prevalence of bipolar spectrum disorder in elderly patients with recurrent depression

Lee CI, Jung YE, Kim MD, Hong SC, Bahk WM, Yoon BH

Neuropsychiatric Disease and Treatment 2014, 10:791-795

Published Date: 8 May 2014

Nonergot dopamine-receptor agonists for treating Parkinson's disease – a network meta-analysis

Thorlund K, Wu P, Druyts E, Eapen S, Mills EJ

Neuropsychiatric Disease and Treatment 2014, 10:767-776

Published Date: 7 May 2014

Psychiatry 2050: from younger psychiatrists' perspective

Hassan TM, Habib W, Mazhar MN, Munshi T

Neuropsychiatric Disease and Treatment 2014, 10:723-726

Published Date: 7 May 2014

Tipepidine in adolescent patients with depression: a 4 week, open-label, preliminary study

Sasaki T, Hashimoto K, Tachibana M, Kurata T, Kimura H, Komatsu H, Ishikawa M, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shiraishi T, Iyo M

Neuropsychiatric Disease and Treatment 2014, 10:719-722

Published Date: 5 May 2014

Comprehensive cognitive and cerebral hemodynamic evaluation after cranioplasty

Coelho F, Oliveira AM, Paiva WS, Freire FR, Calado VT, Amorim RL, Neville IS, Andrade AF, Bor-Seng-Shu E, Anghinah R, Teixeira MJ

Neuropsychiatric Disease and Treatment 2014, 10:695-701

Published Date: 2 May 2014

Increased serum dehydroepiandrosterone sulfate in the first episode but not in subsequent episodes in male patients with schizophrenia

Beyazyüz M, Albayrak Y, Beyazyüz E, Ünsal C, Göka E

Neuropsychiatric Disease and Treatment 2014, 10:687-693

Published Date: 29 April 2014

Dissociative symptoms reflect levels of tumor necrosis factor alpha in patients with unipolar depression

Bizik G, Bob P, Raboch J, Pavlat J, Uhrova J, Benakova H, Zima T

Neuropsychiatric Disease and Treatment 2014, 10:675-679

Published Date: 25 April 2014

Changes in cerebral blood flow after cognitive behavior therapy in patients with panic disorder: a SPECT study

Seo HJ, Choi YH, Chung YA, Rho W, Chae JH

Neuropsychiatric Disease and Treatment 2014, 10:661-669

Published Date: 17 April 2014

Spatial memory impairments in amnestic mild cognitive impairment in a virtual radial arm maze

Lee JY, Kho S, Yoo HB, Park S, Choi JS, Kwon JS, Cha KR, Jung HY

Neuropsychiatric Disease and Treatment 2014, 10:653-660

Published Date: 17 April 2014

Genetic association between the dopamine D1-receptor gene and paranoid schizophrenia in a northern Han Chinese population

Yao J, Ding M, Xing JX, Xuan JF, Pang H, Pan YQ, Wang BJ

Neuropsychiatric Disease and Treatment 2014, 10:645-652

Published Date: 17 April 2014

A case report of suicidal behavior related to subclinical hyperthyroidism

Joo SH, Jeong JH, Hong SC

Neuropsychiatric Disease and Treatment 2014, 10:641-643

Published Date: 17 April 2014

Suicidal ideation and the risk of suicide in patients with fibromyalgia: a comparison with non-pain controls and patients suffering from low-back pain

Jimenez-Rodriguez I, Garcia-Leiva JM, Jimenez-Rodriguez BM, Condés-Moreno E, Rico-Villademoros F, Calandre EP

Neuropsychiatric Disease and Treatment 2014, 10:625-630

Published Date: 16 April 2014

Proposed criteria for schizophrenia remission

AlAqeel B

Neuropsychiatric Disease and Treatment 2014, 10:619-623

Published Date: 16 April 2014

Analysis of cardiac autonomic modulation of children with attention deficit hyperactivity disorder

de Carvalho TD, Wajnsztejn R, de Abreu LC, Marques Vanderlei LC, Godoy MF, Adami F, Valenti VE, Monteiro CBM, Leone C, da Cruz Martins KC, Ferreira C

Neuropsychiatric Disease and Treatment 2014, 10:613-618

Published Date: 11 April 2014

Dopamine transporter changes after unilateral deep brain stimulation in progressive Parkinson's disease: a case report

Zhang HW, Wang YY, Liang JC, Förster S, Wu P, Zhao J, Guan YH, Zuo CT

Neuropsychiatric Disease and Treatment 2014, 10:607-611

Published Date: 8 April 2014

Chorea disclosing a polycythemia vera

Liu GD, Chang J, Liu ZJ, Qiang Q, Gu CH, Zhang YY, Wei WS

Neuropsychiatric Disease and Treatment 2014, 10:563-565

Published Date: 5 April 2014

Suicidal behavior among Turkish patients with Parkinson’s disease

Ozdilek B, Gultekin BK

Neuropsychiatric Disease and Treatment 2014, 10:541-545

Published Date: 26 March 2014

A cross-sectional study on perception of stigma by Chinese schizophrenia patients

Ren ZB, Wang HQ, Feng B, Gu CY, Ma YC, Chen H, Li BL, Liu LY

Neuropsychiatric Disease and Treatment 2014, 10:535-540

Published Date: 26 March 2014

Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone

Hori H, Yamada K, Kamada D, Shibata Y, Katsuki A, Yoshimura R, Nakamura J

Neuropsychiatric Disease and Treatment 2014, 10:527-533

Published Date: 26 March 2014

Prevalence of depression and its relationship with work characteristics in a sample of public workers

Luca M, Bellia S, Bellia M, Luca A, Calandra C

Neuropsychiatric Disease and Treatment 2014, 10:519-525

Published Date: 25 March 2014

Neuropsychological phenotype of a patient with a de novo 970 kb interstitial deletion in the distal 16p11.2 region

Egger JI, Verhoeven WM, Verbeeck W, de Leeuw N

Neuropsychiatric Disease and Treatment 2014, 10:513-517

Published Date: 25 March 2014

Near-infrared spectroscopy and plasma homovanillic acid levels in bipolar disorder: a case report

Miura I, Kono S, Oshima S, Kanno-Nozaki K, Mashiko H, Niwa SI, Yabe H

Neuropsychiatric Disease and Treatment 2014, 10:507-511

Published Date: 25 March 2014

Update on once-daily zonisamide monotherapy in partial seizures

Afra P, Adamolekun B

Neuropsychiatric Disease and Treatment 2014, 10:493-498

Published Date: 19 March 2014

Dissociation in schizophrenia and borderline personality disorder

Pec O, Bob P, Raboch J

Neuropsychiatric Disease and Treatment 2014, 10:487-491

Published Date: 17 March 2014

Improvement of gross motor and cognitive abilities by an exercise training program: three case reports

Alesi M, Battaglia G, Roccella M, Testa D, Palma A, Pepi A

Neuropsychiatric Disease and Treatment 2014, 10:479-485

Published Date: 14 March 2014

When to start aripiprazole therapy in patients with bipolar mania

Sayyaparaju KK, Grunze H, Fountoulakis KN

Neuropsychiatric Disease and Treatment 2014, 10:459-470

Published Date: 13 March 2014

Suicide risk among Thai illicit drug users with and without mental/alcohol use disorders

Kittirattanapaiboon P, Suttajit S, Junsirimongkol B, Likhitsathian S, Srisurapanont M

Neuropsychiatric Disease and Treatment 2014, 10:453-458

Published Date: 13 March 2014

Influence of valproate on the required dose of propofol for anesthesia during electroconvulsive therapy of bipolar affective disorder patients

Hızlı Sayar G, Eryılmaz G, Şemieoğlu S, Özten E, Göğcegöz Gül I

Neuropsychiatric Disease and Treatment 2014, 10:433-438

Published Date: 4 March 2014

Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan

Sugawara N, Yasui-Furukori N, Tomita T, Furukori H, Kubo K, Nakagami T, Kaneko S

Neuropsychiatric Disease and Treatment 2014, 10:427-432

Published Date: 28 February 2014

Long-term efficacy and safety of iloperidone: an update

Rado JT, Janicak PG

Neuropsychiatric Disease and Treatment 2014, 10:409-415

Published Date: 26 February 2014

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease

Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM

Neuropsychiatric Disease and Treatment 2014, 10:391-401

Published Date: 21 February 2014

What’s in the pipeline? Drugs in development for autism spectrum disorder

Sung M, Chin CH, Lim CG, Liew HSA, Lim CS, Kashala E, Weng SJ

Neuropsychiatric Disease and Treatment 2014, 10:371-381

Published Date: 20 February 2014

Perioperative hyperglycemia is associated with postoperative neurocognitive disorders after cardiac surgery

Zhang X, Yan X, Gorman J, Hoffman SN, Zhang L, Boscarino JA

Neuropsychiatric Disease and Treatment 2014, 10:361-370

Published Date: 19 February 2014

Neural basis of three dimensions of agitated behaviors in patients with Alzheimer disease

Banno K, Nakaaki S, Sato J, Torii K, Narumoto J, Miyata J, Hirono N, Furukawa TA, Mimura M, Akechi T

Neuropsychiatric Disease and Treatment 2014, 10:339-348

Published Date: 17 February 2014

Psychological morbidity, quality of life, and self-rated health in the military personnel

Chou HW, Tzeng WC, Chou YC, Yeh HW, Chang HA, Kao YC, Tzeng NS

Neuropsychiatric Disease and Treatment 2014, 10:329-338

Published Date: 17 February 2014

Olanzapine use in a manic patient during second and third trimester pregnancy

Choi L, Joo SH, Jeong JH

Neuropsychiatric Disease and Treatment 2014, 10:325-328

Published Date: 17 February 2014

Altered baseline brain activity in children with bipolar disorder during mania state: a resting-state study

Lu D, Jiao Q, Zhong Y, Gao W, Xiao Q, Liu X, Lin X, Cheng W, Luo L, Xu C, Lu G, Su L

Neuropsychiatric Disease and Treatment 2014, 10:317-323

Published Date: 17 February 2014

Risk factors associated with postpartum depression in the Saudi population

Alharbi AA, Abdulghani HM

Neuropsychiatric Disease and Treatment 2014, 10:311-316

Published Date: 17 February 2014

Frontotemporal lobar degeneration: current perspectives

Riedl L, Mackenzie IR, Förstl H, Kurz A, Diehl-Schmid J

Neuropsychiatric Disease and Treatment 2014, 10:297-310

Published Date: 13 February 2014

Effect of the coadministration of citalopram with mirtazapine or atipamezole on rat contextual conditioned fear

Masuda T, Inoue T, An Y, Takamura N, Nakagawa S, Kitaichi Y, Koyama T, Kusumi I

Neuropsychiatric Disease and Treatment 2014, 10:289-295

Published Date: 11 February 2014

Two cases of mild serotonin toxicity via 5-hydroxytryptamine 1A receptor stimulation

Nakayama H, Umeda S, Nibuya M, Terao T, Nisijima K, Nomura S

Neuropsychiatric Disease and Treatment 2014, 10:283-287

Published Date: 11 February 2014

Screening for autism in preterm children with extremely low and very low birth weight

Dudova I, Kasparova M, Markova D, Zemankova J, Beranova S, Urbanek T, Hrdlicka M

Neuropsychiatric Disease and Treatment 2014, 10:277-282

Published Date: 11 February 2014

Tinnitus: clinical experience of the psychosomatic connection

Salviati M, Bersani FS, Terlizzi S, Melcore C, Panico R, Romano GF, Valeriani G, Macrì F, Altissimi G, Mazzei F, Testugini V, Latini L, Delle Chiaie R, Biondi M, Cianfrone G

Neuropsychiatric Disease and Treatment 2014, 10:267-275

Published Date: 10 February 2014

Two grams of sarcosine in schizophrenia – is it too much? A potential role of glutamate- serotonin interaction

Strzelecki D, Szyburska J, Rabe-Jabłońska J

Neuropsychiatric Disease and Treatment 2014, 10:263-266

Published Date: 4 February 2014

Possible association between haplotypes of the FKBP5 gene and suicidal bipolar disorder, but not with melancholic depression and psychotic features, in the course of bipolar disorder

Leszczyńska-Rodziewicz A, Szczepankiewicz A, Narożna B, Skibińska M, Pawlak J, Dmitrzak-Węglarz M, Hauser J

Neuropsychiatric Disease and Treatment 2014, 10:243-248

Published Date: 3 February 2014

Baseline characteristics of depressive disorders in Thai outpatients: findings from the Thai Study of Affective Disorders

Wongpakaran T, Wongpakaran N, Pinyopornpanish M, Srisutasanavong U, Lueboonthavatchai P, Nivataphand R, Apisiridej N, Petchsuwan D, Saisavoey N, Wannarit K, Ruktrakul R, Srichan T, Satthapisit S, Nakawiro D, Hiranyatheb T, Temboonkiat A, Tubtimtong N, Rakkhajeekul S, Wongtanoi B, Tanchakvaranont S, Bookkamana P

Neuropsychiatric Disease and Treatment 2014, 10:217-223

Published Date: 31 January 2014

Predictors of repeated sick leave in the workplace because of mental disorders

Sado M, Shirahase J, Yoshimura K, Miura Y, Yamamoto K, Tabuchi H, Kato M, Mimura M

Neuropsychiatric Disease and Treatment 2014, 10:193-200

Published Date: 29 January 2014

Design and validation of standardized clinical and functional remission criteria in schizophrenia

Mosolov SN, Potapov AV, Ushakov UV, Shafarenko AA, Kostyukova AB

Neuropsychiatric Disease and Treatment 2014, 10:167-181

Published Date: 28 January 2014

Building a new Rasch-based self-report inventory of depression

Balsamo M, Giampaglia G, Saggino A

Neuropsychiatric Disease and Treatment 2014, 10:153-165

Published Date: 28 January 2014

Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study

Sasaki T, Hashimoto K, Tachibana M, Kurata T, Okawada K, Ishikawa M, Kimura H, Komatsu H, Ishikawa M, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shiraishi T, Iyo M

Neuropsychiatric Disease and Treatment 2014, 10:147-151

Published Date: 24 January 2014

Pediatric neurofibromatosis 1 and parental stress: a multicenter study

Esposito M, Marotta R, Roccella M, Gallai B, Parisi L, Lavano SM, Carotenuto M

Neuropsychiatric Disease and Treatment 2014, 10:141-146

Published Date: 22 January 2014

Unmet needs in the management of schizophrenia

Torres-González F, Ibanez-Casas I, Saldivia S, Ballester D, Grandón P, Moreno-Küstner B, Xavier M, Gómez-Beneyto M

Neuropsychiatric Disease and Treatment 2014, 10:97-110

Published Date: 16 January 2014

Measuring quality of sleep and autonomic nervous function in healthy Japanese women

Sato M, Yasuhara Y, Tanioka T, Iwasa Y, Miyake M, Yasui T, Tomotake M, Kobayashi H, Locsin RC

Neuropsychiatric Disease and Treatment 2014, 10:89-96

Published Date: 17 January 2014

Balance deficits and ADHD symptoms in medication-naïve school-aged boys

Konicarova J, Bob P, Raboch J

Neuropsychiatric Disease and Treatment 2014, 10:85-88

Published Date: 15 January 2014

Identifying the affected hemisphere with a multimodal approach in MRI-positive or negative, unilateral or bilateral temporal lobe epilepsy

Zhang J, Liu Q, Mei S, Zhang X, Liu W, Chen H, Xia H, Zhou Z, Wang X, Li Y

Neuropsychiatric Disease and Treatment 2014, 10:71-81

Published Date: 7 January 2014

Relationship between alexithymia and coping strategies in patients with somatoform disorder

Tominaga T, Choi H, Nagoshi Y, Wada Y, Fukui K

Neuropsychiatric Disease and Treatment 2014, 10:55-62

Published Date: 27 December 2013

Ranitidine reduced levodopa-induced dyskinesia in a rat model of Parkinson’s disease

Cui G, Yang X, Wang X, Zhang Z, Yue X, Shi H, Shen X

Neuropsychiatric Disease and Treatment 2014, 10:39-46

Published Date: 18 December 2013

Quality of life measurement and outcome in aphasia

Spaccavento S, Craca A, Del Prete M, Falcone R, Colucci A, Di Palma A, Loverre A

Neuropsychiatric Disease and Treatment 2014, 10:27-37

Published Date: 17 December 2013

Total sleep deprivation decreases flow experience and mood status

Kaida K, Niki K

Neuropsychiatric Disease and Treatment 2014, 10:19-25

Published Date: 12 December 2013

Effects of maternal psychotropic drug dosage on birth outcomes

Michielsen LA, van der Heijden FMMA, Janssen PKC, Kuijpers HJH

Neuropsychiatric Disease and Treatment 2014, 10:13-18

Published Date: 10 December 2013

Salivary alpha-amylase and cortisol responsiveness following electrically stimulated physical stress in bipolar disorder patients

Tanaka Y, Maruyama Y, Ishitobi Y, Kawano A, Ando T, Ikeda R, Inoue A, Imanaga J, Okamoto S, Kanehisa M, Ninomiya T, Tsuru J, Akiyoshi J

Neuropsychiatric Disease and Treatment 2013, 9:1899-1905

Published Date: 6 December 2013

Randomized, placebo-controlled, double-blind study assessing the efficacy and safety of paliperidone palmitate in Asian patients with schizophrenia

Takahashi N, Takahashi M, Saito T, Iizumi M, Saito Y, Shimizu H, Matsumura T

Neuropsychiatric Disease and Treatment 2013, 9:1889-1898

Published Date: 6 December 2013

Navigated transcranial magnetic stimulation in preoperative planning for the treatment of motor area cavernous angiomas

Paiva WS, Fonoff ET, Marcolin MA, Bor-Seng-Shu E, Figueiredo EG, Teixeira MJ

Neuropsychiatric Disease and Treatment 2013, 9:1885-1888

Published Date: 9 December 2013

22q11 deletion syndrome: a review of the neuropsychiatric features and their neurobiological basis

Squarcione C, Torti MC, Di Fabio F, Biondi M

Neuropsychiatric Disease and Treatment 2013, 9:1873-1884

Published Date: 4 December 2013

Sigma-1 receptor concentration in plasma of patients with late-life depression: a preliminary study

Shimizu H, Takebayashi M, Tani M, Tanaka H, Yamagata B, Kurosawa K, Yamada H, Hachisu M, Hisaoka-Nakashima K, Okada-Tsuchioka M, Mimura M, Iwanami A

Neuropsychiatric Disease and Treatment 2013, 9:1867-1872

Published Date: 6 December 2013

Current clinical application of deep-brain stimulation for essential tremor

Chopra A, Klassen BT, Stead M

Neuropsychiatric Disease and Treatment 2013, 9:1859-1865

Published Date: 2 December 2013

Olfactory functions are not associated with autism severity in autism spectrum disorders

Dudova I, Hrdlicka M

Neuropsychiatric Disease and Treatment 2013, 9:1847-1851

Published Date: 27 November 2013

Adjunctive enteral phenobarbital for adult status epilepticus: a brief report

Tiamkao S, Suttapan K, Pranbul S, Tiamkao S, Sawanyawisuth K, Integrated Epilepsy Research group

Neuropsychiatric Disease and Treatment 2013, 9:1829-1834

Published Date: 26 November 2013

Prevalence of Parkinson’s disease and other types of Parkinsonism in Al Kharga district, Egypt

El-Tallawy HN, Farghaly WM, Shehata GA, Rageh TA, Abdel Hakeem NM, Abd Al Hamed M, Badry R

Neuropsychiatric Disease and Treatment 2013, 9:1821-1826

Published Date: 26 November 2013

Asperger syndrome related suicidal behavior: two case studies

Kocourkova J, Dudova I, Koutek J

Neuropsychiatric Disease and Treatment 2013, 9:1815-1819

Published Date: 22 November 2013

Duloxetine in panic disorder with somatic gastric pain

Preve M, Nisita C, Bellini M, Dell'Osso L

Neuropsychiatric Disease and Treatment 2013, 9:1811-1813

Published Date: 21 November 2013

Effectiveness and safety of Nintendo Wii Fit PlusTM training in children with migraine without aura: a preliminary study

Esposito M, Ruberto M, Gimigliano F, Marotta R, Gallai B, Parisi L, Lavano SM, Roccella M, Carotenuto M

Neuropsychiatric Disease and Treatment 2013, 9:1803-1810

Published Date: 15 November 2013

Early resorption of an artificial bone graft made of calcium phosphate for cranioplasty: case report

Monaco BA, Fonoff ET, Teixeira MJ

Neuropsychiatric Disease and Treatment 2013, 9:1801-1802

Published Date: 15 November 2013

Psychiatric comorbidity distribution and diversities in children and adolescents with attention deficit/hyperactivity disorder: a study from Turkey

Yüce M, Zoroglu SS, Ceylan MF, Kandemir H, Karabekiroglu K

Neuropsychiatric Disease and Treatment 2013, 9:1791-1799

Published Date: 14 November 2013

Epidemiology of nonfatal stroke and transient ischemic attack in Al-Kharga District, New Valley, Egypt

Farghaly WM, El-Tallawy HN, Shehata GA, Rageh TA, Abdel-Hakeem NM, Elhamed MA, Al-Fawal BM, Badry R

Neuropsychiatric Disease and Treatment 2013, 9:1785-1790

Published Date: 18 November 2013